Endothelial Function in Women: The Effect of Time of Day, Age, Menopause and Diet. by Walters, Janie Frances.
Endothelial function in women: the effect of 
time of day, age, menopause and diet
by
Janie Frances Walters
A thesis submitted in accordance with the requirements of the 
University of Surrey for the degree of Doctor of Philosophy
Neuroendocrinology Group 
School of Biomedical and Molecular Sciences 
University of Surrey 
Guildford 
Surrey
November 2005
© Janie Frances Walters 2005
ProQ uest Number: U213857
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent on the quality of the copy submitted.
in the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest U213857
Published by ProQuest LLC (2019). Copyright of the Dissertation is held by the Author.
Ail Rights Reserved.
This work is protected against unauthorized copying under Title 17, United States Code
Microform Edition © ProQuest LLC.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 - 1346
11
Abstract
The incidence o f coronary events appears to increase after the menopause and is reported 
to occur more frequently in the morning hours. Endothelial function has been shown to 
exhibit diurnal rhythmicity and is attenuated in postmenopausal women. The protocols 
used to assess this previously have been confounded by environmental factors (e.g. posture, 
meals, lighting, sleep). Hence uncertainty remains as to whether the reported rhythm in 
endothelial function is truly circadian and if  it changes after the menopause.
The effects o f time o f day, age, menopausal status and dietary fat on brachial artery 
endothelial (%FMD) and smooth muscle function (%GTN) was investigated in women 
using non-invasive ultrasound technology.
Endothelial and smooth muscle function was significantly reduced in postmenopausal (n = 
10) compared to pre-menopausal women (n =  11), with no discernable rhythm in %FMD 
either under constant routine (CR) or normal study conditions. In  contrast, a day-night 
variation in %FMD was observed in middle-aged pre-menopausal women (n =  11) in CR 
conditions and in young women (n — T) under normal study conditions. This variation, 
however, did not persist when the data were corrected for ckcadian phase.
The melatonin rhythm was also advanced in postmenopausal women in CR conditions, 
with a significantly earlier acrophase and earlier melatonin onset (P = 0.057; no t quite 
significant). Extended wakefukiess during the CR resulted in a similar reduction in alertness 
and performance in both the pre-menopausal and postmenopausal women.
Ill
A high fat meal, consumed in the evening, did not affect %FMD in young women although 
increased TAG levels were observed.
The results suggest that the time o f day variation in %FMD is not an endogenous Orcadian 
rhythm and is rather a result o f exogenous factors. Impairment o f both  %FMD and % G TN  
with a loss o f  rhythmicity in endothelial function occurs after the menopause.
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Chapter 1. Literature Review
1.1 Cardiovascular System
The circulatory system, composed o f a complex network o f blood vessels, is designed to 
ensure optimal perfusion o f the working tissues through its adaptation to physiological and 
environmental changes. However, in certain instances, such as in the pathogenesis o f 
coronary heart disease (CHD), altered functioning o f the blood vessels can be the primary 
site o f disease development. Cardiovascular disease (CVD) continues to be one o f the 
leading causes o f morbidity in the westernised world (Walker, 2001). Significantly, statistics 
show that while mortality fcom CHD is falling, the number o f people living with the 
condition is increasing and, in older age groups, has risen by around a quarter since the late 
1980s (BHF statistics summary 2005). In  the U K  alone, it is estimated that around 2.6 
million people (BHF statistics summary 2005) either have or have experienced some form 
o f the disease. I t is now widely acknowledged that established coronary risk factors are not 
only significant for men but also for women, especially with increasing age and menopausal 
onset although the latter remains controversial.
Impaired function o f the cells lining the blood vessels (endothelial ceEs) occurs at an early 
stage in the disease process o f atherosclerosis before any clinical symptoms can be 
detected. Consequently, the endothelium has become an important target in climcal 
research and the elaboration o f primary prevention strategies for cardiovascular diseases.
1.1.1 Structure and function o f the lining o f  blood vessels
The walls o f the larger vessels, comprising the arteries and veins, are made up o f  three 
layers: the tunica intima  ^ tuncia media and tunica adventitia (Figure 1.1). The arteries receive 
blood under high pressure from the ventricles o f the heart. They must therefore be able to
stretch each time the heart beats, and sustain the increased pressure. The tunica adventitia
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forms a layer o f connective tissue around the vessel, consisting o f collagen fibres that 
intertwine with those o f adjacent tissues, which stabilise and anchor the vessel. The tunica 
media is the middle layer o f smooth muscle in a framework o f collagen and elastin fibres 
designed to allow the dilation and contraction of the vessel. The tunica intima is the 
innermost layer o f the vessel composed o f the endothelial cell lining and an underlying 
layer o f connective tissue. The endothelium itself consists of flat epithelial cells that are 
packed closely together, forming a smooth layer thus reducing the fiiction between the 
circulating blood and the vessel wall (Mader, 1992).
Tunica intima (endothelial cells)
Elastic tissue
Tunica media (smooth muscle)
Tunica adventitia
(loose fibrous connective tissue)
Figure 1.1 Structure o f  the artery wall (adapted from Mader, 1992)
The arterial endothelium has autocrine, paracrine, and endocrine functions (Bonetti et al.,
2003) and plays an important role m maintaining vascular homeostasis. The circulating 
blood transports oxygen, nutrients and hormones to the tissues and removes carbon 
dioxide and waste products. The exchange o f solutes, macromolecules and leukocytes is 
regulated by the endothelium, whilst maintaining continued blood flow preventing loss o f 
blood constituents and volume (van Hinsbergh and van Nieuw Amerongen, 2002). Intact
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endothelial cells maintain a delicate balance in the vasculature controlling cell growth 
(Scott-Burden and Vanhoutte, 1994), vasoconstriction and vasodilation (Furchgott and 
Zawadski, 1980; Chen et al., 1995), platelet and leucocyte adhesion (Vane et al., 1990) and 
modulation o f thrombosis and thrombolysis (Wu and Thiagarajan, 1996).
1.1.2 The vascular endothelium
Historically, the vascular endothelium was considered to be a passive organ acting solely as 
a selective barrier between the blood and vessels. This view was challenged foEowing the 
discovery o f an ‘endotheEum-derived relaxing factor’ by Furchgott and Zawadski in 1980 
(Furchgott and Zawadski, 1980) highlighting the vasodEatory capacity o f the intact 
endotheEum. Subsequent studies by Ignarro and coEeagues (Ignarro et al., 1987) later 
identified this factor as nitric oxide (NO). Since then, there has been an explosion o f 
research investigating the biochemical and physiological properties o f the endotheEum in 
both health and disease states.
1.1.2.1 Endothelial control o f vascular tone
The abiEty o f the endotheEum to control the tone o f the underlying smooth muscle occurs 
through complex membrane receptor and signal transduction mechanisms, leading to  the 
synthesis or release o f various vasoactive factors, predominantly N O , prostacyclin and 
endotheEum-derived hyperpolarizing factor (EDHF) (Vanhoutte, 2000).
1.1.2.2 Vasodilator actions o f nitric oxide
Nitric oxide is the principal mediator released fiom  the vascular endotheEum. It is 
generated by the conversion o f the amino acid L-arginine to N O  and L-citruEine (Palmer et 
al., 1988) by the enzyme endothelial nitric oxide synthase (eNOS), a constitutively 
expressed 135-kD membrane-bound protein (Lamas et al., 1992). The endotheEum
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responds to a variety o f  physical and chemical stimuli, which regulate the expression o f  the 
eNOS gene. These stimulating factors include shear stress (the frictional force generated by 
the flow o f  blood) (Xiao et al., 1997), hormones such as insulin (Aljada and Dandona,
2000) and oestrogen (Lantin-Hermoso et al., 1997), coagulation factors such as throm bin 
(Yang et al., 1994), inflammatory proteins such as bradykinin (Kuga et a l, 1997), 
neurotransmitters such as 5-hydroxytryptamine (serotonin) (Haugen et a l, 1997), adenosine 
triphosphate (ATP) (Kennedy et al., 1985; White and Angus, 1987), growth factors (Hood 
et a l, 1998) and vasoconstrictor peptides such as endothehn (CardElo et al., 2000) and 
angiotensin II (Hennington et a l, 1998). In addition, N O  itself may act as a negative 
feedback regulator o f its own biosynthesis (Yao and Huang, 2003).
Stimulation o f the endothelium causes a variety o f  signal transduction mechanisms 
including changes in the membrane potential, activation o f  guanine nucleotide-binding 
proteins (G-protein-coupled receptors), tyrosine kinase activation, protein phosphorylation 
and the activation o f  transcription factors (Davies, 1995).
Shear stress acting on endothelial cells is the major physiological stimulus o f vascular N O  
production (Pohl et a l, 1986). Shear stress induced eNOS activation is thought to be 
mediated by activation o f ion channels, cell hyperpolarization (le. an increase or decrease 
in cell polarity, thus becoming more or less positive or negative), elevation o f  the 
intracellular calcium ion (Ca^^ concentration and protein phosphorylation by a 
serine/threonine protein kinase (Dimmeler et a l, 1999). Proposed mechanisms by which 
the endothelium senses alterations in shear stress levels involve opening o f 
mechanosensitive cation channels, inducing Ca^^ entry and simultaneous activation o f 
hyperpolarizing potassium ion (K ^ currents and membrane hyperpolarization, respectively, 
as part o f the very rapid response to elevated shear stress (Lansman et al., 1987; Hoyer et
Chapter 1_______________________________________________________________________6_
aL, 1998). Nitric oxide is released from the endothelium and diffuses into the underlying 
vascular smooth muscle. It then binds to and activates the intracellular enzyme soluble 
guanylyl cyclase (sGC), resulting in an increase in the levels o f cyclic guanosine-3’,5’- 
monophosphate (cGMP) (Ignarro et al., 1986). Cyclic GMP activates GMP-dependent 
kinases, leading to a downstream signal cascade ultimately causing a decrease in intracellular 
Ca^^ levels which results in vasodilatation (Ignarro, 1990) (Figure 1.2). Generation o f  N O  
continues until intracellular Ca^^ returns to basal levels (Feron et al., 1998).
In addition to its role in the regulation o f  vascular tone, N O  inhibits platelet activation, 
leukocyte recruitment, smooth muscle cell proliferation and has antioxidant properties 
(Vallance and Chan, 2001). Thus, endothelium-derived N O  is a substantial contributor to 
homeostatic vascular function.
Shear Stress
Stress Activated 
Gatechannel
ENDOTHELIAL CELL
NOS + 0;
'+ L-citrulline
NOL-arginine
NO
NO
CONTRACTION
GTP
RELAXATION^ '
VASCULAR SMOOTH MUSCLE CELL
Figure 1.2 Endothelial cell stimulation and NO-mediated vasodilatation (adapted from Vanhoutte, 2000). 
NOS: Nitric oxide synthase; 02-: oxy gen; Ca2+: Calcium ions; K+: Potassium ion; NO: Nitric oxide; 
GTP: Guanosine-5’-triphosphate; cGMP: Cyclic guanosine monophosphate; G: G-protein.
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1.1.2.3 Relationship between peripheral and coronary circulation
The significance o f  N O  in the regulation o f  coronary and systemic vascular tone has been 
demonstrated by inhibiting endogenous N O  production with the competitive inhibitor 
NG-monomethyl-L-arginine (l-NMMA). Infusion o f l-NMMA into the coronary arteries 
o f  patients with angiographically normal arteries results in increased vascular resistance and 
decreased blood flow as a result o f arteriolar vasoconstriction (Quyyumi et al., 1995). In 
patients with one or more coronary risk factors L-NMMA adrninistrafion causes minimal 
constriction, suggesting a deficiency in endothelium-derived N O  in these patients 
(Quyyumi et aL, 1995). Changes in regional N O  production following infusion o f  L- 
NMMA, have also been shown to occur alongside changes in vascular resistance in the 
brachial artery (Shiode et al., 1996). In addition, studies have demonstrated a close 
relationship between the coronary and peripheral circulation in humans (Anderson et al., 
1995; Takase et al., 1998). Anderson et al. (1995) showed that in patients with coronary 
artery endothelial dysfunction (defined as vasoconstriction in response to acetylcholine), 
flow-mediated brachial artery dilatation (FMD) was significantly impaired in comparison 
with that o f patients with normal coronary artery endothelial function (Anderson et aL,
1995). Similarly, Takase et al. (1998) reported a significant correlation between abnormal 
coronary and brachial FMD in patients with suspected coronary artery disease (CAD) 
(Takase et al., 1998).
1.1.2.4 Endothelial dysfunction
Disruption o f the functional integrity o f the vascular endothelium plays a critical role in the 
development o f atherosclerosis, preceding structural alterations in the vasculature (Luscher 
and Barton, 1997; Behrendt and Ganz, 2002). Endothelial dysfunction is characterised by 
an imbalance o f endothelium-derived relaxing and contracting factors (Luscher and Barton,
1997), favouring vasoconstriction, platelet aggregation, white blood cell adhesion and
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smooth muscle cell proliferation (Russo et al., 2002). Dysfunction o f the endothelium 
occurs as a consequence o f inactivation, pathway imbalance and reduced bioavailability o f 
N O , owing to  locally enhanced production o f  reactive oxygen species (ROS) including 
superoxide anion (O^), hydrogen peroxide (H^Og), peroxynitrite (O N O O ), hydroxyl 
radicals (O H ) and oxidised low-density lipoprotein (LDL^J (Behrendt and Ganz, 2002; Li 
and Shah, 2004). Excessive production o f ROS together with high intimai levels o f  LD L 
may lead to the increased generation o f LDL^^ (Sattar et al., 1998). Oxidised LDL has been 
shown to stimulate the production o f HgOg, leading to an increase in endothelial cell 
proliferation and reduced N O  synthesis (Chin et al., 1992). The oxidative enzymes 
responsible for increased oxidative stress include nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase, xanthine oxidase and NOS itself (Cooke, 2000). In 
conditions o f reduced availability o f L-arginine or tetrahydrobiopterin (a cofactor requited 
for NOS activity), the preferred substrate is oxygen, producing superoxide (Vasquez-Vivar 
et al., 1998; Xia et al., 1998). Superoxide production by vascular tissues is thought to play a 
central role as the source for many other ROS (Kojda and Harrison, 1999) and has been 
shown to be increased in animal models o f vascular disease such as hypercholesterolaemia 
(Ohara et al., 1993), hypertension (Grunfeld et aL, 1995) and diabetes (Pieper et al., 1997). 
ROS elicit their effects on vascular tone by influencing intracellular signalling events. An 
increase in vascular Ca^^ concentrations by ROS occurs through stimulation o f  inositol- 
phosphate mediated Ca^^ mobilization, increased cytosolic Ca^^ accumulation and increased 
Ca^^ influx through Ca^^ channels, leading to enhanced vasoconstriction (Volk et aL, 1997; 
Graier et al., 1998; Az-ma et aL, 1999; Tabet et al., 2004).
Several human clinical studies have reported enhanced oxidative stress in heart failure 
associated with increased radical formation (Ghatak et al., 1996; Keith et al., 1998; EUis et 
al., 2000; Tsutsui et aL, 2002; W ohfam et al., 2005). In the healthy vessel, the biological
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activity o f ROS is maintained by antioxidant enzymes, such as glutathione peroxidase, 
superoxide dismutase (SOD), catalase and thioredoxin which act as potent scavengers 
(Zardi et al., 2005). In  patients with CAD, vascular activity o f  endothelium-bound SOD is 
substantially reduced and is positively correlated with the degree o f  endothelium-dependent 
vasodilatation (EDV) (Landmesser et al., 2000; 2002).
Reduced formation o f N O  as a consequence o f altered eNOS expression may also 
contribute to endothelial dysfunction. Expression o f eNOS by endothelial cells is subject 
to modulation by shear stress (Ranjan et al., 1995), atherogenic lipoproteins (Hicata et al., 
1995; Liao et al., 1995) and cytokines (Yoshizumi et al., 1993). Increased circulating levels 
o f eNOS inhibitors, such as asymmetric dimethylarginine (ADMA) and N - 
monomethylarginine (NMA) may also affect eNOS activity at the posttranslational level 
(Cooke, 2000). ADMA, in particular, has been shown to be elevated in patients with CAD 
disease (Usui et al., 1998; Saitoh et al., 2003), hypercholesterolaemia (Boger et al., 1998), 
hypertension (Takiuchi et al., 2004) and in those patients at risk o f CVD (Lundman et al., 
2001, Valkonen et al., 2003) and is inversely correlated with ED V  (Boger et a l, 1998; 
Takiuchi et al., 2004).
Increased free radical production associated with oxidative stress has been shown to result 
in a loss o f nuclear telomere reverse transcriptase (TERT) activity (Haendeler et al., 2003). 
The process o f telomere shortening is counteracted by the activity o f  the enzyme TERT. 
Telomeres are essential for the integrity o f  somatic chromosomes and during each D N A  
(deoxyribonucleic acid) replication cycle, telomere lengths are shortened. Telomere length, 
in vivo, is inversely correlated to endothelial cell age (Chang et al., 1995; Okuda et al., 2000; 
Aviv et al., 2001). Treatment o f cultured endothelial cells with antioxidants and statins can 
restore TERT activity and prevent the onset o f endothelial cell senescence (Haendeler et
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al., 2004). In postmenopausal women, long-term treatment (> 5 years) with combination 
hormone replacement therapy (HRT) has been shown to be associated with longer 
telomere lengths compared with untreated postmenopausal women (Lee et al., 2005).
1.1.3 Postprandial triglyceride metabolism and cardiovascular risk
Postprandial triglyceride QTAG) metabolism refers to the metabolic events that occur 
following the ingestion, digestion and absorption o f a meal containing fat (Sethi et al., 
1993). Dietary fat is principally composed o f TAG, which following digestion and 
absorption stimulates the production o f  chylomicrons (CM) within the in testinal 
enterocyte (Carey et al., 1983), Chylomicrons are triglyceride-rich lipoproteins that are 
secreted from the enterocyte where they acquire apolipoproteins and transport exogenous 
dietary TA G  within the circulation. These surface components are transferred into CM 
from high-density lipoproteins (HDL) along with free and esterified cholesterol and 
phospholipids. The resultant chylomicron remnant (CMR) is catabohsed by the liver. The 
final composition o f  the triglyceride-rich lipoprotein (TRL) remnant is modulated by 
reaction o f  the cholesterol ester transfer protein (CETP) with HDL and hepatic lipase (HL) 
(reviewed in Karpe, 1999) (Figure 1.3). The removal o f  CM TAG is catalysed by adipose 
tissue lipoprotein lipase (LPL), the rate-limiting hydrolytic enzyme, which controls 
triglyceride-rich lipoprotein removal from the circulation (Goldberg, 1996). LPL is also 
present in other tissues with a high fatty acid requirement, including skeletal and cardiac 
muscle (Blanchette-Mackie et al., 1989; Kiens et al., 2004).
Following meal ingestion, insulin secretion stimulates adipose LPL activity and inhibits 
LPL activity in other tissues (Knutson, 2000). As the core TA G  becomes progressively 
smaller, surface materials are transferred to H D L to maintain the stability o f  the CMR. 
Hydrolysis o f CM TAG by LPL results in smaller, relatively protein-enriched particles with
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a redundant surface coating o f  free cholesterol and phospholipid and generates 
monoacylglycerol and non-esterified fatty acids (NEFA). M ost o f these hydrolytic products 
are rapidly transported across the endothelium into parenchymal cells, where they are re- 
esterified into TAG for storage in adipose tissue. LPL activity determines the extent and 
duration o f  postprandial lipaemia. The resultant chylomicron remnant is catabolised by the 
liver. Very-low density lipoproteins (VLDL) are synthesised in the liver firom CMR, from 
where they are released into the circulation acting as transport vesicles for TAG. These 
molecules are highly susceptible to hydrolysis by LPL and as such are the precursor 
molecules o f LDL, which are involved in the transport o f cholesterol to the peripheral 
tissues. The majority o f  remnants are removed firom the plasma by receptor-mediated 
processes, principally involving the LDL-receptor (LDDR) (reviewed in Karpe 1999) 
(Figure 1.3).
TRL
LDL-R
HL
CETP
LIVER
VLDL-R
CMR
VLDL LPL
CHYLOMICRON
7
INTESTINE
Figure 1.3 Postprandial triglyceride metabolism (Adapted from Karpe, 1999)
CM: Chylomicrons; HDL: High density  ^lipoprotein; CMR: Chylomicron remnant; TRL: Triglyceride-rich 
lipoprotein remnant; CETP: cholesterol ester transfer protein; HL: Hepatic lipase; \T D L : Very low density  ^
lipoprotein; LP: Lipoprotein lipase; \T DL -R : \TDL-remnants; LDL-R: Low-density lipoprotein receptor.
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The magnitude o f postprandial lipaemia varies greatly among individuals reflecting 
differences in the capacity to metabolise dietary fat and the influence o f meal composition, 
meal timing and physiological factors such as body weight, age and gender. Lower 
concentrations o f  TAGs, total and LDL cholesterol and higher H DL cholesterol have been 
reported in pre-menopausal women compared with men (Koutsari et al., 2004; Tentor et 
al., 2005). The cicculating levels o f plasma TAG also show arcadian rhythmidty, with 
increased levels during the night associated with increased insulin resistance (Morgan et al., 
1998). The nocturnal increase in plasma TAG levels is exaggerated following consumption 
o f a meal at night and is both higher and elevated for longer in men compared with women 
(Sopowski et al., 2001).
Whilst TAG itself is not a component part o f the atherosclerotic lesion, elevated 
postprandial TAG concentrations lead to the production of atherogenic chylomicron 
remnants. These remnants have the ability to mediate cholesterol influx into the arterial wall 
intima, thereby promoting atherogenesis (Halle et al., 1999). Elevated postprandial lipaemia 
promotes the catabolism o f HDL (Guerin et al., 2002), low concentrations o f HDL- 
cholesterol being associated with an increased risk o f CHD (Boden, 2000). Postprandial 
hypertriglyceridaemia also stimulates the formation o f small dense LDL (Blackburn et al., 
2003), which are highly atherogenic and significantly increase the risk (4 to 6-fold) o f CHD 
(Griffin et al., 1994). TAG-rich lipoproteins have the abihty to activate coagulation factor 
VII (Roche & Gibney, 1997), which is positively associated with CHD mortality (Ruddock 
& Meade, 1994). Thus, the combination o f these factors underlies the positive association 
between postprandial TAG metabolism and the risk o f CHD (Roche, 1999).
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1.1.4 Factors affecting endothelial function
The traditional risk factors for CHD, which include hypercholesterolemia, cigarette 
smoking, diabetes meUitus, high-fat diets, increasing age, male gender and family history o f  
premature vascular disease have aU been associated with impairments in endothelial 
function (Celermajer et al., 1994a). Modification o f  these conditions, with dietary and 
lifestyle changes and therapeutic interventions, improves both endothelial function and 
coronary artery disease outcomes (Cooke, 1997).
1.1.4.1 Diet
Dietary intake is associated with both acute and chronic effects on the cardiovascular 
system leading to the development o f conditions such as obesity, type II diabetes and 
hypertension (de Koning and Rabelink, 2002). The acute effect o f various dietary 
components on the vasculature, in particular glucose and lipids, and their role in the 
aetiology o f cardiovascular disease has been extensively studied.
The western diet typically contains high amounts o f fat and sugars. Long-term 
consumption o f high-fat foods leads to hyperHpidaemia and an increased risk o f  
atherosclerosis (Grundy and Denke, 1990). Studies investigating the effects o f eating a 
high-fat meal on vascular function have provided conflicting reports. Transient changes in 
endothelial function, with impaiced FMD 3-4 hours following consumption o f  a liquid fat 
load or a high fat meal in healthy subjects has been reported by several groups (Williams et 
al., 1999; Marchesi et al., 2000; Gaenzer et al., 2001; Gokce et al., 2001; Schinkovitz et al., 
2001; Steer et al., 2003). Contrary to these findings, some authors have reported no change 
in endothelial function after a high fat meal (Djousse et aL, 1999; Raitakari et aL, 2000b; 
Katz et al., 2001; Sejda et al., 2002). The discrepancy in results can be partly explained by 
the differences in Hpid composition between the different test meals, the existing levels o f
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circulating Hpids, comparative differences in the time intervals between measurements and 
gender differences. The impairment in endothelium-dependent function following an oral 
fat load seen in healthy men with normal fasting lipid values is not observed in healthy age- 
matched pre-menopausal women (Schülaci et al., 2001).
Several studies have reported transient endothelial dysfunction in healthy subjects 
following an oral glucose load (WiUiams et al., 1998; Kawano et al., 1999; Title et al., 2000). 
Postprandial hyperglycaemia occurs when the homeostatic mechanisms that minimise 
glucose fluctuations and restore normal glucose levels after a meal, insuHn-mediated 
glucose uptake and suppression o f cicculating free fatty acids, are impaired (Heine et aL,
2004). In patients with type 11 diabetes, impaired endothelial function is akeady present in 
the fasting state (Anderson et al., 2001), however, a significant decline in FMD still occurs 
after an oral glucose challenge in these patients (Lee et al., 2002).
Both hyperHpidaemia and hyperglycaemia have been postulated to impaic endotheHum- 
dependent vasodilatation via an increased production o f vasoconstricting agents or 
generation o f reactive oxygen species, such as superoxide anions (Kawano et al., 1999; 
Marfella et al., 2001; Ceriello et al., 2002; Tsai et al., 2004). This hypothesis is further 
supported by the evidence that endothelial dysfunction induced by postprandial 
hypertriglyceridaemia can be reversed by the addition o f antioxidant vitamins (Plotnick et 
al., 1997) or by changing to a healthier diet with a greater antioxidant content (Vogel et al., 
2000b).
1.1.4.2 Alcohol
The effects o f alcohol on the cardiovascular system are dependent on the degree o f 
consumption, with heavy alcohol intake associated with an increased risk o f  CAD and
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stroke, whilst light to moderate alcohol intake may confer a protective effect (Puddley et 
al., 2001). The beneficial effects o f  alcohol consumption on reducing coronary risk may 
include effects on lipid metabolism with an increase in H D L cholesterol levels and 
decreased oxidation o f LDL cholesterol (Baer et al., 2002; Wannamethee et al., 2003), 
improved insulin sensitivity (Kiechl et al., 1996), decreased platelet agrégation and 
fibrinogen levels (Pellegrini et aL, 1996) and lower levels o f inflammatory markers (Im hof 
et al., 2001; Volpato et aL, 2004). Endothelial function has also been shown to improve in 
people who consume Light or moderate amounts o f alcohol (Vlachopoulos et al., 2003). In 
particular, consumption o f  red wine, with its antioxidant content o f  polyphenols and 
flavenoids, has been shown to acutely improve endothelial function in both  healthy 
subjects (AgewaU et aL, 2000, Hashimoto et al., 2001) and in individuals with established 
CAD (Whelan et al., 2004). Studies have also shown an acute effect o f  red wine on the 
expression and activation o f eNOS, leading to increased production o f endothelial N O  
(WaUerath et al., 2003).
1.1.4.3 Caffeine consumption and cigarette smoking
Caffeine, widely consumed in the form o f coffee, tea, carbonated drinks, chocolate as well 
as prescription and non-prescription drugs (such as stimulant tablets, drinks and chewing 
gum) is one o f  a group o f  naturally occurring plant-derived chemicals (methylxanthines) 
(Lapeyre 3rd et al., 2004). Caffeine has been shown to acutely raise both systolic and 
diastolic blood pressure (Mahmud and Feely, 2001; Waring et aL, 2003). Consumption o f  
coffee (80 mg caffeine representative o f an average measure) has also been shown to 
acutely decrease FMD in healthy young subjects with no effect following consumption o f  
decaffeinated coffee (<2 m g caffeine) (Papamichael et al., 2004). The mechanism by which 
caffeine exerts its effects on the vascular system may, in part, be mediated via adenosine 
receptor antagonism. Activation o f specific adenosine receptors is thought to be one o f  the
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mediators leading to vasodilatation (Shtyock and BelardineUi, 1997; Yen et al., 1988; 
Olanrewaju and Mustafa, 2000). Adenosine, produced by the tissues under stress in order 
to increase the energy supply and thus decrease the energy demand (Voet and Voet, 1995), 
is thought to decrease the production o f catecholamines and renin, potent 
vasoconstrictors. Competitive binding o f caffeine to the adenosine receptor, is known to 
increase these compounds (Tofovic et al., 1991) leading to peripheral vasoconstriction in 
systemic arteries (Smits et al., 1990).
Cigarette smoking is a potent modifiable risk factor for CVD. Exposure to both active and 
passive cigarette smoke inhalation has been shown to impair ED V  in humans (Celermajer 
et al., 1993; 1996; McVeigh et al., 1996; Woo et al., 2000; Esen et aL, 2004; Papmichael et 
al., 2004). The smoking-related endothelial dysfunction appears to be dose-dependent, 
associated with the number o f years and quantity o f cigarettes (Hght, moderate or heavy) 
smoked (Celermajer et al., 1993). Circulating levels o f antioxidant vitamins, such as 
vitamins C and E  and beta carotene are reduced in smokers (Chow et aL, 1986; Mezzetti et 
aL, 1995; Motoyama et al., 1997). Oral adrninistrafion o f  vitamins C and E  (Raitakari et aL, 
2000a; Takase et al., 2004; Teramoto et al., 2004) and L-arginine (Adams et al., 1997) 
appears to provide short-term improvements in endothelial function.
The mechanisms underlying the effects o f cigarette smoke on the vasculature are no t 
completely understood. Evidence from in vitro studies has shown that serum from smokers 
has a direct toxic effect on cultured endothelial cells, resulting in alterations in the levels o f 
endothelium-derived fibrinolytic and antithrombotic factors (Barua et aL, 2002), 
upregulafion o f proinfiammatory adhesion molecules (Adams et al., 1997; Stone et al., 
2002) and increased generation o f superoxide anions (Jaimes et al., 2004). Free radicals 
produced as a consequence o f smoking may accelerate lipid peroxidation leading to  an
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increase in the formation o f LDL^,.. Indeed, studies have shown that smoking leads to an 
increase in the levels o f circulating products o f lipid peroxidation (Morrow et al., 1995) and 
increased plasma levels o f autoantibody titers to  (Heitzer et al., 1996).
1.1.4.4 Exercise
Epidemiological evidence shows that regular moderate exercise reduces coronary risk and 
cardiovascular morbidity in both men and women (Paffenbarger et al., 1993; Wannamethee 
et al., 1998; Haapanen-Niemi et al., 2000; Sesso et a l, 2000). The effects o f exercise include 
beneficial effects on blood pressure (Brownley et al., 1996; Seals et al., 1997; Dengel et al.,
1998), hpid (Heath et al., 1983; Wei et al., 1997; GUI et al., 2004) and glucose metabolism 
(van Dam  et al., 1998) and changes in vascular tone with improvements in endothelial 
function in the coronary (Hambrecht et al., 2000) and peripheral circulation in both healthy 
individuals (Clarkson et al., 1999; Desouza et al., 2000) and patients with CAD (Gokce et 
al., 2002; Walsh et al., 2003; Edwards et al., 2004). The proposed mechanism for the 
observed improvement in endothelial function as a result o f exercise, is via an increase in 
N O  production (Maeda et al., 2001; Edwards et al., 2004) and enhanced antioxidant 
systems including SOD and glutathione peroxidase, resulting in decreased oxidative stress 
(Edwards et al., 2004).
1.1.4.5 Temperature
It is well known that short-term climactic changes transiently influence cardiovascular 
mortality, with the onset o f winter associated with an increased incidence o f  coronary 
events (Marchant et al., 1993; Spencer et al., 1998; Kloner et al., 1999; A m tz et aL, 2000; 
Gemmell et al., 2000; Stewart et al., 2002). The major physiological response to  cold 
exposure is peripheral vasoconstriction, which restricts the transfer o f heat from the 
internal organs, via the skin, to the environment. In contrast, an increase in core or skin
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temperature induces peripheral vasodilation (Van Someren et aL, 2002). Cold exposure, via 
whole body cooling, has been shown to impart endothelium-dependent function in healthy 
subjects (Leppert et al., 1995; Ringqvist et al., 1998) associated with increased circulating 
levels o f  cGMP (Leppert et aL, 1995).
1.1.4.6 Family history
A family history o f cardiovascular disease is associated with impaired endothelial function 
and increased coronary risk (Celermajer et aL, 1994a; Clarkson et al., 1997; Schachinger et 
al., 1999; de Jongh et al., 2002; Hamburg et al., 2004). The influence o f  a positive family 
history is independent o f  the other well known risk factors (Clarkson et al., 1997) bu t also 
contributes to the endothelial dysfunction associated with hypercholesterolaemia (de Jongh 
et al., 2002) and increasing age (Celermajer et al., 1994a), su^esting  im portant additive 
effects o f genetic and environmental factors.
1.1.4.7 Ageing and gender
Increasing age is an independent risk factor for CVD and is associated witii a progressive 
decline in ED V  in resistance and conduit vessels (Celermajer et al., 1994b; Taddei et aL, 
1995; Sarabi et aL, 1999; Taddei et al., 2001; Desouza et al., 2002). Proposed mechanisms 
for the age-related decline in endothelial function include increased production o f 
cyclooxygenase-dependent endothelium-derived constricting factors and enhanced 
oxidative stress (Taddei et al., 1997; 2001). However, the exact mechanism /s remain to  be 
fuUy elucidated.
In  addition to age, male gender is considered to be a major cardiovascular risk factor. FMD 
appears to be preserved in men under 40 years o f age and in women up to  the age o f  50, 
around the time o f the menopausal transition (Celermajer et al., 1994b). W hether the
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decline in endothelial function occurs at the same (Jensen-Urstad and Johansson, 2001) or 
a greater rate (Celermajer et al., 1994b) in women, than in men, after the age o f fifty 
remains controversial. Possible reasons for the gender difference in FMD with age include 
changes in circulating levels o f oestradiol in women before and after the menopause 
(Taddei et al., 1996). However, consideration o f gender differences in vessel size m ust be 
taken into account when interpreting the results o f these studies Qoannides et al., 2002).
1.1.5 Oestrogen and the vascular system
Oestrogen receptors are found throughout the arterial tree. The variations in oestrogen 
concentrations during the menstrual cycle are reflected in changes in the levels o f  various 
circulating factors including N O , vascular endothelial growth factor (VEGF), adhesion 
molecules and homocysteine (Williams et al., 2001).
1.1.5.1 Cardio protective properties o f oestrogen 
The cardio protective effects o f oestrogen are partly associated with the direct effects o f 
oestrogen on the endothelium via ceE surface receptors (Russell et al., 2000). Physiological 
levels o f  oestradiol have been shown to induce both endothelium-dependent and 
endothelium-independent relaxation in animal and human coronary arteries (Mugge et al., 
1993; Chester et al., 1995; Ma et al., 1997). In vitro studies have shown that relaxation o f 
pre-contracted human coronary arteries in response to 17B-oestradiol is greater in arteries 
obtained ftom  women compared with those obtained ftom  men (Mugge et a l, 1993). 
Oestrogen also appears to have antioxidant properties. Studies have shown that exposure 
o f cultured endothelial cells to 17B-oestradiol can protect against lipid peroxidation (Yen et 
a l, 2001) and reduce the production o f ROS (Wagner et al., 2001; Yen et a l, 2001). 
Vascular reactivity to exogenous melatonin (see section 1.2.5.2) has also been shown to
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vary over the oestrous cycle in animals, with circulating levels o f oestradiol associated with 
enhanced melatonin MT2 receptor-mediated vasodilatation (Doolen et al., 1999).
1.1.5.2 Menstrual cycle changes in endothelial function
Natural hormone fluctuations during the menstrual cycle are associated with changes in 
lipoprotein composition (Kim and Kalkhoff, 1979; Tonolo et al., 1995), N O  (Teran et al., 
2002), V EG F (Agrawal et a l, 1999), and P-selectin (Jima et al., 1996). Studies have shown 
that ED V  o f  the brachial artery increases ftom  the menstrual to late follicular phase, 
decreases in the early luteal phase and increases again in the late luteal phase (Hashimoto et 
al., 1995; Kawano et al., 1996; English et a l, 1998; Chan et al., 2001; Williams et a l, 2001). 
These changes are coincident with changes in the levels o f  endogenous oestrogens during 
the menstrual cycle, which rise during the early stages o f the cycle, fall during early luteal 
development and rise slightly during the remainder o f the cycle.
Cardiovascular risk has been associated with a lifelong history o f  menstrual irregularity in 
both  young and middle-aged women (La Vecchia et a l, 1987). This finding combined with 
the increased cardiovascular risk after the menopause (section 1.1.4.7) (Taddei et al., 1996; 
McCrohon et al., 2000) provides strong evidence to support an interaction between 
circulating oestradiol levels and cardiovascular function in women.
1.1.5.3 Effect o f  oral contraceptives
Epidemiological studies have suggested an increased risk o f cardiovascular disease in 
women taking high dose combination oral contraceptives (OCs) (Tanis et al., 2001). So- 
called third generation OCs, with lower doses o f  oestrogen and synthetic progestérones 
have been reported to have a lower cardiovascular risk potential bu t are still associated with 
potential atherothrombotic disease (Lewis et al., 1993; Spitzer et al., 1996). However, low
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dose combination OCs do not appear to affect endothelial function in pre-menopausal 
women (John et al., 2000; Merki-Feld et al., 2002; Virdis et al., 2003).
1.1.5.4 Menopause
The menopause is associated with a number o f  changes in the coronary risk factor profile 
that may affect endothelial function. A significant increase in serum cholesterol precedes 
the natural menopause by several years (Akahoshi et al., 1996; 2001). Studies have shown 
that the menopausal transition is associated with increased levels o f LD L cholesterol and 
TAGs and reduced H D L cholesterol levels (Adams et al., 1997). Postprandial TAG levels 
have been shown to be higher in postmenopausal women when compared to pre­
menopausal women following an oral fat load (Adams et aL, 1997).
High oestrogen levels are associated with greater fibrinolytic activity and lower 
plasminogen activator (PAI-1) levels (Gebara et al., 1995). Consequently, the menopause is 
associated with changes in haemodynamic function with increased blood pressure 
(Amigoni et al., 2000) and a decrease in the nocturnal fall in blood pressure (Sherwood et 
al., 2001). There are also reports o f  changes in body fat distribution in postmenopausal 
women with an accumulation o f abdominal and intra-abdominal fat (Soler et al., 1989; Ley 
et al., 1992). Some authors have suggested that these changes are a result o f  the level o f 
physical activity in postmenopausal women, rather than due to changes in oestrogen levels 
(BCanaley et a l, 2001). Adipose tissue is an im portant source o f several cytokines that may 
influence endothelial function and atherosclerotic plaque development, such as interleukin- 
6 (IL-6), leptin and possibly resistin (Chu et al., 2001).
Smoking alters the metabolism o f oestradiol, causing more to be converted to  its less 
biologically active derivatives (Comuz et ai, 1999), thus women who smoke tend to have
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lower levels o f oestrogen, and this may be an additional contributor to theit increased 
coronary risk (section 1.1.4.3).
Large scale studies have shown that the age-related decline in endothelial function occurs at 
a steady rate in women up until menopausal age (early to mid 50s), at which time there is a 
rapid decline in endothelial function compared with men (Celermajer et al., 1994b). In 
older normotensive and hypertensive women (> 60 years o f age), age-related endothelial 
dysfunction is similar to that o f men o f the same age (Celermajer et al., 1994b, Taddei et al.,
1996). The addition o f coronary risk factors, such as hypercholesterolaemia, has been 
shown to further reduce the endothelial response to reactive hyperaemia in 
postmenopausal women (Sanada et al., 2003a). An impaired response to sublingual glyceryl 
trinitrate (GTN) in postmenopausal (61 ±  3 years) women compared with younger pre­
menopausal (28 ±  5 years) women has also been reported (McCrohon et al., 2000). O ther 
studies in contrast have reported a weak correlation between endothelium-independent 
function (measured in response to  sodium nitroprusside) and age (Taddei et al., 1996) or 
no difference with increasing age (Celermajer et al., 1994b) in both men and women. The 
results ftom  these studies suggest that the physiological changes associated with the 
menopausal transition are independently associated with changes in both endothelial and 
smooth muscle function.
1.1.5.5 Horm one replacement therapy (HRT)
Results ftom  a large prospective study (Nurse’s Health Study; 1980-1994), investigating the 
effects o f HRT as a secondary prevention in women with documented atherosclerosis or 
history o f previous myocardial infarction (MI) showed that the cardiovascular mortality 
rate was lower in women on long-term HRT compared to those women who had never 
received HRT. N o dear differences were observed between those women on oestrogen
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alone compared to those on combined therapy (Grodstein et al., 1997). The results o f 
similar studies are inconsistent. The HERS study (Heart Estrogen-Progestin Replacement 
Study; 1990-1994) was the first large-scale clinical trial to investigate the efficacy and safet)'  ^
o f  HRT on the cardiovascular disease outcome in postmenopausal women. The study 
showed no significant difference between the outcome o f the groups on HRT or placebo 
(HuUey et al., 1998). Prospective analysis o f the HERS has suggested that HRT may 
increase the risk o f  adverse coronary events during the initial treatment period (Hulley et 
al., 1998). These results have induced caution regarding the use o f commonly prescribed 
doses o f HRT for women with CAD (Smith et al., 2001). In  comparison, low-dose HRT 
has been reported to be as effective as commonly prescribed doses for long-term 
cardiovascular protection (Grodstein et a l, 2000) in healthy postmenopausal women. 
Improved endothelial function in systemic arteries has been demonstrated following short- 
and long-term administration o f o estro^n , with or without progesfins in both healthy 
postmenopausal women (Lieberman et al., 1994; McCrohon et al., 1996; Tagawa et al., 
1997; Al-Khahh et a l, 1998; Bush et a l, 1998; Gerhard et a l, 1998; Guzic-Salobir et al., 
2001; Higashi et al., 2001; Sanada et al., 2001a; 2001b; 2002) and in women with CAD 
(Herrington et al., 1999; Sitges et al, 2001; Blumel et al., 2003).
Low-dose HRT has also been shown to improve both endothelial function and lipid 
profiles in postmenopausal women (Mercuro et al., 2003; Sanada et al., 2003b; Wakatsuki et 
al., 2004). The potential cardiovascular benefits o f  lower doses o f  oestrogens and 
progesfins may thus improve longer term use o f HRT in postmenopausal women at risk o f  
CHD.
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1-1.6 Endothelium-independent function
Nitrates are widely used in the management o f CAD in patients with angina, acute MI and 
congestive heart failure. The therapeutic efficacy o f  these drugs is due to peripheral venous 
and arterial dilatation that results in decreased myocardial oxygen consumption (Münzel,
2001). G TN  is commonly used in research as a method o f assessing endothelium- 
independent function since it acts ditectly on the underlying smooth muscle independently 
from the vascular endothelium (see Section 1.1.7.2). G TN  is readily absorbed through the 
sublingual mucosa and skin and has a short life estimated at 1-4 minutes (up to 40 minutes 
for the clearance o f its dioitrate metabolites) (Jensen and Dahl, 1994; Jensen and 
Mikkelsen, 1997). It is assumed that G TN  induces vasorelaxation by releasing N O  via an 
enzymatic biotransformation step, with 1,2-glyceryl dinitrate being the predominant 
metabolite (Kawamoto et al., 1990). G TN  bio transformation is both tissue and cell specific 
and dose-dependent (Chen et al., 2002). The principal mechanism o f  GTN-induced 
smooth muscle relaxation is via the activation o f  the sGC/ cGM P/ protein kinase signalling 
pathway (KatsuM et aL, 1977; Axelsson et al., 1979; Ignarro and Gruetter, 1980; Ignarro et 
al., 1981; Brien et al., 1988). Several enzymes are known to metabolise G TN  including 
glutathione S-transferase (Yeates et al., 1989), cytochrome P450 (Doel et al., 2001), 
xanthine oxidoreductase (Bennett et al., 1992) and mitochondrial aldehyde dehydrogenase 
(Chen et al., 2002). However, the exact molecular mechanisms involved are no t known and 
m ore recent studies have suggested that GTN-induced vasodilatation occurs w ithout 
intermediate N O  production (Kleschyov et aL, 2003). One proposed mechanism for the 
metabolic activation o f G TN involves its enzymatic conversion to an J-nitrosothiol 
compound in the presence o f  cysteine and stimulation o f soluble GC by this N O  adduct, 
either directly or indirecdy via the release o f N O  (Ignarro et al., 1981; Yeates et aL, 1985; 
Kurz et al., 1991; Kearney et al., 1998).
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1.1.7 Methods used in the assessment o f endothelial function
Direct measurement o f  N O  m vivo is extremely difficult due to its very short half-life and 
radical nature (von Bohlen und Halbach, 2003) and the uncertainty o f its o r i ^  when 
assessing biological samples. Measurement o f  endothelium-dependent, NO-mediated 
function has therefore emerged as a useful method to assess the functional integrity o f the 
endothelium and serves as a surrogate marker o f  N O  bioavadability (Behrendt and Ganz, 
2002). There are several techniques available to measure endothelial function in the 
macrocirculation. The m ost commonly described methods include plethysmography, flow- 
mediated dilatation and pulse wave velocity.
1.1.7.1 Plethysmography 
Venous occlusion strain gauge plethysmography (\^OP) is a widely used, invasive m ethod 
designed to assess forearm blood flow in response to inter-arterial infusion o f  
pharmacological stimuli (such as acetylcholine and bradykinin), which enhance the release 
o f N O  (Benjamin et al., 1995). This m ethod was first described by Hewlett and van 
Zwaluwenberg in 1909 (Hewlett and van Zwaluwenberg, 1909), and apart firom the 
development o f less cumbersome mercury in-silastic (i.e. silicone rubber) strain gauges and 
computerisation, the technique has remained essentially unchanged (Alam et al., 2005). The 
underlying principle involves direct inter-arterial infusion o f a drug, usually acetylcholine, 
whilst briefly interrupting the venous return firom the forearm, by inflating a cuff placed 
around the upper arm to around 40 mmHg which does no t alter arterial inflow such that 
blood can enter the forearm but not escape, causing the arm to swell (i.e. increase in 
volume). This linear increase in forearm volume over time is proportional to arterial blood 
inflow and reflects forearm vascular resistance (Benjamin et al., 1995). Changes in vascular 
resistance (resistance to blood flow) are associated with changes in the levels o f  N O  and 
thus reflect endothelial function (Stamler et aL, 1994). Forearm V OP with local brachial
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artery infusion is considered to be one o f the ‘gold standard’ methods in the assessment o f 
in vivo vascular function in humans (Hijmermg et al., 2001; Higashi and Yoshizumi, 2003). 
However, the invasive nature o f  these methods makes it unsuitable for use in young 
children and the elderly (Raitakari and Celermajer, 2000).
1.1.7.2 Flow-mediated dilatation 
The non-invasive m ethod o f using ultrasound to assess endothelial function has become 
increasing popular as a research tool in clinical trials. This technique measures flow- 
mediated changes in larger conduit arteries, such as the brachial, radial or femoral arteries 
rather than resistance vessels (i.e. small arteries and arterioles) (Raitakari and Celermajer, 
2000). The diameter o f the target artery is measured by high-resolution ultrasound whilst 
the artery is at rest and in response to an increase in blood flow (resulting in increased 
shear stress) during reactive hyperaemia. This is induced by inflation and then deflation o f 
a sphygmomanometer (blood pressure) cuff around the limb, distal to  the area being 
scanned and is a measure o f endothehum-dependent vasodilatation. Sublingual (under the 
tongue) adrninistration o f nitroglycerin, which acts directly on the underlying smooth 
muscle is used as a positive control for the assessment o f endothelium-independent 
function (section 1.1.6) (Celermajer et al., 1992; Sorensen et al., 1995).
The measurement o f  brachial artery FMD, was first described by Anderson and Mark in 
1989 (Anderson and Mark, 1989). Development o f this technique in the early 1990s by 
Celermajer et al. (Celermajer et aL, 1992) has subsequently become the m ost widely used 
method. Healthy arteries typically show an increase in diameter in the range o f  5% to 15% 
(Fauhc et al., 2003). Pre-treatment with NOS inhibitors has been shown to block the arterial 
dilator response to shear stress, suggesting that this mechanism is predominantly due to 
endothelial release o f N O  Qoannides et al., 1995).
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Endothelial function can be reliably estimated by both strain gauge plethysmography and 
ultrasound imaging and the two methods show good correlation in healthy subjects (Trace 
et al., 2001).
1.1.7.3 Pulse wave velocity 
Pulse wave analysis (PWV) is a relatively new technique that provides a non-invasive 
m ethod o f assessing global endothelial function (Hayward et al., 2002). The m ost 
commonly used method is radial artery applanation tonometry, which involves using a 
small pencil like probe device (the tonometer) over the point o f maximal arterial pulsation 
to minimally flatten (applanate) the arterial wall. Electrical resistance o f a piezoelectric 
crystal at the tip o f the tonometer varies directly with inter-arterial pressure, thus producing 
the pressure waveform (Hayward et aL, 2002). The accuracy o f the pressure waveform has 
been validated in humans (Chen et al., 1996). The arterial pulse waveform is reflected ftom 
the peripheral circulation back to the central circulation (O'Rourke and Kelly, 1993) which 
may confound the observed radial waveform. To account for this endothelial function is 
assessed by changes in the augmentation index (Alx), which is a function o f  the 
relationship between the reflected arterial and primary aortic waves (O'Rourke and Kelly, 
1993, Wddnson et al., 2000). Endothelium-dependent function is assessed following 
inhalation o f the p-adrenergic receptor agonist salbutamol, which is shown to be inhibited 
by co-administration o f  the NOS inhibitor, L-NMMA. In contrast, GTN-mediated 
(endothelium-independent) dilatation is unaffected suggesting that salbutamol stimulates 
the L-arginine/NO pathway (Dawes et al., 1997; Chowienczyk et al., 1999; Hayward et al.,
2002). The inhibition o f the response to salbutamol caused by L-NMMA is similar in 
magnitude to the inhibition o f acetylcholine in the human forearm (Chowienczyk et al., 
1993; Dawes et al., 1997).
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Similar methods which have been described to measure the arterial waveform and are 
su ^ested  to measure endothelial function, include photoplethysmography which involves 
the transmission o f  infrared light through the finger which is proportional to blood 
volume. The resulting digital pulse waveform is measured in response to the same P~ 
adrenergic stimuli (Chowienczyk et al., 1999). PWV measurements are reported to be 
affected by factors such as heart rate (Lantekne et al., 2002), height (Kelly et al., 2001), 
gender (Hayward and Keky, 1997, Kelly et aL, 2001) and age (Kelly et al., 1989) and careful 
consideration o f these factors should be made when interpreting results. There have been 
several studies to date, which have aimed to validate these methods (Chen et aL, 1996; 
1997; Pauca et al., 2001), however accurate information firom studies in which PWA^ is 
performed and calibrated entirely non-invasively at peripheral sites is currently lacking.
1.1.7.4 Recent method developments
There is continuing interest in the development o f  non-invasive methods to assess 
endothelial function. Magnetic resonance imaging (MRI) techniques have been applied to 
the assessment o f vascular elasticity (Mohiaddin et aL, 1993) and quantification o f  luminal 
and vessel wall parameters (Fayad and Fuster, 2001) and allows for a detailed, 
comprehensive view o f the vascular system. More recently, high-resolution MRI has been 
shown to be a useful non-invasive m ethod o f  accurately assessing both  peripheral 
endothelial function and central vascular function in humans (Wiesmann et aL, 2004). The 
obvious disadvantage o f  this technique is the necessity for expensive imaging equipment 
and experienced technicians, which may limit its general application in the field o f research.
1.1.7.5 Accuracy and reproducibility o f FMD
The ultrasound technique has significantly improved over recent years with the 
development o f new high-resolution ultrasound scanners and state-of-the-art image
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analysis methods (Kobayashi et al., 1996; Newey and Nassiri, 2002). However, the reported 
variability o f brachial artery measurements varies significantly between studies. The 
reported coefficients o f variation (CVs) (within-subject standard deviation (SD) divided by 
mean baseline diameter) o f baseline measurements vary from 1.5% to 6%. Within-subject 
variability o f FMD is less consistent, ranging firom 1.2% to as much as 50% (Celermajer et 
al., 1992; Sorensen et al., 1995; Uehata et al., 1997; Liang et al., 1998; Schroeder et aL, 1999; 
Hijmering et al., 2001; D e Roos et al., 2003). Much o f the reported variation in 
measurements can be explained by differences in the methodology for measuring FMD.
1.1.7.5.1 Occlusion cuff position
The occlusion cuff may be placed either on the forearm (below the elbow or at the wrist) 
or on the upper arm. When positioned on the forearm, hyperaemia is induced distal to  the 
site o f measurement at the anticubital fossa (i.e. fold o f  the elbow), with lower %FhfD and 
a shorter duration when the cuff is positioned at the wrist (Betik et al., 2004). In  the upper 
arm position, ischaemia is induced proximal to the site o f measurement and also at the site 
o f  measurement, thus inducing a larger increase in blood flow (Mannion et al., 1998; Berry 
et al., 2000; V o ^ l  et al., 2000a; Agewall et al., 2001; D oshi et aL, 2001; Betik et al., 2004). 
The forearm cuff position is better tolerated by subjects (Mannion et al., 1998). U pper arm 
occlusion is technically more challenging as the ultrasound image is temporarily distorted 
by collapse o f the brachial artery and movement in the soft tissue (Corretti et al., 2002).
1.1.7.5.2 Occlusion pressure and time course
Duration o f brachial artery occlusion has been shown to affect the degree o f  vessel 
dilation. In  brachial ultrasound studies, forearm occlusion times range firom 4 (Dorup et al.,
1999) to 4.5 min (Celermajer et al., 1992) compared with upper arm occlusion times o f  4 
(Liang et al., 1998), 4.5 (Neunteufl et al., 1997) or 5 min duration (Vogel et al., 2000a; Berry
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et al., 2000). The minimum time o f 4.5 min is sufficient to elicit a maximal dilator response 
(Leeson et al., 1997) and reduces the discomfort to the volunteers (Leeson et al-, 1997; 
Uehata et al., 1997). Cuff pressure also varies between studies, minimally at 50 m m Hg 
above systolic blood pressure (approximately 170 m m H ^, more commonly in the range o f  
200-300 m m Hg (Celermajer et al., 1992; Corretti et aL, 2002).
1.1.7.5.3 Choice o f  maximum diameter 
Immediately after cuff release the brachial artery starts to  dilate and reaches maximal 
dilation approximately 1-2 min after cuff release (Uehata et al., 1997; Liang et aL, 1998; 
Berry et aL, 2000) . To calculate the percentage diameter, either the peak (largest) diameter 
that is reached is considered or the diameter reached after 60 to 90 s.
1.1.7.5.4. Arm dominance and vessel size
Repeated measurements o f FMD are always measured on the same side o f a subject, either 
in the right or left arm. Studies investigating the effect o f arm dominance on forearm blood 
flow have shown conflicting results, reporting that the blood flow response after 
hyperaemia is greater in the dominant arm than in the non-dominant arm (Smolander, 
1994) or that there is no difference between the responsiveness o f either the right or left 
arm  (Kamper and Chang, 1999). The response to reactive hyperaemia and to  G TN  is 
inversely correlated with resting vessel diameter and this response has been reported to be 
enhanced in  females compared to males (Schroeder e t al., 2000; SRber et aL, 2005).
1.1.7.5.5. Analysis methods
Accurate analysis o f brachial artery reactivity is greatly dependent on the quality o f the 
ultrasound images. M ost analysis is completed ‘off-line’ by independent observers, with the 
images stored on a video cassette or computer. Once the image for analysis is chosen, the
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boundaries o f the vessel for diameter measurements are identified manually with electronic 
calipers or automatically using edge-detection software. Automated analysis for the 
boundary detection o f  the vessel wall reduces intra- and inter-reader variability compared 
to m anu al assessment, with less likelihood o f bias, improved precision and increased speed 
at which measurements can be obtained (Preik et aL, 2000; Mancini et aL, 2002).
1.2 Circadian Timing System
Biological clocks are fundamental to all organisms, ultimately controlling the cyclic pattern 
o f  molecular, physiological and behavioural functions. In  humans, the periodicities o f 
biological rhythms (lengths o f  time taken to complete one cycle) closely match those o f  the 
daily light/dark cycles caused by the rotation o f the earth around its axis and the sun. 
Rhythms can vary with periods shorter than 24 h  (ultradian), periods close to 24 h  
(circadian) and greater than 24 h  (infradian). Circadian rhythms are found in orgamsms 
from simple unicellular bacteria to flowering plants, insects and mammals (Roenneberg and 
Merrow, 2001). W hen isolated from environmental time cues (desynchronize^, the 
biological clock displays its endogenous Qntrinsic) period (tau or t) and is said to be ‘free- 
running’ (Arendt, 1995). Period length {r) can vary substantially between different 
organisms, in humans it is found to be in the range o f 23.9 to 24.5 h in sighted subjects 
(Middleton et al., 1996; Czeisler et al., 1999). In simple terms, there are three major 
components o f biological clocks; the input pathway, such as light or humoral factors firom 
peripheral tissues, the clock mechanism itself and the output rhythms.
1.2.1 The suprachiasmatic nuclei (SCN)
The fnAfnmalian clock is hierarchical, with a master circadian pacemaker located within the 
small, paired SCN o f the anterior hypothalamus in the brain, situated just above the optic 
chiasm. The SCN are responsible for the generation o f  circadian rhythms. Lesions which
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destroy this area o f  the brain, abolish the vast majority o f biochemical, physiological and 
behavioural rhythms such as sleep (Eastman et al., 1984), locomotor activity (Watanabe 
and Hiroshige, 1981) and hormone production (Scott et al., 1995). Individual neurons o f  
dissociated SCN tissue, in vitro, show robust circadian rhythms o f electrical firing with each 
neuron exhibiting a free-running rhythm with a slightly different period from its neighbour 
(Welsh et aL, 1995), suggesting that that circadian mechanism is an autonomous feature in 
cells. Transplantation experiments show that SCN encased in semipermeable membranes 
can restore circadian locomotor activity but fail to  restore rhythms in neuroendocrine 
functions (Silver et al., 1996), suggesting that the SCN uses both diffusible signals and 
neuronal efferents to convey timing information to other parts o f the brain and periphery.
1.2.1.1. Molecular clock mechanism 
In the SCN, coupled transcriptional/translational feedback loops regulate the circadian 
expression o f core oscillator components as well as many circadian outputs. Analysis o f  the 
circadian patterns o f activity and emergence from mutant fruit flies (Drosophila sp), revealed 
several genes that encode essential elements o f the clock (review Helfrich-Forster, 2005). 
The components o f  the mammalian circadian oscillator consist o f  a complex 
transcriptional feedback circuit o f three period gesi&s (per1,per2 andperJ) (Zylka et al., 1998), 
two cfyptocbrome genes (cry1 and cry2) (Kume et al., 1999), a clock gene (clU) (Gekakis et aL,
1998) and the gene encoding brain-muscle aryl hydrocarbon receptor nuclear translocator 
(ARNT)-like proteinl {bmall) (Oishi et al., 1998). BMALl and CLOCK are transcription 
factors that bind to E-box elements in the Per and Ciy clock genes and effect a positive 
feedback loop o f circadian rhythm regulation (Gekakis et aL, 1998). The mammalian 
PERIO D  (PERI and PER2) and CRYPTOCHROME (CRYl and CRY2) proteins act as 
negative regulators o f transcription driven by the BMALl / CLOCK heterodimer (Kume et 
aL, 1999). PER and CRY proteins form heterodimers and translocate back into the nucleus
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where CRY acts as a negative regulator o f B M A Ll/CLO CK  driven transcription (Kume et 
al., 1999) (Figure 1.4).
In tats, peri in the SCN is shown to peak in the daytime and trough in the subjective night 
under both light/dark (LD) and dark/dark (DD) conditions. In contrast, the peak o f  per2 
occurs at the transition o f day to subjective night under the same LD and D D  conditions 
(Yan et al., 1999). Thus, the expression o fperi and per2 is overlapping but asynchronous by 
approximately 4 hours (Albrecht et aL, 1997). This pattern o f p e rd u e  expression is similar 
in the mouse (Tei et al., 1997). Expression o f  bmall also undergoes circadian oscillation in 
the rat SCN but is almost 180® out o f phase with peri (Sumova et al., 2003). In contrast, 
expression o f  the mammalian clock gene does not appear to be rhythmic (Takata et aL,
2002). Functional mutations in the human per gene have been associated with Orcadian 
sleep disorders, such as advanced sleep-phase syndrome, which is characterised by a very 
early sleep onset and offset (Toh et al., 2001) and delayed sleep-phase onset in which 
individuals suffer with sleep-onset insomnia and difficulties waking at desired times in the 
m orning (Ebisawa et al., 2001; Archer et al., 2003).
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Figure 1.4. Molecular model o f the mammalian circadian clock.
CLOCK and BMALl form heterodimers which activate transcription o f Per and Ctj1 genes by 
binding to E-box promoter sequences (CACGTG). CRY and PER proteins form complexes at 
tlieir C-terminal domains necessary for nucleus translocation where they negatively regulate the 
transcription o f Per and Cry genes and positively regulate transcription o f Bmal1. Phosphoryla­
tion o f PER proteins may regulate their cellular location and stabiUt)'^ , CRY proteins present in 
the nucleus interact with CLOCK and BMALl to negatively regulate CLOCK:BMAL1 medi­
ated transcription. (Adapted from Reppert & Weaver, 2002).
1.2.1.2 Input (afferent) pathways 
Periodic environmental cues, zeitgeibers (time givers) entrain or synchronize the circadian 
clock. The daily LD cycle is the most dominant entraining stimulus in mammals (review 
Mistlberger and Skene, 2004). Light information received from the retina is conveyed to 
the SCN primarily via two anatomical pathways. Direct projection firom retinal ganglion 
cells to the dendrites o f SCN neurons forms the retinohypothalamic tract (RHT) (Cassone 
et al., 1988). The integrity o f the RHT is essential for synchronisation o f circadian rhythms
Chapter 1 35
to the 24 h  day. Lesioning o f primary and accessory optic tracts, leaving the RHT intact,
alters the phase relationship o f  a rhythm to the LD cycle but does not completely abolish
circadian rhythmicity (Donaldson and Stephan, 1982; Sisk and Stephan, 1982). Lesioning o f
the RHT itself produces free-running rhythms (Johnson et al., 1988). An indirect
projection to the SCN from the thalamus occurs via the intergeniculate leaflet (IGL) and
the geniculohypothalamic tract (G H l) (Pickard et aL, 1987). This latter pathvi^ay has been
shown to modulate photic entrainment o f the circadian system (Pickard et al., 1987) and
appears necessary for non-photic entrainment/phase shifting o f  the circadian clock
(Wickland and Turek, 1994; Maywood et al., 1997) (Figure 1.5).
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Figure 1.5. Overview o f the basic organisation o f the circadian tirning system
Information from photoreceptors is conveyed via a direct retinoh)p)othalamic tract (RHT) 
projection to the SCN and an indirect thalamic geniculoh}y>othalamic tract (GHT) projection 
via the intergeniculate leaflet. The rh}lhmic output o f the internal pacemaker controls functions 
that exhibit circadian regulation. (Adapted from Earnest et al, 2001).
Retinal ganglion cells (RGC) that send axonal projections to the SCN are intrinsically 
photoreceptive responding to light independent o f the rod and cone photoreceptors used 
for vision (Berson et al., 2002). Recent evidence supports melanopsin (Provencio et al.,
2000) as the primary candidate for a circadian photopigment. K nockout studies in mice 
have indicated that melanopsin plays an important role in both phase-shifts o f  the circadian
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clock and pupillary responses to light (Ruby et al., 2002; Hattar et al., 2003; Lucas et al.,
2003). Heterologous expression o f melanopsin has been shown to confer photosensitivity 
upon previously light-insensitive cells acting via a G-protein signalling cascade resulting in a 
transient increase in intracellular calcium (Melyan et al., 2005; Panda et al., 2005; Qiu et al., 
2005).
1.2.1.3 O utput (efferent) pathways 
The efferent connections o f  the SCN have been described in the rat and hamster (Watts et 
al., 1987; Kalsbeek et al., 1993). The most prominent projections, run dorsally ftom  the 
subparaventricular zone (sPVz) below the hypothalamic paraventricular nulceus (PVN), 
with a smaller number o f neural fibres extending into the paraventricular nucleus o f  the 
thalamus (PVT) and dorsomedial and medial nuclei o f the hypothalamus (DMH and 
VMH). Studies in the human brain have shown that the human SCN has a m ore dominant 
projection to the ventral part o f  the PVN compared to that in the rat and hamster, bu t the 
projections are otherwise comparable (Dai et al., 1997). Circadian neuroendocrine 
pathways have been proposed for melatonin (see section 1.4), corticosterone and 
gonadotrophins. The best described is the multisynaptic pathway controlling the diurnal 
synthesis o f the pineal hormone melatonin, consisting o f GABA ^amma-aminobutyric 
acid)-ergic projections firom the SCN to the PVN, projections from the PVN  to the spinal 
cord, then to the superior cervical ganglion (SCG) and finally to the pineal gland (Kaslbeek 
et a l, 1999).
1.2.2 Peripheral clocks
Peripheral oscillators have been identified in the liver, heart (Storch et al., 2002) and 
pancreas (Mühlbauer et al., 2004). These peripheral clocks have been shown to operate 
independently o f die SCN clock w vivo (Yamazaki et al., 2000). However, under norm al
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conditions, SCN input is required to ensure appropriate phasing o f output regulation in the 
different tissues and organs (Panda and Hogenesch, 2004). In the absence o f SCN signals, 
oscillations in clock gene expression in peripheral tissues are rapidly dampened (Yamazaki 
et al., 2000). Damping is likely the effect o f a gradual attenuation o f clock gene expression 
and loss o f synchronisation between cells (Schibler et al., 2003). Balsalobre et al. (1998) 
reported that fibroblast cell lines, which do no t show rhythms o f clock gene expression 
under basal conditions, show clear rhythmic expression for several cycles after brief 
treatment with high concentrations o f serum (serum shock) (Balsalobre et aL, 1998). 
Exogenous stimuli such as forskolin and endothelin, can be shown to induce rhythmic 
expression o f clock genes, thus it appears that all tissues are capable o f rhythmic expression 
after stimulation and synchronisation by the appropriate stimuli (Yagita et al., 2001).
Transcripts produced by clock-controlled genes accumulate in different phases suggesting 
that different cellular functions must be performed at different clock times (Panda et al., 
2002; Storch et al., 2002). The physiological purpose o f circadian gene expression in 
peripheral cells is not entirely known. In the hver, m ost known genes expressing rhythmic 
outputs encode enzymes or regulatory proteins involved in food processing and e n e r^  
homeostasis (Damiola et al., 2000). In contrast to the central clock, factors other than light 
can entrain the rhythm o f peripheral organs, which can be uncoupled ftom  the SCN, for 
example by restricted feeding schedules (Stokkan et al., 2001). Daytime restricted feeding 
schedules in rats and mice result in an inversion in clock gene expression (jyer 1,per2, per 3 
and qy/) in peripheral tissues, whilst fasting and night-time feeding has little effect, 
su^esting  that food is a dominant zeitgeber for peripheral clocks in different mammalian 
species (Damiola et al., 2000, Kobayashi et al., 2004). This is further supported by the 
eHdence that daily, timed carbohydrate-rich meals in humans can alter the circadian phase
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position o f core body temperature and heart rate without significantly affecting the phase 
position o f melatonin (Krauchi et al., 2002).
1.2.3 Assessment o f  circadian rhythms
The evolution o f endogenous biological clocks, which drive the rhythms in physiological, 
biochemical and behavioural variables such as core body temperature (CBT), sleep-wake, 
TAGs, alertness, performance and the synthesis and secretion o f many hormones including 
melatonin and cortisol enables the organism to adapt to environmental change (Figure 1.6). 
The 24 h  profiles o f  circadian rhythms are found to exhibit diurnal and nocturnal states, a 
biological 'day' and 'night', and show abrupt transitions between these two states (Wehr et 
al., 2001). In particular, the circadian rhythms o f CBT, melatonin and cortisol levels have 
been extensively studied and are often used as surrogate markers o f  clock function and its 
response to environmental stimuli (Klerman et al., 2002). Traditionally, the nadir o f  the 
CBT rhythm was the m ost ftequentiy used marker o f  circadian phase (Minors and 
Waterhouse, 1984; Czeisler et aL, 1986). Assessment o f  the CBT rhythm in humans under 
constant e2q>erimental conditions (section 1.2.3.3) shows higher levels during the biological 
day and lower levels during the biological night, with a nadir around 4 am (Wehr et a l,
2001). The rhythm in CBT is positively related to  the circadian rhythm in neurobehavioural 
performance, with performance reported to be best when body temperature is at or near its 
circadian peak and worst near the CBT minimum (Wyatt et al., 1999; Wright Jr. et al.,
2002).
Development o f the radioimmunoassay for melatonin has established melatonin as a m ore 
stable marker o f circadian phase, since unlike CBT and cortisol it is no t masked by sleep, 
stress and activity (section 1.2.3.1). The pattern o f secretion o f melatonin is characterised 
by very low levels during most o f the day, rising abmptly in the evening and remaining high
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throughout the night, eventually returning to basal levels in the period around awakening 
(reviewed in Arendt, 2005). The peak o f the melatonin rhythm is temporally associated 
with the nadir o f the CBT rhythm during the normal sleep period (Cagnacci et al., 1992). 
Exogenous administration o f  melatonin has been reported to be a hypothermic agent 
(DoUins et al., 1994; Hughes and Badia, 1997), but it remains unclear whether physiological 
levels o f endogenous melatonin produce significant declines in body temperature. Under 
entrained conditions, the onset and offset o f melatonin secretion is also shown to coincide 
with the onset and offset o f  the nocturnal increase in sleepiness resulting firom the 
increased homeostatic drive for sleep (Cajochen et al., 1999). In contrast, the circadian 
rhythm in cortisol secretion, with elevated levels in the early morning around the period o f 
awakening and a nadir around midnight (Rivest et al., 1989; W ehr et al., 2001), is 
considered to be more closely related to the timing o f the sleep-wake cycle than to  the 
circadian rhythm in melatonin secretion (Wehr et al., 2001). Indeed, the onset and offset o f 
the nocturnal period o f increasing cortisol levels lag by 1-3 h o f the onset and offset o f 
nocturnal melatonin secretion (Wehr et al., 2001).
1.2.3.1 Relationship between rhythms o f alertness/ performance and melatonin 
Sleep and wakefulness, as well as neurobehavioural performance during wakefulness, are 
controlled by the interaction between the circadian pacemaker and a sleep-wake dependent 
homeostatic process (Cajochen et al., 1999). Studies o f free-running humans have shown 
that the phase o f alertness and sleepiness is uniquely timed to facilitate sleep at night and 
wakefulness, with high levels o f alertness, throughout the day (Dijk et al., 1992). Extended 
periods o f  wakefulness, such as during sleep deprivation studies, are associated with 
marked decrements in neurobehavioural function because o f the sleep promoting effects o f 
the circadian pacemaker (Dijk et al., 1992). Thus close to bedtime a sharp decrease in 
subjective alertness and cognitive throughput occurs, referred to as the "opening o f  the
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sleep gate" (which was first described by Lavie) (Lavie, 1986; Cajochen et aL, 1999). 
Endogenous melatonin secretion is thought to participate in the circadian regulation o f  the 
sleep-wake cycle and variations in alertness by inhibiting the central nervous system 
wakefulness generating system (Strogatz et al., 1987). Studies investigating subjective 
alertness and sleepiness under conditions o f  prolonged wakefulness have shown that the 
decrease in alertness occurs 1 h  before to  4 h  after melatonin onset (Leproult et aL, 2003) 
and an increase in subjective sleepiness occurring within 2 hrs o f melatonin onset 
(Cajochen et al., 1999),
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Figure 1.6 Circadian rhythms of physiological and behavioural functions (adapted from 
Rajaratnam and Arendt, 2001).
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1.2.3.2 Masking
[xA key reason for imposing experimental controls over subjects in constant routine 
(section 1.2.3.3) and forced desynchrony (section 1.2.3.2) protocols is to minimise the 
influence o f  environmental and endogenous 'masking' factors that may occur and alter the 
characteristics o f a circadian rhythm (Minors and Waterhouse, 1989). These masking 
effects can be either positive, resulting in an increase in activity, or negative masking effects 
which inhibit the activity o f the circadian rhythm. These opposing effects are frequently 
observed in diurnal animals, for example the effects o f light on the feeding activity o f  rats 
(Madrid et al., 1998).
In humans, masking factors include sleep (Barrett et al., 1993; Damlenko et aL, 2003; 
Backhaus et al., 2004), physical activity (Gander et al., 1986; Buxton et al., 2003; Barger et 
al., 2004), postural changes (Deacon and Arendt, 1994; Moul et al., 2002), food intake 
(Krauchi et al., 2002) and light (Shanahan and CzeMer, 1991; Deacon and Arendt, 1994; 
Boivin et al., 1994; Botvin and Czeisler, 1998; Zeitzer et al., 2000) (see section 1.2.4.3).
Under normal circumstances it is difficult to separate the contributions o f the endogenous 
circadian pacemaker from the influence o f exogenous masking factors on a circadian 
rhythm, for example the effect o f the daily sleep-wake cycle on the rhythms o f 
physiological variables. The effects o f masking factors on the shape o f the endogenous 
component can be reliably distinguished using constant routine (section 1.2.3.4) and forced 
desynchrony methods (section 1.2.3.2) (Figure 1.7).
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Figure 1.7 Comparison of the profiles of physiological variables under normal conditions 
entrained to a regular sleep-wake c}xle (left panel) and under constant routine conditions (right panel). 
W: Wake; S: Sleep; TSH: Thyroid stimulating hormone (Adapted from Roth et al., 2005).
1.2.3.3 Forced desynchrony
In order to prove the existence o f endogenous self-sustained rhythms, experimental 
paradigms must be applied that allow for desynchronisation o f  internal time ftom  external 
time. The ‘forced desynchrony’ protocol involves subjects living on artificial day lengths 
which deviate ftom 24 h (Dijk et al., 1999). The imposed desynchrony between the sleep- 
wake schedule and the output o f the circadian pacemaker enables “control over masking 
factors without eliminating them, while sleep deprivation effects are avoided” 
(Koorengevel et aL, 2002). W hen the period o f a zeitgeiber is varied slowly but 
continuously, entrainment limits can be evaluated precisely. Under altered sleep/wake 
schedules (such as increasing ’day' length) and in conditions o f temporal isolation, the 
rhythms o f different variables, for example the rhythms o f the sleep/wake cycle and
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performance, “may separate from one another and run with distinctly different periods” 
(Folkard et al., 1983). This temporal separation excludes the possibility o f functional 
interdependencies between the variables under consideration. This method o f  'fractional 
desynchronisation' enables the determination o f the physiological connection between 
different variables.
1.2.3.4 Constant routine (CR)
The CR protocol, in which the confounding effects o f the light-dark cycle, the sleep-wake 
cycle and other cues are excluded, is considered to be the ‘gold standard^ for deterrnining 
the existence o f intrinsically generated circadian rhythms (Mills et al., 1978; Czeisler et aL, 
1985). The advantage o f the CR protocol is that masking factors such as posture, light 
levels, food intake and physical activity are strictly controlled and therefore allow the 
assessment o f physiological circadian rhythms, which are considered to reflect the activity 
o f the endogenous circadian pacemaker (Duffy and Dijk, 2002). However, in the CR 
protocol there is no desynchronisation between the sleep-wake cycle and the Orcadian 
pacemaker. Therefore the effects o f prolonged wakefulness in a CR protocol are 
superimposed on the circadian profile o f  various neurobehavioural variables, such as 
alertness and performance (Dijk et al., 1992). There are many modified versions o f the CR, 
for example introducing periodic changes in posture, which may potentially affect the 
rhythms being investigated (Duffy and Dijk, 2002). I t is unclear whether the CR itself 
affects circadian phase (for example, the dim light conditions or the sleep deprivation). 
Results from animal studies suggest that sleep deprivation alone can induce a phase 
advance in the locomotor activity and c-fos proto-oncogene protein expression in die SCN 
o f hamsters (Ande and Misdberger, 2000). Despite this, the CR remains a useful tool for 
determining information about the phase o f a circadian pacemaker in humans.
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1.2.4 Melatonin and the pineal gland
The pineal gland (ep^hysis cerebr^ is a small, unpaired structure in the brain, which 
synthesises the neurohormone melatonin in humans and other higher vertebrates (Reiter, 
1991) in response to sympathetic stimulation by the SCN in response to  the LD cycle 
(Arendt, 1995).
1.2.4.1 Melatonm synthesis 
Melatonin is synthesised within piuealocytes from tryptophan taken up from the circulation 
and converted to serotonin. The synthesis o f melatonin is initiated by norepinephrine 
binding to adrenergic a^-receptors and subsequent activation o f  pineal adenylate cyclase, 
leading to increased intracellular cyclic adenosine monophosphate (cAMP) (Schomerus et 
al., 2002). Synthesis o f  melatonin occurs via a two-step process involving the sequential 
activities o f two enzymes, serotonin-N-acetyl transferase (AANAT) which is the rate 
limiting step and hydroxyindole-O-methyl transferase (HIOMT) (Klein and Moore, 1979) 
(Figure 1.8).
Chapter 1 46
COOH
Trjqjtophan
l f ) 7ptophan-5-hydroxylase 
NH,
COOH
5-Hydrox}"tr)y)tophan
5HTP-decarboxylase
CH2 —  CH2 —  NH2 Serotonin 
(5-Hydroxytr}y>tamine, 5H1)
Serotonin-N-acet)4transferase (AANAT)
CH2 —  CH2 —  NH —  C —  CH3 N-Acetjdserotonin
O
Hydrox}indole-0-methyltransferase (HIOMT)
CHi —  CHt —  NH —  C —  CM Melatonin
Figure 1.8. Biosynthetic pathway o f melatonin from tryptophan (Adapted from Arendt, 1995).
In  humans, the circadian pattern o f melatonin production typically begins in the late 
evening preceding the onset o f  sleepiness and the fall in body temperature (Wyatt e t al.,
1999), peaking around 02:00-03:00 h and returning to basal levels between 08:00-09:00 h 
(Arendt, 1995). During the day, melatonin levels decrease 10-fold and persist for about 16 
hours (Reiter, 1991). The rhythm in melatonin persists in the absence o f  all time cues and 
the shape, period and amplitude is highly reproducible in healthy individuals entrained to 
the 24 h  day (reviewed in Arendt, 1988; Selmaoui and Touitou, 2003).
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The dim light melatonin onset (DLMO) and offset time is often used to determine the 
phase o f the internal pacemaker (Lewy et al., 1999).
1.2.4.2 Melatonin metabolism 
Melatonin displays lipophilic and hydrophilic properties, which facilitates passage across 
cell membranes. Following biosynthesis, melatonin is released into capillaries, where up to 
70% is bound to albumin (reviewed in Macchi and Bruce, 2004). The primary site for 
metabolism is in the liver, which clears more than 90% o f the circulating melatonin, but 
some metabolic functions also occur in the kidneys. Melatonin is firstiy hydroxylated at the
6-position, then excreted in the urine largely as sulphate and to  a lesser extent as 
glucuronide conjugates, with around 1% remaining in the unconjugated form (Arendt et aL, 
1985; Francis et al., 1987). O ne o f the key enzymes involved in the 6-hydroxylation o f 
melatonin in the hver has been identified as the microsomal cytochrome P450 enzyme- 
CYP1A2 in both rats (Skene et al., 2001) and humans (Facciola et al., 2001). More recently, 
in tissues such as intestine and cerebral cortex, the human cytochrome P450- GYP IB 1 has 
also been shown to be involved in the 6-hydroxylation o f melatonin (Ma et al., 2005). The 
main urinary metabolite in humans is 6-sulphatoxymelatonin (aMT6s). Excretion o f aMT6s 
is shown to closely parallel the plasma melatonin profile (Arendt et al., 1985). In patients 
with liver and renal disease, the clearance rate o f melatonin is decreased, with subsequent 
alterations in the plasma melatonin rhythm and increased levels o f  daytime melatonin 
(Iguchi et aL, 1982; Viljoen et al., 1992; Steindl e t aL, 1995; Karasek et aL, 2002).
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1.2.4.3 Factors affecting melatonin secretion
1.2.4.3.1 Light
The predominant factor affecting melatonin production is light. Nocturnal light exposure is 
known to acutely suppress melatonin levels (Lewy et aL, 1980; Bojkowski et al., 1987; 
Zeitzer et al., 2000) and to induce phase shifts o f  the arcadian clock in individuals with 
conscious light perception (Czeisler et al., 1986; Aoki et al., 1998; Boivin et aL, 1996; Boivin 
and Czeisler 1998; Zeitzer et al., 2000). The amount o f light required to suppress melatonin 
varies with the time o f night and previous light exposure with a greater degree o f 
suppression seen in humans following exposure to dim light (Owens and Arendt, 1992; 
Hebert et al., 2002; Smith et al., 2004). Earlier human studies reported that only bright light 
(>2500 lux) was able to suppress plasma melatonin levels (Lewy et al., 1980). Subsequent 
studies showed that melatonin levels can be suppressed by much lower lower light 
intensities (Bojkowski et aL, 1987; McIntyre et aL, 1989; Aoki et aL, 1998), with half o f  the 
maximal suppression achieved in response to a single episode o f dim room  light ~100 lux 
(Zeitzer et aL, 2000) in a dose-dependent manner. The degree o f melatonin suppression is 
also dependent on the duration, intensity and wavelength o f light exposure (McIntyre et aL, 
1989; Brainard et aL, 2001; Thapan et al., 2001). In humans, maximum suppression is seen 
with short wavelength light, such as blue light (459-465 nm), with an action spectrum 
distinct firom visual pathway photoreceptors (rod and cone photoreceptors) (Brainard et al., 
2001; Thapan et aL, 2001).
1.2.4.3.2 Posture
Postural changes have been shown to alter both plasma (Deacon and A rendt 1994, N athan 
et aL, 1998) and salivary melatonin concentrations (Deacon and Arendt 1994). Increasing 
melatonin concentrations are observed when moving from a supine to standing position 
and decreasing melatonin concentrations observed when moving from a standing to a
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supine position, with no difference when changing from a semi-recumbent to a standing 
position. The reason for the observed changes in melatonin concentration have been 
attributed to the effects o f  gravity, when moving from a supine to standing position there 
is a decrease in plasma volume which results an increase in plasma constituents particularly 
proteins and binding molecules.
1.2.4.3.3 Exercise
Studies reporting the effects o f exercise on melatonin production have provided conflicting 
reports. Increases in melatonin production following acute bouts o f moderate and 
strenuous exercise have been reported to occur in both men (Theron et al., 1984; 
Monteleone et al., 1990) and women (Carr et al., 1981; BuHen et al., 1982; Ronkainen et aL, 
1986; Skrinar et al., 1989; Knight et al., 2005). Acute increases in melatonin levels have also 
been reported immediately following a period o f meditation yoga (Tooley et al., 2000). In 
contrast, the results from one study failed to show an effect o f  strenuous (treadmill) 
exercise on melatonin production in male subjects (Elias et al., 1993). Physical exercise at 
night has also been shown to decrease plasma melatonin levels in young m en (Monteleone 
et al., 1990). Thus it is possible that observed differences between studies investigating the 
effects o f exercise on endogenous melatonin levels may be due to the time o f  day at which 
the measurements were conducted.
Nocturnal exercise has also been shown to elicit phase delays o f the melatonin rhythm 
(Van Reeth et al., 1994; Buxton et al., 1997; Barger et al., 2004) and accelerate entrainment 
to a shifted sleep-wake period (Eastman et al., 1995). In  contrast, daytime physical exercise 
can induce a phase advance o f the melatonin rhythm to a shortened sleep-wake period 
(Miyazaki et al., 2001). The phase delaying effects o f nocturnal exercise also appear to be 
preserved in older adults (55-73 years) (Baehr et aL, 2003). Van Reeth et al. (1994) found
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that 3 h  o f moderate intermittent exercise induced approximately the same phase shift as a 
3 h, 5000 lux light pulse (Van Reeth et al., 1994). Furthermore, bright light (3000 lux) 
combined with exercise has been shown to induce a significant phase delay o f  the 
melatonin rhythm (Youngstedt et al., 2002). Further studies are required to investigate the 
interaction between exercise o f varying levels o f intensity and duration and the phase- 
shifting effects o f  light o f  lower intensities and duration on the melatonin rhythm.
1.2.4.3.4 Caffeine and alcohol
Previously, studies in humans have shown that nighttime administration o f caffeine can 
acutely reduce the levels o f  melatonin in men (Wright et aL, 1997; Shilo et al., 2002) and 
women in the luteal phase o f  the menstrual cycle (Wright et aL, 2000) near the time o f 
melatonin onset. This suppressing effect o f caffeine on melatonin production appears to be 
augmented by the addition o f bright light (5000 lux) (Wright et al., 1997; 2000). In  addition, 
moderate doses o f  ethanol have been shown to inhibit nocturnal melatonin secretion 
(Rojdmark et al., 1993). This inhibition appears to be dose-dependent, with a greater 
reduction in melatonin levels with increasing consumption o f  alcohol (Ekman et al., 1993; 
Stevens et al., 2000). The mechanism by which ethanol inhibits melatonin production is 
unclear. Studies in rats have shown that ethanol has an inhibitory action on 
norepinephrine-stimulated melatonin synthesis with decreased levels o f  N-acetyl 
transferase (NAT) (Chik and Ho, 1992).
1.2.4.3.5 Prescription drugs
Several drugs are reported to affect the nocturnal melatonin rhythm, including non­
steroidal anti-inflammatory drugs (NSAID), such as ibuprofen (400 mg) and aspirin (Surrall 
et aL, 1987; Murphy et al., 1996). Nocturnal administration (24:00 h) o f  ibuprofen has been 
shown to reduce plasma melatonin levels 2 h  after adrninistration, and evening
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administration (18:00 h) reduces the nocturnal surge in melatonin production (Surrall et al., 
1987). Evening administration o f ^-adrenergic blockers, such as atenolol and propranolol, 
decreases nocturnal melatonin secretion and abolishes the arcadian rhythm o f urinary 
aMT6s in a dose-dependent manner (Cowen et al., 1983; Arendt et al., 1985; Deacon et al., 
1998; N athan et al., 1997) via specific inhibition o f adrenergic P receptors (Stoschitzky et 
al., 1999). Antidepressant drugs, such as desipramine, a noraderenaline uptake inhibitor, 
have been shown to affect the melatonin rhythm. Administration o f  desipramine in the 
early evening (16:00 h) increased the evening melatonin concentration, advanced melatonin 
onset and increased the duration o f melatonin secretion (Franey et al., 1986; Skene et al., 
1994).
1.2.4.3.6 Menstrual cycle
Conflicting reports o f the effects o f menstrual cycle phase on the melatonin rhythm 
include decreased melatonin amplitude (Shibui et al., 2000) and increased melatonin levels 
(Wetterberg et al., 1976; Webley and Leidenberger 1986; Brun et al., 1987) in the luteal 
phase, or no difference in melatonin levels between the menstrual cycle phases (Brzezinski 
et al., 1988).
1.2.4.3.7 Ageing
Numerous studies have shown a reduction in the amplitude o f  the melatonin rhythm 
associated with aging in both men and women (Touitou et al., 1981; Iguchi et aL, 1982; 
Touitou et al., 1984; Sack et al., 1986; Sharma et al., 1989; Bokjowski and Arendt, 1990; 
Ohashi et aL, 1997; Okatani et al., 2000; Zhao et al., 2002; Zhou et al., 2003; Magri et aL, 
2004; Münch et al., 2005). In  normal daüy environmental conditions the amplitude o f  
salivary melatonin in healthy, middle-aged (41-53 yrs) and older (66-72 yrs) women is 
shown to be 60% o f that observed in younger men and women (Zhou et al., 2003).
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However, in older men and women (> 60 yrs) under CR conditions, the melatonin 
amplitude is reported to be similar to that observed in young m en (Zeitzer et al., 1999). 
These conflicting results suggest that strict selection criteria for subjects and differences in 
experimental conditions (light/dark control, CR conditions) may influence the observed 
patterns o f  melatonin (reviewed in Skene and Swaab, 2003).
1.2.4.4 Melatonin receptors 
In humans, the effects o f melatonm are mediated by activation o f  G  protein-coupled 
melatonin receptors, identified as MT^ (Reppert et al., 1994) and MT2 (Reppert et aL, 1995),
formerly known as naelj^ and mel^y, respectively. These receptors are expressed in the SCN
and are involved in phase shifting and SCN activity (Liu et al., 1997; Dubocovich et al., 
1998). The M Tl receptors are also involved in vasoconstriction and MT2 receptors induce 
vasodilation o f coronary vessels (Doolen et al., 1998). Since melatonin receptors are 
exposed to daily melatonin stimulation for prolonged periods o f time, receptor 
desensitization is thought to be an essential component underlying the physiological effects 
o f melatonin. Indeed, in vivo studies have shown that acute and prolonged exposure o f  
M Tl and MT2 receptors to supraphysiolo^cal concentrations o f melatonin results in 
down-regulation and rapid desensitization (Hazlerigg et al., 1993; W itt-Enderby et aL, 
1998). However, the underlying mechanisms are unknown. It is postulated that melatonin 
receptor function may be regulated by melatonin itself (Gerdin et al., 2004a) or by other 
stimuli, such as oestrogen levels (Clemens et al., 2001) and the photoperiod (Masson-Pevet 
et al., 2000). Pre-treatment o f human MT2 receptors with physiological concentrations o f  
melatonin decreases the number o f receptors in a dose-dependent manner (Gerdin et aL, 
2004a). However, prolonged exposure o f the MT-1 receptor to physiological 
concentrations o f  melatonin, mimicking nocturnal peak levels, does no t affect the num ber
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o f  melatonin receptors, the affinity for melatonin, or the functional sensitivity o f  the 
receptor (Gerdin et al., 2004b).
1.2.4.5 Melatonin as a reliable marker o f  circadian phase 
Melatonin concentrations can be reliably measured in blood plasma by radioimmunoassay 
(RIA). However, plasma sampling is an invasive method, which has little scope outside o f 
the laboratory or clinic. The alternative methods o f obtaining melatonin in urine (as 
aMT6s) and in saliva have been used extensively in clinical research and field studies.
Melatonin rhythms can be detected in plasma, sahva, cerebrospinal fluid and urine (Arendt 
et al., 1985; Mcityre et al., 1987; Voultsios et al., 1997; Kennaway and Voultsios, 1998; 
Rizzo et al., 2002). The levels measured in saliva tend to be significantly lower than that in 
plasma as the saliva levels reflect the unbound melatonin concentration, which is estimated 
to be 23% o f the total serum melatonin (McIntyre et al., 1987; Kennaway and Voultsios, 
1998). Collection o f melatonin in saliva is non-invasive and more convenient than urine 
collection, enabling greater frequency o f  sample collection although, due to hyposalivation 
and low levels o f circulating melatonin, saliva measurements are less feasible in elderly 
subjects (Gooneratne et a l, 2003). The collection o f saliva samples necessitates subjects 
being awake. This does no t pose a problem during CR, as subjects remain awake during the 
CR protocol.
Plasma and salivary melatonin concentrations appear to be significantly correlated, with 
reports o f  correlation coefficients r  >  0.80 (McIntyre et al., 1987; Nowak et al., 1987; 
Laakso et al, 1990; Deacon and Arendt, 1994; Voultsios et a l, 1997; Kennaway and 
Voultsios, 1998). The RIA for salivary melatonin (English et al., 1993) shows close 
correlation with the plasma melatonin onset and acrophase, even after a light induced
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phase shift (Deacon and Arendt, 1994) making this a reliable and alternative m ethod o f 
assessing melatonin concentrations.
1.2.5 The circadian clock and the cardiovascular system
Disrupted biological rhythms have been implicated in the pathogenesis o f  cardiovascular 
disease. The diurnal pattern in the incidence o f  angina pectoris, myocardial infarction and 
sudden cardiac death is well reported in the literature, with the peak onset occurring in the 
morning hours after waking with a second lower peak in the late afternoon or evening 
(Muller et aL, 1985; Rocco et al., 1987; Wilhch et al., 1987; Mulcahy et aL, 1988; Hjalmarson 
et al., 1989; van der Païen et al., 1995). Studies have also shown a similar diurnal variation 
in the onset o f myocardial ischaemia in both  men and women (Mulcahy et al., 1996). There 
are several physiological triggers that have been implicated in the observed morning 
increase, including alterations in blood coagulability (Tofler et al., 1987), fibrinolysis 
(Andreotti et al., 1988), vascular tone (Panza et al., 1991) and nocturnal waking associated 
with increased heart rate (Barry et al., 1991). Figure 1.9 shows examples o f  reported 24 h 
rhythms in some cardiovascular variables. Studies have shown time-dependent changes in 
the activity o f several components o f the vascular system, including endothelial function 
and these may play a critical role in the pathophysiology o f  thrombotic events (House et al.,
1997). However, these observed rhythms are modulated by both endogenous and 
exogenous influences and it is not yet proven that these rhythms are intrinsically generated.
1.2.5.1 Rhythms in cardiovascular function
Blood pressure (BP) and heart rate (HR), under normal conditions, vary according to  the 
sleep-wake cycle in humans with activity generally beiug higher during the day and is 
associated with increased sympathetic activity at night (Baumgart, 1991). N on-CR studies 
in young women have shown significant variations in systolic blood pressure (SBP) with a
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nadir at 02:00 h followed by a subsequent increase in the morning (Ringqvist et al., 2000). 
The 24 h  BP profile is affected by both  environmental and behavioural factors, including 
posture (Mallion et al., 2000), food intake (Kohara et al., 1998), physical activity (Leary et 
al., 2000b) and mental stress (Sudano et al., 2005). Studies conducted under CR conditions 
have shown that in young healthy subjects (19-28 years) blood pressure does not change 
during the day, suggesting that exogenous factors are the sole determinants o f  the observed 
rhythms (Kerkhof et al., 1998, van Dongen et al., 2001) whilst there is a significant 
endo^nous rhythm in heart rate, with values being higher during the day (Krauchi and 
Witz-Justice 1994). The diurnal rhythm in blood pressure fiom  day to night is considered 
to  be a risk factor for cardiovascular disease (van Dongen et al., 2001).
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Figure 1.9 Daily variation in some cardiovascular variables (adapted from Bridges et al., 199land Kerkhof et al., 1998). 
tPA: tissue plasminogen activator; PAI: plasminogen activator inhibitor; bpm: beats per minute; lU: international units; 
Au: arbitrary units.
Endothelial function has been reported to show diurnal rhythmicity in both  men and 
women (Etsuda et al., 1999; Gaenzer at al., 2000; Ringqvist et al., 2000; O tto  et aL, 2004). 
In these studies, however, CR conditions were not employed thus lighting, posture and 
food intake were not controlled for and in some cases subjects were allowed to  sleep whilst
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measurements were taken (Etsuda et al., 1999, Gaenzer at aL, 2000, Ringqvist et al., 2000, 
O tto  et a l, 2004) (Table 1.1).
I t has also been reported that rhythmicity in endothelial function is attenuated in 
individuals with established CHD (Shaw et al., 2001). The extent to which these exogenous 
factors influence endothelial function is not yet known.
Rhythmic production o f circulating vasoactive factors has been also shown in humans. 
Elherik et al. (2002) demonstrated a significant diurnal variation in endothelin-1 (an 
endothelium-derived vasoconstrictor) concentrations in men (20-41 yrs), with peak levels 
occurring at 20:00 h and 08:00 h  in a 24 h  period. Nitric oxide levels showed a borderline 
trend towards a diurnal variation with higher levels at 20:00 h and low levels at 04:00 h, 
although the data was no t statistically significant (Elhefik et a l, 2002). Cell adhesion 
molecules, specifically soluble (s)-E-selectin and (s)-ICAM-l have been shown to peak at 
approximately 12:00 h  with a nadir at 24:00-04:00 h in young, healthy subjects (Maple et a l,
1998) and the circulating levels o f  fibrinolytic factors gave also been shown to express 
diurnal rhythmicity (Andreotti et al., 1991; Bridges et al., 1991). The levels o f  endothelium- 
derived tissue-type plasminogen activator (tPA), which activates the breakdown o f  fibrin in 
the blood, have been shown to be highest at 18:00 h falling dramatically to barely 
detectable levels at 03:00 h with concomitant changes in PAI-1, with low levels at 18:00 h 
and greatest activity a t 03:00 h  (Andreotti et a l, 1991). This variation in fibrinolytic activity, 
with lower levels in the early morning could favour thrombus formation in the early 
morning and be associated with the reportedly higher incidence o f  acute throm botic events 
(Irokawa et al., 1998).
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1.2.5.2 Melatonin and the coronary circulation 
The effects o f exogenous melatonin on the cardiovascular system include increased cardiac 
vagal tone, decreased blood pressure and decreased norepinephrine (Arangino et al., 1999). 
The effects o f endogenous melatonin on the cardiovascular system, however, are less clear. 
A reduction in nocturnal melatonin production has been reported in patients with coronary 
artery disease (Brugger et a l, 1995; Sakotnik et a l, 1999; Girotti et al., 2000; Yaprak et al., 
2003), which has been associated with decreased melatonin receptor expression 
(Ekmekcioglu et al., 2003). The high affinity melatonin receptors, M Tl and MT2, have 
been isolated in human coronary arteries (Ekmekcioglu et a l, 2001a; Ekmekcioglu et a l, 
2003). These receptors have been mainly localised to the vascular sm ooth muscle (Masana 
et a l, 2002). W hether these receptors are also found on the vascular endothelium has yet to 
be elucidated. The expression o f the M Tl receptor has also been shown to vary over 24 h 
in human coronary vessels with the lowest values detectable in the early morning, when 
circulating levels o f melatonin are higher, with a gradual increase up to  midnight 
(Ekmekcioglu et a l, 2001b).
Studies investigating the effects o f exogenous melatonin on vascular function have 
provided conflicting reports. In animal studies, melatonin has been shown to p o ten tate  the 
constrictor response to serotonin (Yang et a l, 2001) but can also induce vasodilation 
(Satake et al., 1991). The expression o f specific receptor subtypes in different parts o f  the 
vasculature could, in part, explain these differences. The removal o f  the endothelium firom 
sections o f  vascular tissue has been shown to abolish tbe vasorelaxant effects o f melatonin 
(Anwar et al., 2001) suggesting the presence o f melatonin receptors on the endothelium 
itself. In addition, adtnioistration o f  exogenous melatonin (1 m ^  has been shown to 
improve vascular function, with increased levels o f N O  in both  pre-menopausal women 
(Cagnacci et al., 1998) and postmenopausal women on HRT (Cagnacd et a l, 2000; 2001).
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Thus, melatonin appears to play a direct role in the maintenance o f  vascular tone in both 
humans and animals.
1.2.5.3 Clock genes and the heart 
Studies have shown that in the rat heart all mammalian homologues o f  known Drosophila 
clock genes {peri, peri, per3, cryl, cryl, clock, bmalT) show Orcadian patterns o f  expression 
(Young et al., 2001). Rhythmic expression o f  clock genes has also been demonstrated in 
vascular smooth muscle cells in response to angiotensin II (Nonaka et a l, 2001). In 
addition, two key transcription factors involved in circadian rhythm generation, BMALl 
and CLOCK, undergo rhythmic changes over the course o f  a day in the heart (Young et aL, 
2001). The circadian rhythm o f clock genes in the heart may enable the heart to adapt to 
various physiological stimuli, which change during the day, independent o f the SCN.
1.3 Research Aims and Objectives
An increasing body o f  research su^ests  the existence o f a rhythm in endothelial function. 
This rhythm is likely to be a result o f both endogenous and exogenous factors. Using a 
constant routine protocol it is possible to dissect out the endogenous circadian rhythm  
from the exogenous influence.
The î<itn o f  the work presented in this thesis was to assess the potential influence o f  the 
circadian clock on the vascular system, specifically the vascular endothelium. A series o f 
controlled constant routine experiments were conducted to answer the question o f  whether 
a true circadian rhythm exists in endothelial function and the effect o f  both physiological 
changes (melatonin) and exogenous factors (age, menopause and diet) on this rhythm  
(Figure 1.10).
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Figure 1.10 Possible interaction between endogenous and exogenous factors on the day/night rhythm 
and functioning of the vascular endothelium.
The aims o f this thesis were to:
«I» establish a reproducible way o f measuring FMD and GTN-mediated dilatation o f  
the brachial artery using non-invasive ultrasound technology 
4* investigate the effects o f  ageing and menopausal stams on endothelial and sm ooth 
muscle function in women 
4» assess whether an endogenous circadian rhythm in endothelial function, blood 
pressure and heart rate exists using CR methodology in pre menopausal and 
postmenopausal women;
*  investigate the phase relationship between the rhythm in endothelial function and 
the melatonin rhythm;
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A  determine the effects o f  acute sleep deprivation on subjective mood, alertness, 
sleepiness and cognitive performance in pre-menopausal and postmenopausal 
women;
assess the effect o f a high fat meal in the evening on endothelial function in young 
women;
^  assess the effect o f age on the day/night differences in endothelial function;
4* compare the day/night differences in endothelial function in non-CR and CR 
conditions to determine the relative contribution o f the endogenous circadian clock 
and exogenous factors on the observed rhythm.
The results from these studies should help to clarify the nature o f  a time-dependent change 
in endothelial function and the influence o f  both endogenous (circadian) and exogenous 
factors (age, menopause, diet) upon it.
6 2
C H A P T E R  2:
G eneral M aterials and  M eth od s
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Chapter 2: General Materials and Methods
2.1 Pre-study procédures for subject selection
All experimental protocols were approved by the University o f Surrey Ethics Committee 
(Ethics N°: EC/2002/37/SBLS; EC/2004/77/SBM S) and studies were conducted in the 
Clinical Investigation Unit in the School o f Biomedical and Molecular Sciences, University 
o f Surrey.
2.1.1 Participants
The demographic details o f each subject are detailed in the relevant chapter,
2.1.2 General inclusion and exclusion criteria for all studies
All subjects recruited to the studies were healthy, free from all medication with the 
exception o f minor analgesics, within 10% o f their ideal body weight and were non- 
smokers. Subjects were excluded from participation in the studies if they had a familial or 
personal history o f psychiatric disorders, epilepsy, sleep disorders, diabetes, CHD, 
hypertension, liver disease, had either undertaken a transmeridian flight or night shift work 
within one month o f the start o f the study and /or had received an experimental drug 
within three months prior to the start o f  the study.
AH subjects were provided with a detailed information sheet and asked to complete a 
recruitment questionnaire to assess their overall suitability to participate in the study and 
theit general health stams (Appendix I), together with two validated sleep and diurnal 
preference questionnaires (Pittsburgh Sleep Quality Index, Horne-Ostberg questionnaire) 
(Appendix II).
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The Home-Ostberg questionnaire is designed to assess an individual’s diurnal preference 
(Home and Ostberg, 1976). Subjects were asked to answer a series o f questions. Each 
answer was awarded a value between 1-5. The overall total was used to assess diurnal 
preference according to the following scale:
Horne-Ostberg Score Diurnal Preference
16-30 Definitely evening type
31-41 Moderately evening type
42-58 Neither type
59-69 Moderately morning type
70-80 Definitely morning type
The Pittsburgh Sleep Quality Index (PSQI) (Buysse et al., 1989) involved answering a series 
o f questions relating to habitual sleep patterns. A value > 5 indicates a possible sleep 
disorder.
2.2 General pre-study conditions for all studies
For one week prior to the study, subjects were asked to refrain from taking all non­
prescribed vitamin or herbal supplements that may affect endothelial function and thus 
influence the results. Throughout the day before and during the study, subjects were asked 
to refrain from consuming any alcohol and caffeine-containing food or drink and to avoid 
excessive exercise during this time as these factors are known to affect both endothelial 
function and melatonin production (section 1.1.4).
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2.3 Constant routine (CR)
Subjects were maintained under conditions o f constant dim light (<10 lux white light in the 
ditection o f gaze) and maintained wakefulness. Subjects were maintained in a semi- 
recumbent posture for the duration o f the study, with the exception o f toilet breaks. Toilet 
breaks were taken in between the measurements and ultrasound investigations. During the 
ultrasound assessment subjects were maintained in a fully recumbent position. Ambient 
room  temperature was maintained between 22-25 °C. Subjects were provided with access 
to television (study lighting conditions were assessed with the television turned on to 
ensure levels were maintained below 10 lux) and radio and were allowed to read in order to 
keep awake.
2.3.1 CR protocol
Subjects were asked to provide an hourly saliva sample, after rinsing the m outh with water, 
prior to consuming the study meal. The liquid study meal (section 2.3.2) was given 
immediately following saliva collection. M ood and performance tests (section 2.6) were 
subsequently completed. This procedure lasted no more than 8 minutes, and was 
conducted hourly. Endothelium-dependent (section 2.4.1) and endothelium-independent 
function (section 2.4.2) was assessed every 2 and 4 hours, respectively (Figure 2.1).
2.3.2 Nutritional content o f CR study meal
Liquid meals o f ‘Fortisip’ (Nutricia Clinical Care, Trowbridge, Wiltshire, UK) consisted o f 
48% carbohydrate, 13% protein and 39% fat. Each subject was given 38 kcal/kg body 
weight o f Fortisip hourly throughout the study. Water was provided ad libitum.
2.3.3 Collection and storage o f saliva samples
A non-citrated cotton SaHvette® (Starstedt Ltd, Leicester, UK) was used to collect saliva. 
The samples were immediately frozen upon collection and stored at -20 °C.
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2.4 A ssessm ent of endothelial function
Subjects were maintained in a fully recumbent position and rested with their right arm 
outstretched and hand slightly raised using foam supports. A tourniquet, connected to an 
inflation device, was placed around the arm just below the elbow. The right brachial artery 
was scanned in longitudinal section, 2-15 cm above the elbow using a 7 MHz linear array 
transducer and an Ultramark 9 ultrasound machine (ATL Ultrasound, Philips Medical 
Systems, Reigate, Surrey, UK). Subjects were requested to remain still and not to talk 
during the examinations to reduce the effect o f movement on the image quality. When a 
satisfactory image o f the artery was obtained with a clear image o f the anterior and 
posterior waU interface, the transducer was held in position using a clamp developed ‘in 
house’ (Figure 2.2). For repeated measurements, the subject’s arm was marked to ensure 
the same position was identified on each examination and a photographic record taken at 
each baseline scan. All scans were continuously recorded onto super-VHS videotape for 
subsequent analysis.
Figure 2.2 Set up of ultrasound scan of the right brachial artery for the determination of 
endothelial function
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2.4.1 EndotheKum-dependent function
A baseline scan o f  the artery at rest was recorded for 1 minute. The tourniquet was inflated 
to a pressure o f 200 m m Hg for 5 minutes to occlude the normal blood flow in the arm. 
Deflation o f the tourniquet induced an increase in blood flow due to the build up o f 
pressure behind the point o f occlusion resulting in dilation o f the artery. Scans were 
recorded continuously and for a further 5 minutes following cuff deflation for the 
assessment o f endothelium-dependent vasodilatation (Figure 2.3a).
2.4.2 Endothelium-independent function
A baseline scan o f the artery at rest was recorded for 1 minute. Glyceryl trinitrate (GTN) 
(25 pg) (Servier Laboratories Ltd, Fulmer, Slough, Berkshire, U.K.) was administered 
sublingually. Scans were recorded continuously for 5 minutes for the assessment o f 
endothelium-independent vasodilatation (Figure 2.3b).
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2.5 Measurement of blood pressure and heart rate
Blood pressure and heart rate was assessed hourly in the subject’s left arm and immediately 
prior to each measurement o f endothelial function using an automated oscillometric blood 
pressure monitor, Omron M4-I (Omron Electronics Ltd, Milton Keynes, UK) (Figure 
2.4a). Subjects rested for at least 5 minutes and were requested to remain stdU and sdent 
during measurements. This non-invasive method determines variations in air volume in 
response to cuff deflation. Inflation o f the blood pressure cuff increases the external 
pressure on the artery, thus the artery is increasingly compressed. At systolic blood 
pressure, small amounts o f  blood pass through the compressed artery causing changes in 
the artery volume, which is conducted to the cuff leading to pressure oscillations in the cuff 
in response to each heart beat. The heart rate denotes the frequency o f the heart beat, that 
is the number o f contractions o f the heart in one minute. These oscillations increase with 
lower cuff pressures as more blood passes through the compressed artery. As the falling 
cuff pressure approaches diastolic blood pressure, the oscillation amplitude decreases and 
remains at a low level (Figure 2.4b). The systolic and diastolic blood pressures can be 
characterised and measured by the cuff pressure at different oscillation amplitudes by 
means o f  a pressure transducer, signal amplifier, the control unit with an integral algorithm 
to calculate blood pressure from the recorded oscillations and an LED display (Figure 2.4) 
(Bonnafoux, 1996).
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Figure 2.4 Oscillometric blood pressure monitor (A) Omron M5-I monitor and (B) Oscillations 
in cuff pressure in response to changes in blood flow (adapted from Geddes, 1991).
2.6 Behavioural m easurem ents
2.6.1 Sleep diaries
Subjects completed a sleep diary on the morning after waking for each o f the three days 
prior to the laboratory study. Each diary recorded the time o f retiring to bed, time taken 
trying to sleep, how long it took to fall asleep, the number and duration o f night 
awakenings, the rime o f waking and time o f getting up. Sleep quality was rated on a scale o f 
1-9 (1; best sleep ever, 9: worst sleep ever) (Appendix III).
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2.6.2 M ood scales
Subjective alertness, anxiety, mood and energy was self-rated using a visual analogue scale 
by marking a point on a 10cm line on paper as illustrated below:
- +
very drowsy very alert
0 10
- 4-
very anxious very calm
0 10
- +
very sad very happy
0 10
- +
very lethargic very energetic
0 10
2.6.3 KaroRnska Sleepiness Scale (KSS)
Subjects were asked to place a mark next to or between the statement/s m ost accurately 
relating to the degree o f sleepiness experienced at that moment in time as illustrated below:
Ef
VERY ALERT 1
2
ALERT-NORMAL LEVEL 3
4
N E IT H E R  ALERT N O R  SLEEPY 5
6
SLEEPY BUT N O  GREAT EFFORT TO  STAY AWAKE 7
8
VERY SLEEP GREAT EFFORT TO K EEP AWAKE 9
The KSS has been validated with respect to objective measures o f sleepiness, with a value 
o f 7 related to physiological symptoms o f sleepiness such as drooping eyelids (Akerstedt 
and GiUberg, 1990).
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2.6.4 Samn-Perelli (SP) Sleepiness Scale
The scale consists o f a series o f ten statements as Tlustcated below:
Better than Same as Worse than
1. V E R Y  L IV E L Y
2. E X T R E M E L Y  T IR E D
3. Q U IT E  A L E R T
4. SL IG H T L Y  W E A R Y
5. E X T R E M E L Y  E N E R G E T IC
6. M O D E R A T E L Y  A L E R T
7. J A D E D
8. W ID E A W A K E
9. R A T H E R  W E A R Y
10. R E A D Y  T O  D R O P
Subjects were asked to indicate whether they were “better than”, “the same as” or “worse 
than” each o f the ten statements, by placing a mark in the corresponding box. The answer 
given for each o f the ten statements was then assigned a value: “better than” = 2 points, 
“same as” = 1 point or “worse than” = 0 points, with a maximum score o f 20 and a 
m in im u m  score o f 0. The higher the score, the less fatigued the subject feels. The scale 
described in this thesis is a modified version o f  the original Samn-PereUi checklist (Samn 
and PereRi, 1982), which has been vaRdated in field studies o f aircrew (Samel et al., 1997).
2.6.5 Digit Symbol Substitution Test (DSST)
This was a paper-based performance test. Subjects were provided with a single page o f 400 
randomised numbers (0-9) arranged in 20 rows (Appendix IV). Each number represented a 
different symbol, which were Rlustrated on the first line o f  the page. Subjects were asked to 
draw the correct symbol corresponding to the number, starting on the left hand side and 
working along each Rne down the page. Each subject was given 2 minutes to complete as 
many substitutions as possible. The total number o f substitutions completed in that time 
was recorded (Borland et al., 1986). The higher the score the better the performance.
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2.7 Radioimmunoassay of melatonin in saliva
Salivary melatonin concentrations were determined using a modification o f the RIA 
method developed by English et al. (1993).
2.7.1 General principles
The samples, standards and controls were incubated with a fixed amount o f antigen 
together with trace amounts o f radioactive iodomelatonin (^^I-2-melatonin; kindly supplied 
by Dr. Benita Middleton, Stockgrand Ltd., University o f Surrey, Guildford, UK). ^^ ^1-2- 
melatonin competes with the non-radiolabeRed antigen for the limited number o f antibody 
binding sites in the sample. The number o f antibody binding sites and the amount o f 
radiolabeUed melatonin is constant, thus the amount o f radiolabelled antigen that can bind 
with the antibody is dependent on the concentration o f melatonin in the sample. The assay 
mixture was incubated overnight to allow the system to reach equilibrium, after which time 
both the free and antibody-bound fractions o f melatonin were separated using a solid- 
phase second antibody precipitating system. The concentration o f melatonin in the 
unknown samples was determined by comparing the amount o f radioactivity measured in 
the fiee fiaction to that in a series o f standards o f known concentration.
2.7.2 Materials
2.7.2.1 Reagents;
Tricine buffer (0.1 M) was used in the preparation o f all dilutions and made fireshly each 
week. This consisted o f tricine (0.1 m m ol/L), 0.9% NaCl and 0.2% gelatine made up in 
double glass-distiUed water (DGDW) to give a stock solution o f pH  5.5. This was adjusted 
to a pH  o f 8.0 with IM  N aO H  and heated to 50 °C for 30 min to dissolve the gelatine.
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The antiserum used in this assay was sheep anti-melatonin antiserum (A B/S/08) 
(Stockgrand Ltd., University o f Surrey, Guildford, UK). The antibody cross-reactivity was 
13.3% with 6-hydroxymelatonin, 5.0% with N-acetyltryptamine, 2.47% with 5-methoxy- 
indole acetic acid and less than 0.6% with other related indoles. The antiserum was 
supplied freeze-dried (133 pi o f  1:10 dilution). Each freeze-dried vial was reconstituted 
with 2 ml D G D W  to give an intermediate dilution o f 1:150. Aliqouts o f  50 m l were 
stored at -20 °C. The working dilution for the antiserum was achieved by diluting one 
50 pi aliquot with 10 m l tricine buffer, which provided sufficient antiserum for 100 
assay tubes with a final working dilution o f  1:30000.
A solid phase second antibody-coated cellulose suspension, SAC-CEL, was used as 
supplied as the separation system. Brij/SaHne solution (0.15M NaCl, 2% Brij 35) was used 
as the detergent wash solution.
RadiolabeUed melatonin, ^^^I-2-iodomelatortin was diluted in tricine buffer to give 
approximately 10,000 cpm in 100 pL
Melatonin standards were supplied from Sigma Ltd (Bedford, UK). The melatonin stock 
solution was made up to 1 m g/m l by dissolving 10 mg melatonin in 0.5 ml absolute 
ethanol and adjusting the volume to 10 ml with DGDW . The solution was stable for at 
least a year stored at 4 °C. The working standard was made freshly from the stock solution 
for each assay as foUows:
100 pi o f stock solution (1 mg/ml) to 100 ml D GD W  to give 1 pg/m l
500 pi o f  1 pg/m l solution to 50 ml D G D W  to give 10 ng /m l
50 pi o f 10 ng/m l to 2.5 ml tricine buffer to give 0.2 ng /m l (200 p g /m l top
standard).
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The top standard was further diluted with buffer to give the range 2 to 200 pg /m l for the 
standard curve as follows (Table 2.1):
Table 2.1 Preparation o f assay standards
Melatonin concentration 
pg/m l
Standard (pi) 
Taken from 0.2 ng/m l
Assay buffer (pi)
0 0 500
2 5 495
4 10 490
10 25 475
20 50 450
50 125 375
100 250 250
200 500 0
All samples, standards, total counts tubes, non-specific binding tubes and quality controls 
were set up in duplicate. Zero binding tubes (0 pg /m l melatonin) were set up in 
quadruplicate.
2.7.3 Procedure
Saliva samples were thawed on the day o f the assay and centrifuged at 3000 rpm  for 10 
minutes prior to RIA. The standards, quality controls and saliva samples were incubated 
with 100 pi antiserum at room  temperature for 30 minutes. 100 pi o f ^^^I-2-iodomelatonin 
was added to all assay tubes, vortexed and incubated overnight at 4 ®C. The free and 
antibody-bound fractions were separated by adding 100 pi o f SAC-CEL to all assay tubes 
except the total counts tubes. The assay mixture was incubated at room  temperature for 
one hour with intermittent mixing every 15 minutes to prevent settling o f the second
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antibody. After the 1 hour incubation, 100 pi o f Brij/Saline wash solution was added and 
the tubes immediately centrifuged at 3000 rpm  for 10 minutes at 4 °C and the supernatant 
discarded. The remaining pellet was counted in a gamma radiation counter and the 
melatonin concentrations determined ftom  the standard curve using a computer program 
which automatically determines the percentage o f total counts o f the free fraction plotted 
as a function o f the melatonin standards o f known concentration. The curve is fitted based 
on a smoothing spline calculation method, which determines the curve o f Best-fit' with the 
least number o f attempted fits to the curve.
2.8 Automated enzymatic analysis of plasma triglycerides
This spectrophotometric assay is a fully enzymatic procedure in which the serum 
triglycerides are first hydrolysed by microbial glycerol lipase to form glycerol, thereby 
initiating a series o f enzymatically coupled reactions involving the following sequence 
(McGowan et al., 1983):
Triglycerides
Glycerol +  ATP  
glycerol-3-phosphate +  O 2
lipases
glycerol +  fatty acids
Glycerol kinase
Glycerol-3-phosphate oxidase
2 H 2O 2+  4-aminoantipyrin +  4-chlorophenol
glycerol-3-phosphate +  A D P
dihydrox}^acetonephosphate +  H 2C
P O D
quinoneimine +  HCl +  4H2Ü
ATP: Adenosine-5’-triphosphate
ADP: Adenosine-5’-diphosphate
O 2: Molecular oxygen
H 2O 2: Hydrogen peroxide 
POD: Peroxidase 
HCl: Hydrochloric acid
H 2O: Water
CHAPTER 2 78
The absorbance of the quinoneimine end product is measured biochromatically at 505/692 nm 
and is direcdy proportional to the concentration o f  triglycerides in the sample. The enzyme 
reagents and buffer are provided ready made and are combined together and dissolved. 
When dissolved the ACE™  Triglyceride reagents (Alfa Wasserman Inc, West Caldwell, 
New Jersey, USA) have the following composition (Table 2.2):
Table 2.2 Triglyceride assay reagent composition
Active Ingredients Concentration as formulated
BUFFER:
Pipes buffer 
4-chloro-phenol 
Magnesium ions 
ATP 
Lipases 
Peroxidases 
Glycerol kinase 
Sodium azide
40 m m ol/L , pH  7.5
5.0 m m ol/L
5.0 m m ol/L
1.0 m m ol/L
> 150 U /m l
> 0.5 U /m l
> 0.4 U /m l 
0.05%
ENZYM E REAGENT: 
4-ammoantopyridine 
Glycerol-3-phophate oxidase 
Sodium azide
0.4 m m ol/L  
> 1.5 U /m l 
0.05%
The reagents are stored at 4 °C. The reconstituted reagent is stable for 6 weeks when 
stored on the ACE™  clinical chemistry system at 10-14 °C.
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2.9 Data analysis
2.9.1 Endothelium-dependent and endotheHum-independent function
Brachial artery diameter was assessed from recorded images using automated edge- 
detection software (Brachial Analyzer™, Medical Imaging Applications, LA, USA) at the 
Vascular Physiology Department, Instimte for Child Health, Great Orm ond Street 
Hospital, London, UK. Images were captured onto a computer equipped with a frame 
grabber (each frame capturing 3 seconds o f recording. The measurements were obtained 
from a manually defined region-of-interest (ROI) that was centred in the lumen o f the 
vessel image in a region with clear, contrasted anterior and posterior waUs and calibrated to 
10 mm. The baseline diameter was calculated as the average o f the first 20 3-second 
frames. Percentage change in diameter (D) (expressed as %FMD or %GTN-mediated 
dilatation) was defined as AD/Dbasdme x 100 (Figure 2.5).
2.9.2 Melatonin data
2.9.2.1 Cosinor analysis
The salivary melatonin data for each individual was subjected to cosinor analysis (software 
provided by D r D.S. Minors, University o f Manchester, UK). The acrophase time, 
‘goodness o f  fit’ o f  the data to  a cosine curve and percentage variabihty in the data 
(% rhythm) was automatically calculated. Only data with a significant fit to the cosine 
curve, set at P <0.05, was used.
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2.9.2.2 Dim Light Melatonin Onset (DLMO)
The DLMO (melon50%) was defined as the time o f the mid-range crossing point between 
the basal and maximum melatonin concentrations (Warman et al., 2003). Baseline 
melatonin levels were defined as the mean o f the melatonin values between 12:00-14:00 h 
when melatonin is known to be significantly reduced in the circulation.
2.9.3 Blood pressure and heart rate data 
The data was plotted and subjected to statistical analysis as described in section 2.10.
2.10 Statistical analysis
All data were analysed using the SPSS^^ statistical software package (SPSS v.11.0 
Macintosh, SPSS Inc., Chicago, USA). All data were normally distributed and thus subject 
to parametric statistical analysis. Two-way repeated measures analysis o f variance 
(ANOVA) was performed on the data to detect any differences between subject groups, 
time and the interaction between subject group and time where a full set o f data was 
available. Tukey’s post hoc test was subsequently performed to identify where the 
significant differences occurred. One-way ANOVA was used when there were missing sets 
o f data, to analyse the data from each subject group separately.
Where data was normalised, the method o f normalisation is described in the relevant 
chapters. Paired (within-subject) and unpaired (between subjects) Student’s t-tests were 
also used to identify any significant differences when the data were grouped. Regression 
analysis was used to determine any relationship between different variables. The statistical 
tests used are described in the relevant chapters. Significance was defined as P <0.05.
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Chapter 3: Reproducibility of the assessment of endothelial function
3.1 Introduction
Flow-mediated dilatation (FMD) is widely used to evaluate endothelial function in 
experimental studies, and impaired FMD appears to be predictive o f  future coronary 
events (Neunteufl. et al., 2000; Schâchinger et al., 2000). The diameter o f  the brachial artery 
can be measured reproducibly by high-resolution ultrasound. In healthy individuals, FMD 
is usually 5-15% o f the baseline diameter (section 1.1.7.2). The reproducibility o f  this 
technique as reported in the literature, however, is inconsistent. The intra-individual 
(within-subject) variation o f the baseline (resting) brachial artery diameter is low, ranging 
from 1.5-6.0 %. However, the reported variability o f FMD ranges from 1.2-50.0 % (section 
1.1.7.5).
Most reproducibility studies are based on a small number o f repeated measurements, often 
only two measurements, in less than 10 subjects and it is Hkely that the highest 
reproducibility will be shown over a short interval since the individual vasodilator response 
is unlikely to have changed in response to environmental or other influences (Corretti et al., 
2002).
Blood pressure (BP) measurement has also been shown to vary considerably, being 
associated with factors such as the number o f  measurements and number o f days on which 
measurements are taken (Glasgow et aL, 1988; Scott et al., 1989), the BP device used 
(Rosner et al., 1990; Pavlik et al., 2000; Cuckson et a i, 2004) and physiological factors 
including posture, age and gender (Bamett et al., 1999). Fewer studies have reported the 
reproducibility o f resting HR, although heart rate variability (HRV) has been shown to
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display reasonable reproducibility in healthy young subjects (both males and females aged 
20-28 years), dependent on posture (Lobnig et al, 2003).
Repeated measurements on the same individual tend to  differ because o f natural variation 
in the individual (biological variation), variation in the measurement process or both  (Bland 
and Altman, 1996). W hen measurements ate less reliable or are characterized by large day- 
to-day variation, it is difficult to accurately identify statistically significant changes.
3.2 Aims
The aim o f the study was to establish the reproducibility o f measures o f endothelial 
function, resting blood pressure and heart rate.
3.3 Methods
3.3.1 Subjects
Ten healthy subjects (5 males and 5 females), aged between 22-53 years (30 ± 1 0  years; 
mean ±  SD) and BMl 24 ±  3 kg/m^ were recruited from the University o f  Surrey (see 
Table 3.1 for subject details). Subjects were asked to refrain ftom consuming any alcohol 
and caffeine and to eat approximately the same meal at a similar time on each occasion 
prior to each ultrasound scan.
3.3.2 Protocol
Endothelial function (%FMD) (section 2.4.1), BP and H R (section 2.5) were assessed in 
each subject, under conditions o f dim light (<10 lux) and controlled ambient temperature 
(22-24 °C) on five different occasions (by the same investigator) at the same clock time. AH 
scans were conducted between 08:00-14:00 h  on different days at least one week apart. 
Measurements o f BP and H R were taken twice on each occasion, immediately before and
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after each ultrasound scan. AH BP measurements were taken on the left arm, whHst the 
subject was rested in a recumbent position.
Table 3.1 Subject details
Subject Gender Age BMl Smoker Time o f scan (h)
code 1 11 111 IV V
1 F 41 26 N o 10:14 10:23 10:36 10:29 11:00
2 F 53 22 N o 12:34 13:02 12:34 12:35 12:30
3 M 30 28 Light 10:10 10:11 10:17 10:23 10:16
4 F 24 19 N o 09:41 09:28 09:05 09:26 09:22
5 F 22 21 N o 14:14 14:15 14:09 14:02 14:05
6 F 29 26 Light 11:42 11:44 11:42 11:46 12:05
7 M 23 20 N o 10:47 11:07 10:40
8 M 24 27 N o 09:51 09:54 09:59 09:53 10:02
9 M 28 27 N o 08:53 08:38 08:41 08:44 08:47
10 M 24 24 N o 12:15 12:06 12:29 12:38 12:06
F: Female; M: Male; BMI: Body Mass Index (Weight (kg)/[Height (m)]^; 
Light smoker = <5 cigarettes/day
3.3.3 Data analysis
Data are presented as mean values ± SD. The coefficient o f variation (CV) was calculated 
as CV = {SD/mean} x 100. Two-way repeated measures ANOVA was used to  determine 
the effect o f  day and gender in all o f the measured parameters. In  order to perform  
repeated measures ANOVA some o f  the values for individual subjects were averaged, 
where data was missing as a result o f poor scan image quality or missed time poiats, to 
provide a rectangular grid necessary for ANOVA calculations. Subject 7 was excluded ftom  
the analysis, as there was insufficient data available to be averaged. Significance was defined 
as P  <0.05.
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3.4 Results
3.4.1 Endothelial function 
The mean values o f  the parameters o f  brachial artery function for each subject are 
presented in Table 3.2. Repeated measures ANOVA did not show any significant 
differences in baseline and maximum brachial artery diameters or %FMD between the five 
repeated measurements (Figure 3.1).
The reproducibility o f  baseline brachial artery diameter measurements from the entire 
subject group (n =  10), irrespective o f gender, was 3.3% CV (range 1.1-7.1%), maximum 
diameter 3.4% CV (range 0.3-8.0%) and %FMD 15.1% CV (range 6.9-27.2%) (Table 3.2). 
As expected, the overall variation in arterial diameter and endothelial responses between 
subjects was much greater, the baselme diameter ranging firom 2.9-4.6 m m  and the 
corresponding %FMD ranging ftom  2.9-13.0%.
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Figure 3.1 (A) Mean baseline diameter and maximum arterial diameter and (B) %FMD in n -  10 
subjects after each ultrasound assessment. Data are expressed as mean ± SD.
Two-way repeated measures ANOVA revealed a significant effect o f  gender on the baseline 
diameter (F^^ = 10.6; P <0.005) and the maximum diameter (F^ ^  ^ =  25.1; P <0.005), which 
was greater in the males compared with the female subjects. Conversely %FMD was 
significantly greater in the female subjects compared with the male subjects (F ,^^ =  7.9; P  <0.05 
(Table 3.3). To detect the difference in endothelial function between male and female 
subjects, a power o f 0.74 was obtained retrospectively for %FMD.
CHAPTER 3 89
Table 3.3 Gender difference in repeated brachial arter)^ measurements
Male Female
Mean SD % C V * Mean SD %cv* Significance*
Baseline diameter (mm) 4.1 0.4 2.6 3.2 0.2 4.1 P < 0.005
Maximum diameter (mm) 4.3 0.4 2.4 3.5 0.2 4.4 P < 0.005
% FM D 4.6 0.7 18.9 8.6 2.6 11.3 P < 0 . 0 5
^Variability o f 5 repeated measurements in n = 5 subjects 
* Two-way repeated measures ANOVA (n = 9 subjects)
3.4.2 Blood pressure and heart rate 
The mean values o f BP and HR for each subject are presented in Table 3.4. There were no 
significant differences in BP and H R measurements taken immediately before and after 
each ultrasound scan. The pre-scan and post-scan data for each individual subject was then 
averaged to obtain a single value for each day, which was used in the subsequent analysis.
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The change in BP and H R over the 5 days is shown in Figure 3.2. Repeated measures 
ANOVA did not show any significant effect o f day on blood pressure or heart rate.
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Figure 3.2 (A) Mean systolic and (B) diastolic blood presure and (C) heart rate taken 
immediately before and after each ultrasound scan in n = 10 subjects. Data are expressed 
as mean ± SD. #  pre-scan; Q  post-scan
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There was a significant effect o f gender on SBP = 13.1; P  <0.01), but no difference 
between male and female subjects in either diastolic blood pressure (DBP) or HR 
(Table 3.5).
Table 3.5 Gender difference in repeated blood pressure and heart rate measurements
Male Female
Mean SD % C V ^ Mean SD % C V * Significance*
Systolic blood pressure 
(mmHg)
123 5 4 107 4 3 P < 0.01
Diastolic blood pressure 
(mmHg)
66 5 7 65 3 4 NT
Heart rate (beats/min) 59 4 7 62 4 6
N S
i Variability o f 5 repeated measurements in n = 5 subjects 
* Two-way repeated measures ANOVA (n = 9 subjects); N S  = N ot significant
3.5 Discussion
3.5.1 Arterial diameter and endothelial function 
The reproducibility of the FMD technique in this study is 15.1% CV at a mean FMD of 6.6 +  2.7%. 
This is greater than the 10% CV normally accepted for analytical analysis, however since 
FMD is a percent-ratio measure, small differences between measurements appear very 
large. The CVs for baseline and maximum diameter were less than 5% and are within 
acceptable limits.
Numerous factors can contribute to the variability o f  FMD, including equipment and 
operator influences. To reduce the influence o f these variables on FMD a strict protocol 
was adhered to. The validity o f this m ethod is supported by the good reproducibility o f  the 
baseline diameter measurements between sessions (3.3 ± 0.02% CV).
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The variability o f  the FMD technique has been reported to be as much as 50% CV in 
young, healthy subjects (De Roos et al., 2003). However, the FMD responses seen in the 
present study are comparable with several other brachkl ultrasound studies, reporting 
much lower levels o f variance. Hijmering et al. (2001) reported variability o f  13.9% FMD in 
young, healthy male and female subjects (26 ±  5 years) measured under similar 
experimental conditions but on only two occasions. Hashimoto et al. (1995) measured 
%FMD in 8 male subjects (25 ±  0.8 years) on 5 occasions, as per the present study, with a 
reported variance o f 9.7% in FMD. The age range o f  the subjects was closely matched ia 
both  these studies, whereas in the present study the age range o f subjects was much greater 
(22—53 years). In  a larger study, Liang et aL (1998) studied the repeatability o f  brachial 
ultrasound measurements in a similar subject population to that o f the present study 
(mixed gender, mean age 46.5 years) and reported a variability o f  10.3%. However, only 
two measurements were made and FMD was calculated using the manual calliper m ethod 
(section 1.1.7.5.5), which is considered to be a less reliable method o f measurement, subject 
to human error and bias.
Physiological and environmental factors can exert profound effects on endothelial 
function, factors such as dietary intake (see section 1.1.4.1) and exercise (section 1.1.4.4). 
The protocol used in this study was aimed at reducing the effect o f dietary intake on 
individual FMD responses, by requesting each subject to maintain a similar dietary intake, 
and to  abstain from strenuous physical activity prior to each ultrasound scan. However, 
without the use o f  invasive blood sampling to  assess the metabolic status o f  each individual 
and activity monitors to assess physical activity prior to and at each study session, the 
overall subject compliance is difficult to ensure and any deviation from the imposed study 
conditions could result in increased variability in the FMD response.
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Both age and gender are variables that are known to affect the endothelial response 
(section 1.1.4.7). In the present study, the male subjects had significantly larger arterial 
diameters (4.1 ± 0.4 mm) compared with the female subjects (3.2 ± 0.2 mm). The change 
in diameter in response to reactive hyperaemia was much smaller in the male subjects 
resulting in a lower mean FMD value (4.6%) compared with the female subjects (8.6%). 
Similar gender differences in resting arterial diameter and FMD have been reported to 
occur in both young and older subjects. Perregaux et al. (1999) reported FMD values o f 
4.2% in men and 11.5% in women (mean age 27 ±  0.8 years). More recentiy, Kapuku et al. 
(2004) found that the greater FMD responses in female subjects (14.4%) compared with 
males (10.5%), was related to the smaller initial artery size in female subjects. In  older 
subjects (44-78 years), the gender difference in resting arterial diameters and %FMD 
remains, with an average baseline diameter o f  4.6 mm in men and 3.9 mm in women and a 
corresponding FMD o f 3.8% in men and 5.6% in women (Schroeder et al., 2000).
The reported FMD values vary gready between studies and are generally higher than those 
observed in the present study. This may be due to the differences in age, subject inclusion 
criteria, the influence o f exogenous factors (such as dietary intake, exercise and nicotine 
consumption prior to the measurements) and different methods of measurement (i.e. manual 
versus automated diameter measurements) between the different studies. Nonetheless, the 
results from these and the present study clearly indicate that gender is an im portant variable 
in the measurement o f endothelial function. Indeed, despite the relatively small num ber o f  
subjects in each gender group, the power o f the study was greater than P — 0.70.
3.5.2 Blood pressure and heart rate 
The profiles o f  BP and HR are known to vary considerably over the course o f  the day and 
in response to numerous physiological and external stimuli. The protocol employed in this
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study was designed to reduce the variability in the repeated measurements o f  BP and HR 
by taking each measurement in the same arm, whilst the subject was in a recumbent 
position and at rest under the controlled experimental conditions o f  the laboratory. The 
reproducibility o f  repeated measurements o f both SBP and DBP and heart rate in this 
study were reasonable a t <8% CV.
Systolic blood pressure was found to be significantly higher in the male subjects (123 ± 5 
mmHg) compared with the female subjects (107 ±  4 mmHg), although still within the 
normal reference range for BP readings. This gender difference in BP is supported by 
evidence fiom  other studies in the literature. In a large study in Denmark, 24 h ambulatory 
BP monitoring o f 352 normotensive men and women, aged between 20-79 years with a 
uniform distribution o f  subjects in aU age groups, revealed that men had higher 24 h  mean 
BP by approximately 6—10 mmHg than women, up until the age o f  70 when BP was similar 
for men and women (Wiinberg et al., 1995). Similarly, Smulyan et al. (2001) reported higher 
H R (71 ±  12 versus 68 ± 12 beats/min) and lower BP (142 ±  22 versus 146 ±  18 m m H ^  in 
middle-aged women compared with age-matched men. The mean difference in BP between 
males and females in the present study, assessing a much smaller number o f  subjects, was 
greater (16 mmHg). In addition, the male subjects in the present study were all o f a similar 
age (24-30 years), whereas the age range o f the female subjects was much larger (22-53 
years). Proposed mechanisms underlying the gender differences in BP include reduced 
autonomic tonic regulation in women (Christou et aL, 2005) and the genetic linkage o f  SBP 
to a region o f  the X  chromosome encompassing the H R  (androgen receptor) gene in men 
(Ellis et al., 2001).
In conclusion, the results fi:om this study show satisfactory reproducibility in all 
measurements o f arterial function when performed under similar conditions by the same
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investigator. There is a significant effect o f  gender on measurements o f endothelial 
function, with smaller arterial diameters in women resulting in greater FMD, and BP with 
lower SBP in women.
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Chapter 4: Rhythms in endothelial function under constant routine 
conditions in pre- and postmenopausal women
4.1 In troduction
The influence o f rhythmic changes in components o f the vascular system on the timing o f  
cardiovascular events has been widely investigated. Endothelial function has been reported 
to show diurnal rhythmicity in both men and women (section 1.2.5.1). This rhythmicity is 
reported to be lost in individuals with CHD (section 1.2.5.1).
CHD is one o f the leading causes o f morbidity in middle-aged women, with increasing age 
and oestrogen deficiency widely considered to contribute to the increased incidence, in part 
associated with a decline in endothelial function (section 1.1.5.4). However, whether the 
diurnal rhythm in endothelial function is altered after the menopause has no t previously 
been investigated. In addition, many o f the studies investigating diurnal variation in 
vascular function have no t taken account o f the effect o f exogenous environmental stimuli 
and have only taken a small number o f repeated measurements in a 24 h  period (Table 1.1, 
section 1.2.5.1). I t is therefore unclear whether the rhythms shown in these studies are due 
to environmental influences or are indeed endogenously generated (circadian).
4.2 Aims
The aim o f the present study was to investigate the existence o f an endogenously generated 
circadian rhythm in endothelial function, whilst also assessing the circadian variation in 
blood pressure and heart rate, under controlled experimental “constant routine” 
conditions. The study also aimed to determine whetiher these rhythms are altered after the 
menopause.
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4.3 M ethods
4.3.1 Subjects
Healthy non-smoking women (n =  24) were recruited ficom the general population and the 
University o f  Surrey staff and postgraduate student population, according to the 
inclusion/exclusion criteria outlined in Section 2.1. Subjects were reimbursed for time and 
travel inconveniences, for their participation. Eleven pre menopausal women aged between 
35-40 years (42 ±  4 years; mean ±  SD) and 13 postmenopausal women aged between 50- 
60 years (55 ±  2) with body mass indices (BMI) 23 ± 2 kg/m^ participated in the study (see 
Table 4.1 for subject details).
4.3.2 Protocol
Both menstrual cycle phase and menopausal status, defined as no evidence o f 
menstruation for at least 12 months, were confirmed by blood horm one analysis 
(Chemical Pathology Laboratory, Southampton University Hospitals NHS Trust, 
Southampton, Hampshire, UK). AU participants were asked to adhere to the pre-study 
conditions outlined in Section 2.2. Participants were also instructed not to consume any 
food or drink with the exception o f  water from 20:00 h the day prior to consuming the 
first ‘study meal’ at 07:00 h the foUowing morning in theit hom e environment. 
Participants arrived at the Clinical Investigation Unit (School o f  Biomedical and 
Molecular Sciences, University o f  Surrey) and were studied for 22 h under constant 
routine conditions (see section 2.3) starting at 08:00 h.
Endothelium-dependent FMD was assessed every 2 h, beginning at 08:30 h, with an 
additional measure o f endothelium-independent GTN-mediated dilatation every 4 h 
according to the method described in Section 2.5. BP and HR were assessed at hourly 
intervals (see Section 2.6). In addition, hourly saliva samples were coUected for the
CHAPTER 4_________________________________________________________________ 100
measurement o f melatonin to determine each individual's circadian phase (see Chapter 5). 
Two subjects were assessed during each 22 h  study period and the same investigator was 
present throughout each study. Ethical approval for the study was obtained fcom the 
University o f Surrey Ethics Committee prior to study commencement (see section 2.1).
4.3.3 Data analysis
The data from four subjects was excluded from the analysis. One subject became 
hypertensive during the study and another two subjects experienced nausea due to 
intolerance o f the study meal. For these three subjects the study was terminated. The data 
from a fourth subject had to be excluded due to poor image quality o f the ultrasound 
scans.
Two-way repeated ANOVA was used to determine the effect o f  menopausal status and 
time o f day on blood pressure and heart rate. W hen an overall effect o f time was observed, 
Tukey's post hoc analysis was performed. One-way ANOVA was used to determine the 
effect o f  time o f day on endothelial function for each study group since missing data at 
some time points meant that two-way repeated ANOVA could no t be performed. 
Endothelial function data were also grouped into two time periods: “day” 08:30-16:30 h 
and “night” 18:30-06:30 h (these periods were defined as the presence or absence o f  the 
pineal hormone melatonin). Data were compared within the study group (paired Student’s 
/-tests) and between groups (unpaired Student’s /-tests). Linear regression analysis was 
used to  assess any correlation between age and the clinical variables measured. Statistical 
significance was defined as P  <  0.05.
CHAPTER 4 101
10
u
1
I
II
I I
I  ^
I I
8
+1T C ,
i n
I I
I I
ac/3P4
§ I
liÜ
I
II
■I
I
I
I
nVi
O
fS
'O' "0^
3 3
C/5 C/5
B B 
.B .B
a a 
8 8 
B B
13 "Oii
VO m T—4 o in CMT—I CMT-l CMVO VO m 00 m
d T—1 d d CMd rH d T—• T—I d d d d d d d d d
+1 + 1 +1 +1 +1 +1 +1 +  1 + 1 +I +1 +1 +1 +1 +1 +1 Tl +1
O  '' o m o •s/IX o T—I ^  CO o 00 r- 00 VO T—< o o CMm oCM iq TT r-H m o o (N cq TT in M- CMCMin CM
VO id id vd id vd vd vd vd m vd vd id vd id vd id vdo o o o o o o o o o o o o o o o o o o
cn m q m r—f r- VO T—4 VO CM q O 00 VO CV CM
d d d T—• d d d d d d d d T—<d d d d d CM
+1 +1 +1 + 1
X
+1 4-1 4-l -M 4-1 4-1 4-1 4-1 4-1 -hi 4-1 4-1 4-1 -hi 4-1
O 00 m CM m ^ o o m o in tH o O m in o m q
CM in cn CM cn CM Tt CM cn tH o CM in cn CM in o m CM
cd T—4 r—1 cd cd cn cd cd CM CM CM cd cd CM CM T—t 4t CM T—1
CM CM CMCM CM CM CM CM CM CM CM CM CMCM CM CM CM CM CM
Tj- VO It CM \ \  r-H T—<CM CM VO (M CM m Tt cn Tt m VO
<Nm CM r- VO VO VO VO Lo m l^vOiOr^CvCMCMvO'^OOCTvCM^- Tt - vovoi nvomvovovovomvovo
t « ( n Wc f l c n a ) C« a i ( n wt n ( n ( n ( U' « ' « ' « ( U' " i Ui U< U< U< Uo B o o o o o o B o o B B B o o o ; - 4 0 ^ ^ ^ ^ j 4
P 4 p 4 p 4 f l 4 p 4 p 4 p 4 p 4 p 4 P 4 ( ^ P l 4 p 4 P l 4 P 4 P 4 p 4 P l 4 P 4 p 4 p 4 p 4 P l 4 P l 4
oooo c Mc <3 T- <v o ' ^ T- HLn c M' ^ c v c Mr - i i o c MT- i c n c r v T- <c Mc o c OLnCMCMCMCMCMCMCMCMCMCMCMrHCMCMCMCMCMCMr-iCMCMCMCNCM
L n o o o o c Mo o c n c Mc o o m o o r - L n ' r H ' O L O ' ^ ' ^ t ^ ' ^ c MO v o o o
l O M ’ L D i o m L O L n i O T f L n L O T t r t ^ i o i r i L O c n i o ^ T t - ' ^ ' ^ m
r - (CMcnr j - iovor -ooiovoTH c Mc n ' ^ i o \ o r ^ o o c v O ' < - i c Mr n i t  T-4 T—< T-4 T—I T—I T—I T—I T~< CM CM CM CM CM
I
c/5
Î  I
13
a
I I
f£
0cJI,
IIa 13
l |pQ a
I
CHAPTER 4____________________________________________ 102
4.4 Results
4.4.1 Reproducibility o f  arterial diameter measurements
The baseline brachial artery diameter was 3.3 ±  0.04 mm (mean ±  SEM) and 3.4 ±  0.04 
mm, with a corresponding coefficient o f variation o f 1.21 % and 1.24 % for the pre­
menopausal and postmenopausal women, respectively. Reproducibility o f %FMD could 
no t be calculated as scans were all performed at different clock times on the same day in 
each individual
4.4.2 Endothelium-dependent and -independent function in pre- and 
postmenopausal women
The average endothelial response (%FMD) in the pre menopausal women (9.9 ± 1 . 0  %; 
mean ± SEM) (n = 11) was significantly greater (P < 0.01) than in the postmenopausal 
women (6.5 ±  0.5 %; n = 10) (unpaired Student’s /-test) throughout the study. G TN - 
mediated dilatation (i.e. endothelium -independent function) was also significantly 
greater (P < 0.005) in the pre menopausal (18.2 ± 1 . 8  %; mean ±  SEM) than in the 
postmenopausal women (11.5 ± 1.6 %). To determine the minimum detectable difference 
o f  3.4% FMD between pre-menopausal and postmenopausal women, a power o f  0.64 was 
obtained. Linear regression analysis revealed a significant inverse correlation between 
%FMD and age (r — -0.45, d f = 20; P  <0.05) and %GTN-mediated dilatation and age (r =  
-0.59, d f =  20; P  <0.01) when the data from both study groups were combined. However, 
when the data fiom  each study group were analysed separately (i.e. pre-menopausal and 
postmenopausal data) there was no statistically significant relationship between %FMD 
and %GTN-mediated dilatation with age (Figure 4.1).
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4.4.3 Time o f  day and %FMD 
The %FMD in the pre-menopausal and postmenopausal women over the 22 h study is 
shown in Figure 4.2. Pre-menopausal women showed a variation in %FMD over time with 
the lowest values observed during the early part o f the day, gradually increasing through the 
evening and night. One-way ANOVA o f the data, however, revealed no significant 
differences in %FMD between the 12 time-points in either the pre- or postmenopausal
women.
14-1
12 -
4 -
2 -
8.30 10.30 12.30 14.30 16.30 18.30 20.30 22.30 24.30 2.30 4.30 6.30
Clock time (h)
Figure 4.2 Time-dependent variation in endothelium-dependent, flow-mediated dilatation (%FMD) 
of the brachial arter}  ^ during 22 h constant routine in pre-menopausal (n = 11) ( ■) and 
postmenopausal women (n = 10) (□). Data are expressed as mean ± SEM.
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Grouping the data into the two time periods: “day” 08:30-16:30 h  and “night” 18:30-06:30 
h (shown in Figure 4.3), %FMD was significantly lower (P < 0.05) in the day (9.2 ±  0.8 %) 
compared to the night (10.4 ± 1 %) in the pre-menopausal women paired Student’s /— 
test). In contrast, there was no significant variation in %FMD in the postmenopausal 
women (day 6.8 ±  0.6 %; night 6.0 ±  0.4 %). The postmenopausal women had significantly 
reduced %FMD during both time periods compared to the pre-menopausal women (day; P 
< 0.05 and night; P  < 0.005).
14-1
+1
C
I
8:30-16:30 18:30-6:30
ClockTime (h)
Figure 4.3 Variation in %FMD in pre-menopausal (■) (n =11) and postmenopausal (□) (n = 10) women. 
In pre-menopausal women, %FMD varied significandy between the two time periods (*P <0.05). Post­
menopausal women had significantly reduced %FMD during both time periods compared to the pre­
menopausal women (**P <0.05 during the day ***P <0.005 during the night).
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The majority o f women in the pre-menopausal group (9/11; 82%) showed an increase in 
FMD at night compared with the day. The postmenopausal women, however, did not 
show this increase in %FMD at night. O n the contrary, there was a trend towards a decline 
in FMD at night 80% (8/10) o f  the postmenopausal women showing a decline in 
endothelial function (Figure 4.4).
A. B.
16.0-1 16.0-1
14.0- 14.0-
12.0 -
8
g  10.0-
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1.0 -
6 .0 - 6 .0 -
4.0- 4.0-
2 .0 - 2 .0 -
0.0 0.0
18:30 - 6:301:30 -16:30 18:30-6:301:30 -16:30
Clock time (h)Clock time (h)
Figure 4.4 Individual %FMD responses in the (A) pre-menopausal (n = 11) and (B) postmenopausal 
women (n = 10).
4.4.4 Time o f day and GTN-mediated dilatation 
Endothelium-independent (GTN) function over the 22 h study is shown in Figure 4.5. 
One-way ANOVA o f the data showed no significant differences over time in either the 
pre- or postmenopausal women. Separation o f  the data into “day” and “night” periods also 
failed to show differences in the pre-menopausal (day 17.9 ± 1%; night 17.9 ±  2%) and 
postmenopausal (day 12.5 ± 2 %; night 11.9 ±  1 %) women.
CHAPTER 4 107
I
"O
T3Ü
o
25
20
15
10
5
0
06:3018:30 22:30 02:3010:30 14:30
Clock time (h)
Figure 4.5 Time-dependent variation in GTN-mediated dilatation o f the brachial artery 
during 22 h “constant routine” in pre-menopausal (n = 11) ( H )  and postmenopausal 
women (n = 10) ( □  ). Data are expressed as mean ± SEM.
There was a non-significant trend towards a decline in GTN-mediated dilatation at night 
(P = 0.07) with over half o f the pre-menopausal women (55%) and 50% o f the 
postmenopausal women showing reduced GTN-mediated dilatation at night (Figure 4.6).
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Figure 4.6 Individual GTN-mediated dilatation in the (A) pre-menopausal (n — 11) and 
(B) postmenopausal women (n = 10).
4.4.5 Time o f day and blood pressure and heart rate 
BP and H R varied significantly during the 22 h constant routine in both pre-menopausal 
and postmenopausal women (Figure 4.7). Two-way repeated measures ANOVA revealed a 
significant effect o f  time on SBP (F^ 22,374) ~  3.00; P <0.0001) and D BP (Fp2,3?4) — 2.08; 
P  <0.005) and HR (F ^ ^ ^  = 4.29 P <0.0001). SBP was significantly higher (P <0.05) in the 
postmenopausal women (overall mean 117 + 4.3 mmHg; mean + SEM) compared with 
the pre-menopausal women (109 ±  2.4 m m H ^, with no difference in DBP between the 
two groups. H R  was significantly higher in the pre-m enopausal wom en (overall m ean 
69 ±  2.5 beats/min) (P <0.05) compared with the postmenopausal women (60 ±  2.3 
beats/min) throughout the 22 h CR. There was no interaction between time and 
menopausal status in any o f  the measured variables.
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Figure 4.7 Time-dependent variation in (A) systolic and (B) diastolic blood pressure and 
(C) heart rate in pre-menopausal women (n = 11) (■ ) and postmenopausal women 
(n = 10) (□ ). Data are expressed as mean ± SEM.
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4.6 D iscussion
4.6.1 EndotheKum-dependent function
The results £com this study show that endothelium-dependent function (%FMD) was 
significantly reduced in postmenopausal women (6.5 ±  0.5%) compared with the younger, 
pre-menopausal women (9.9 ±  1.1%). This finding supports the results o f  other studies 
investigating endothelial changes in older and middle-aged women. Taddei et al. (1996) 
reported reduced forearm blood flow in response to acetylcholine, measured using strain- 
gauge plethysmography (section 1.1.7.1), in normotensive postmenopausal women (> 45 
years o f  age), compared with younger normally menstruating women. The phase o f  the 
menstrual cycle during which the pre-menopausal women were studied, however, was no t 
described. In a similar study in Japanese women, forearm blood flow responses to  reactive 
hyperaemia were found to be significantly impaired in postmenopausal women (48-59 
years) compared with younger pre-menopausal women (38-46 years) (Sanada et al., 2003a). 
The pre-menopausal women, as per the present study, were all investigated during the 
follicular phase o f  the menstrual cycle when endothelial function is reported to be greatest 
(section 1.1.5.2). In both o f these studies, all measurements were conducted in the morning 
(08:00-08:30 h) in a quiet, temperature-controlled room  after subjects had undertaken an 
overnight fast (Taddei et al., 1996; Sanada et ah, 2003a). Using similar methodology as the 
present study (i.e. brachial ultrasound), McCrohon, et al. (2000) also reported a significant 
decline in endothelium-dependent dilatation in postmenopausal women (2.7 ±  3%; 6 1 + 3  
years) compared with younger pre-menopausal women (8.4 ±  3%; 28+ 5 years) recruited 
fiom  the general population in Western Australia. All measurements were conducted in the 
study hospital or health centre, however, the paper did not describe any details pertaining 
to the study conditions such as subject nutritional status, menstrual cycle phase o f the pre­
menopausal women, environmental temperature and the time at which measurements were 
taken. The overall difference in FMD between the pre- and postmenopausal wom en as
CHAPTER 4_____________________________________  111
reported by M cCrohon et al. (2000) is greater than observed in the present study. This may 
be due, in part, to the differences in the experimental conditions compared with the 
present study.
Larger studies have shown that there is an age-related decline in endothelial function, 
which occurs at a steady rate in pre-menopausal women and to a much lesser extent than in 
men o f the same age (see section 1.1.4.7). However, there is a rapid decline in endothelial 
function in women after the menopause (> 50 years o f  age) compared with men, until 
around the age o f  60 years when the extent o f endothelial dysfunction is similar for both 
m en and women (Celermajer et al., 1994b; Taddei et al., 1996). Linear regression analysis o f  
the combined data from both the pre-menopausal and postmenopausal women in the 
present study showed a significant negative correlation between %FMD and age. However, 
when the data fiom  each study group were analysed independently, this inverse relationship 
between endothelium-dependent function with increasing age was lost. This supports the 
findings o f other studies that did no t find an association between %FMD and age 
(Schroeder et al., 2000; Jensen-Urstad and Johansson, 2001). Thus, the results fiom  the 
present study suggest that although there may still be a general effect o f  ageing on 
endothelial function in both men and women, there appears to be some additional factor 
which influences that rate o f  decline in endothelial function in postmenopausal women, 
which does not occur in men.
It is plausible that the rapid decline in endothelial function that occurs around the time o f  
the menopause is related to the rate o f change in endogenous hormone levels, in particular 
the decline in the circulating levels o f  endogenous oestrogen in women after the 
menopause (section 1.1.4.7). In contrast, the higher circulating levels o f endogenous 
oestrogen in pre-menopausal women may confer some degree o f protection to the vascular
CHAPTER 4_________________________________________________________________ 112
endothelium fiom  the debilitating effects o f  physiological ageing (section 1.1.5.1). This 
theory is supported by the evidence that oestrogen replacement therapy can acutely 
improve endothelial function in postmenopausal women (see section 1.1.5.5).
4.6.2 Endothelium-independent function
Endothelium-independent (GTN-mediated) function was also significantly greater in the 
pre-menopausal women compared with the postmenopausal women suggesting that both 
the endothelium and underlying smooth muscle are less responsive in women after the 
menopause. These findings support the work o f McCrohon et al. (2000) who reported an 
impaired response to sublingual G TN  in postmenopausal (61 ± 3 years) women compared 
with younger pre-menopausal (28 ±  5 years) women.
Linear regression analysis o f  the combined data fiom  the pre-menopausal and 
postmenopausal women also showed a significant inverse correlation between G TN - 
mediated dilatation and age. This inverse relationship between increasing age and smooth 
muscle function did no t persist when the data fiom  each study group were analysed 
independently. This lack o f an age-dependent effect on smooth muscle function is in 
agreement with the findings o f other studies in both men and women (Celermajer et al., 
1994b; Schroeder et al, 2000; Jensen-Urstad and Johansson, 2001).
4.6.3 Time o f day and endothelium-dependent function
A major finding o f  this study is the absence o f  a day/night rhythm in endothelial function 
in postmenopausal women studied under controlled CR laboratory conditions. This has 
no t been reported previously. In contrast, in pre-menopausal women %FMD showed a 
variation over time with the lowest values observed during the early part o f  the day, 
gradually increasing through the evening and night. When subdivided into two time
CHAPTER 4_________________________________________________________________ 113
periods, a significant increase in %FMD was observed in pre-menopausal women at 
“night” compared to the “day” . Our finding supports the results o f previous studies in 
young men and pre-menopausal women showing that the sensitivity o f  the vascular 
endothelium to shear stress induced by increased blood flow is maximal at night and lowest 
in the morning hours in healthy individuals under normal conditions ^ a b le  1.1, section 
1.2.5.1). Since the mechanism o f vasodilatation is mediated by endothelium-derived factors, 
in particular N O  (section 1.1.2.2), this finding implies that the release o f these mediators 
may be subject to circadian control.
Although the conditions within the experimental laboratory, in the present study, were 
regularly monitored and the ambient internal temperature remained constant throughout aU 
o f the studies, there was undoubtedly a difference between studies in the external 
environmental temperature outside o f  the laboratory as studies were conducted throughout 
the year. Consequently it is possible that there may be a seasonal effect on endothelial 
function that was not accounted for in the study. However, a previous study investigating 
endothelial function in younger pre-menopausal women (mean age 27.8 years) conducted 
during winter and summer months, did not find any effect o f season on %FMD (Klein- 
Weigel et al., 2003). However, the average time interval between subject arrival at the CIU, 
in the controlled temperature conditions, and the first %FMD measurement (at 08:30 h) 
was less than 1 hour. I t is possible that this may explain the variability o f the first %FMD 
measurement, but it is unhkely to have affected subsequent measurements as there was a 2 h 
interval between successive FMD measurements thus the subjects would have been 
acclimatised to the temperature conditions o f  the CIU.
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4.6.4 Time o f day and endothelium-independent function
In contrast to endothelium-dependent vasodilatation (section 4.6.3), endothelium- 
independent (GTN-mediated) vasodilatation did n o t show a significant variation over time. 
This finding supports the study o f Gaenzer et aL (2000) who reported no significant 
difference in GTN-induced brachial artery dilatation over time with values o f  15.7%, 
15.0% and 13.7% at 08:00 h, 12:00 h and 16:00 h, respectively in young men (28-37 years). 
More recently, O tto et al. (2004) reported similar results in older men and women (mean 
age 42 years) over different time periods with values o f 17.3%, 17.2% and 18.5% at 
21:00 h, 06:00 h and 11:00 h, respectively.
However, in the present study there was a non-significant trend towards a decline in G TN - 
mediated dilatation over time in both groups o f women, which could be a result o f  nitrate 
tolerance in response to repeated dosing and thus reduced efficacy. However, continuous 
therapy with G TN  at a much greater dose than in the present study (0.6 m g /h /2 4  h for 
6 days) has been shown to impaic FMD but not GTN -mediated dilatation (Gori et aL, 2004). 
In  the present study, the dose o f G TN  administered was much lower (0.025 m g/4h) and 
after repeated doses o f G TN  had been administered FMD was found to increase rather 
than decline. Thus the rate o f  administration and dose o f G TN  used in the present study 
was sufficient to induce dilation o f the smooth muscle but had no direct effect on the 
endothelium-dependent response.
I f  the smooth muscle response to stimulation is preserved throughout 24 h, increased 
bioavailability o f endothelium-derived N O  balanced with the production o f other 
substances at night (such as a decrease in N O  inhibitor production) could lead to enhanced 
vasodilatation and could, in part, ejqjlain the observed increase in endothelium-dependent 
function in the present study.
CHAPTER 4_________________________________________________________________ 115
4.6.5 Blood pressure 
The results fiom  the present study showed that SBP was significantly higher in 
postmenopausal women compared with the pre-menopausal women, widi no difference in 
DBP between the two groups. Investigations into the influence o f  menopause on BP, has 
provided conflicting reports. The results fiom an early longitudinal study conducted in the 
Netherlands (1979-1989), showed that the number o f  years since menopause was 
negatively correlated with both SBP and DBP at a rate o f decline o f 1.34 m m Hg and 0.63 
mmHg/year, respectively (van Beresteyn et aL, 1989). In contrast, Staessen et al. (1989) 
reported higher SBP (132 ±  17 m m H ^ and DBP (81 ±  9 mmHg) in postmenopausal 
women (mean age 53 ± 5 years) with an increase o f 0.5 m m Hg/year in SBP with age, 
compared with younger, leaner pre-menopausal women (mean age 43 ±  5 years). Although 
the pre-menopausal women in the study by Staessen et al. had significantly lower body 
mass, the difference in BP between the pre- and postmenopausal women persisted after 
correction for BMI. Similarly, Portaluppi et al. (1997) reported higher SBP in healthy 
postmenopausal women (134 mmHg) compared with both pre-menopausal (129 mmHg) 
and peri-menopausal women (131 m m H ^, with no significant difference in DBP. After 
correction for BMI, blood pressure changes associated with menopausal status persisted, 
bu t statistical significance was lost after correction for age. These two studies agree with 
the results o f the present study although the mean values for SBP were much lower in the 
current study (pre-menopausal 109 ±  4 mmHg; postmenopausal 117 ±  4 mmHg) than 
those reported in the previous studies. Differences between these studies and the present 
study may be largely a result o f  the different subject selection criteria. In  particular, there 
were no significant differences in BMI between the pre-menopausal and postmenopausal 
women who participated in the current study and since an increase in body mass is 
associated with an increase in both SBP and DBP in women, especially in older women
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(~ 50 years old) (Kaufitnan et al., 1997; Wilsgaard et al., 2000; Droyvold et al., 2005), this 
could explain, in part, the higher BP readings observed in other studies. In addition, the 
women in the present study were maintained under CR conditions during which nutrient 
intake and activity were controlled and subjects were maintained under very low lighting 
conditions. These controlled experimental conditions minimise the effects o f exogenous 
stimuli and may also have resulted in subjects being in a more relaxed state thus resulting in 
lower BP readings.
The results o f previously reported CR studies do not show evidence o f a circadian riiythm 
in BP (Kerkhof et al., 1998; van Dongen et al., 2001) and thus it has been postulated that 
the day-night differences observed from 24 h ambulatory BP data are solely the result o f 
sleep-wake and exogenous, environmental effects. However, in contrast with these 
findings, the results fiom  the present study show that both SBP and DBP varied 
significantly over time, with levels being higher during the day than at night in both  the 
pre-menopausal and postmenopausal women. It is difficult to determine the reasons for 
the discrepancy in the results. Since the conditions o f the CR in the present study are 
comparable with those reported in the previous studies (Kerkhof et al., 1998; van Dongen 
et al., 2001), with subjects maintained awake in semi-recumbent posture, allowed 
intermittent toilet breaks, with regular nutrient intake under conditions o f  CR and dim 
light. However, in the present study, the frequency o f  postural changes was hkely to have 
been greater than in the previously reported studies (Kerkhof et al., 1998; van D ongen et 
al., 2001). Firstly, the practical restrictions o f  the ultrasound protocol (section 2.4) m eant 
that the subjects’ posture changed fiom a semi-recumbent to a supine position. However, 
these postural changes occurred at regular (2 h) intervals and would have been consistent 
for all subjects. Secondly, although subjects were encouraged to take toilet breaks only in 
the interval between measurements, the frequency and duration o f  these breaks were no t
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monitored, thus there may have been some differences in the amount o f postural changes 
between individual subjects.
The light levels o f  the present study were much lower (< 1 0  lux) than in previous studies 
(< 100 lux), however, there is no evidence in the literature to suggest that bright light has 
any effect on BP, thus it is unlikely that differences in ambient light levels would affect the 
outcome o f the results.
In  addition, the subjects in the present study were administered with a vasodilator (GTN) 
at regular (4 h) intervals. Adrninistration o f G TN  (at a dose o f between 0.3-0.8 mg) has 
been shown to induce acute reductions in both SBP and DBP in patients with CAD 
(Sumimoto et al., 1993; Kawakami et al., 1995; Kiraly et al., 1998), The dose administered 
in the present study was lower at 0.025 mg. W hether this dose had a significant effect on 
the levels o f blood pressure immediately following administration o f G TN  was not 
determined in the present study. However, G TN  is rapidly metabolised and its metabolites 
are cleared from the circulation after approximately 40 minutes (section 1.1.6). 
Nonetheless, since the blood pressure measurements were conducted at hourly intervals, it 
is possible that there may have been some residual effect o f  G TN  administration on the BP 
readings taken after the corresponding endothelium-independent measurement had been 
conducted.
In a more recent study in younger male and female subjects (19-38 years) maintained under 
modified CR conditions (awake, semi-recumbent, under dim light (< 25 lux), liquid meals 
provided every 2 h during bed restriction), a significant negative correlation was found 
between DBP and CBT (r = -0.3, P  <0.05) such that an increase in DBP occurred during 
the descending portion o f the CBT curve (reaching a nadir around 05:00 h  and remaining
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low until around 09:00 h) (Conroy et al., 2005). This result is in agreement with the BP 
profiles o f both SBP and DBP in the present study with the increase in BP occurring fiom  
around 24:00 h, which suggests that, contrary to the findings o f  some other studies 
(Kerkhof et al., 1998; van Dongen et al., 2001), there does appear to be some endogenous 
control o f  BP variation in men and women.
4.6.6 Heart rate
H R was also shown to display circadian rhythmicity, with markedly reduced levels during 
the night in both pre-menopausal and postmenopausal women. This result is consistent 
with several studies in the literature describing a circadian variation in H R under CR 
conditions (Krauchi and Wirz-Justice, 1994; Burgess et al., 1997; Scheer et al., 1999; Van 
Dongen et al., 2001). The daily rhythm in H R is thought to be mainly due to changes in 
cardiac vagal tone (i.e. brainstem parasympathetic regulation o f cardiac activity via the 
vagus nerve) (Scheer et al., 2004), which prepares the body for the activities o f the day.
H R is also sensitive to light o f different intensities, increasing in response to increasing 
light levels (Scheer et al., 1999). This suggests, that under normal conditions, the increase in 
H R  in response to increasing light levels in the early morning upon awakening may be 
partly regulated by sympathetic cardiac activity.
One unexpected finding in the present study, was the significantly higher H R in the pre­
menopausal women compared with the postmenopausal women. Since H R has been 
shown to increase and HRV to decrease with increasing age in healthy men and women 
(Tasaki et al., 2000), it would be e^qpected that the postmenopausal women would have 
higher HR. The pre-menopausal women who participated in the present study were aU 
healthy, non-smokers and had adhered to the same pre-study conditions as the 
postmenopausal volunteers. In addition, both groups o f  women were studied under the
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same CR conditions and all measurements were taken using the same methodology 
(section 2.5). Several studies have reported higher resting H R during the luteal phase o f the 
menstrual cycle when compared with the menstrual and follicular phases (Hassan et aL, 
1990; Manhem and Jem , 1994; M oran et al., 2000). The pre-menopausal women in the 
present study were all studied during the follicular phase o f  the menstrual cycle; 
consequently the reasons for this difference in H R remain unclear. A repeat o f the HR 
assessment in healthy pre-menopausal and postmenopausal women under CR conditions is 
required to confirm these results.
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Chapter 5: Circadian rhythms in melatonin, subjective mood and 
performance and the relationship with vascular function
5.1 Introduction
Changes in both physiological and neurobehavioutal function are regulated by both  the 
endogenous circadian pacemaker and sleep-wake homeostasis. Normalising data according 
to circadian phase serves to isolate the endogenous circadian profile o f  the variable o f  
interest by removing the contribution o f clock time.
The circadian rhythms o f CBT and melatonin are known to be associated with 
neurobehavioural rhythms such as subjective alertness and cognitive performance (section 
1.2.3.1). During sleep deprivation, both alermess and performance have been shown to 
decline as the period o f wakefulness increases and are lowest near the CBT minimum (Dijk 
et al., 1992; Monk et al., 1997) and peak o f melatonin production (Cajochen et aL, 1999; 
Leproult et al., 2003). Much o f the human research has focused on men and younger 
women; however, none have specifically investigated the effects o f the menopause on the 
endogenous melatonin rhythm and its relationship to neurobehavioural variables and 
vascular function.
5.2 Aims
The aims o f  the studies presented in this chapter, were to investigate the effect o f  the 
menopause on the circadian rhythm in melatonin. To test the hypothesis that the nocturnal 
increase in melatonin concentrations contributes to decrements in alertness, sleepiness and 
performance under CR conditions. To determine whether the observed rhythm in 
endothelial function in pre-menopausal women (section 4.4.3) persists when normalised as
CHAPTER 5_________________________________________________________________ 122
a function o f  each individuals’ circadian phase and its relationship to the endogenous 
circadian rhythm in melatonin.
5.3 Methods
The work presented here was conducted as part o f  the study described in chapter 4.
5.3.1 Protocol
Each subject recorded the details o f their habitual sleep-wake pattern in a sleep diary 
(section 2.6.1) for three days prior to the study. Saliva samples were collected at hourly 
intervals prior to consuming each study ‘meal’ (section 2.3.3). Saliva samples were frozen 
(-20°C) immediately upon collection, for later analysis. Measures o f  subjective mood, 
alertness and sleepiness and performance were assessed hourly, following collection o f  the 
saliva sample. M ood and alertness was recorded using a visual analogue scale (section 
2.9.2). Subjective sleepiness was determined using two methods, the Karolinska Sleepiness 
Scale (KSS) (section 2.9.3) and Samn-PereDi (SP) sleepiness scores (section 2.9.4). 
Psychomotor performance (the co-ordination o f cognitive processes and visual-motor 
activity) was assessed using the Digit Symbol Substitution test (DSST) (section 2.9.5).
The FMD, blood pressure and heart rate data for each individual subject were binned 
according to each individual’s circadian phasing using DLM O (section 5.3.4). The value o f 
the dependent variable that corresponded to the DLM O was set to circadian time, CT14 
(Lockley et al., 2000). CT 14 is estimated relative to the timing o f  awakening or “lights on”, 
which is taken to be CT 0. On average, the time o f the DLM O occurs 14 h after lights on.
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5.3.2 Melatonin assays 
Saliva samples were thawed on the day o f assay and centrifuged at 3500 rpm  for 10 mins at 
4°C. Salivary melatonin was measured by specific radioimmunoassay (see section 2.7). The 
limit o f  detection o f the assay was < 2 pg/m l. The intra-assay coefficients o f variation (CV) 
were 12%, 5% and 12% and the inter-assay CVs were 13%, 16% and 9% for the low 
(7 pg/m l), medium (15 pg/m l) and high (50 pg/m l) pooled saliva samples, respectively.
5.3.3 Data analysis
M elatonin concentrations were analysed as absolute values and the incremental area 
under the curve (AUC) calculated using the trapezoid method. The time o f  melatonin 
onset was defined as the time o f  melatonin onset at midrange (melon50%) and was 
used as the primary marker o f  melatonin phase (section 2.9.2.2). Individual melatonin 
rhythms were normalised to baseline (mean o f  each subject’s melatonin values between 
12:00-14:00 h). The amphtude o f  the melatonin rhythm  was defined as the difference 
between the baseline and the peak (mean o f  the three highest melatonin values). Single 
cosinor analysis was used to determine the melatonin acrophase (peak time o f  
production). Melatonin offset (meloff50%) and melatonin duration could n o t be 
calculated as m ost o f  the subjects’ melatonin profiles faded to  return to basal levels by 
the end o f  the sampling period (06:00 h). D ata from  two postm enopausal wom en had 
to be excluded from  the analysis as one woman failed to  complete the entire study and 
the other had no detectable melatonin rhythm.
Two-way repeated measures ANOVA (SPSS v. 11.0.3, SPSS Inc., Chicago, XL, USA) was 
used to determine the effect o f circadian phase on blood pressure and heart rate. One-way 
repeated measures ANOVA (GraphPad Instat™, GraphPad Inc, San Diego, CA, USA) 
was used to determine the effect o f circadian phase on vascular function for each study
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group (due to missing data between time points two-way repeated measures ANOVA 
could not be used).
All raw data from the visual analogue scales (alertness, mood, anxiety and energy), 
sleepiness and performance (DSSl) data were analysed according to clock time. The data 
were also normalised to baseline (which was taken as the mean o f all the values between 
08:00 h-18:00 h) and subsequently adjusted for circadian phase. The amplitude o f  the 
alertness/sleepiness rhythm was defined as the difference between the baseline and peak 
(mean o f  the three highest values). Alertness offset (alert50%ofQ and sleepiness onset 
(sleepiness50%on) were defined as the time midrange between the baseline and peak 
values. All raw data values were subjected to two-way repeated ANOVA (factors: time o f 
day and menopause). The data from one subject was excluded from the analysis as she had 
failed to complete the study and the data set was incomplete. Parameters derived from the 
melatonin and alermess rhythms were compared between the pre- and postmenopausal 
women using unpaired Smdent’s t  tests.
Relationships between the changes (expressed as the relative magnimde o f increase or 
decrease) in melatonin concentrations, subjective alermess, sleepiness and mood, 
psychomotor performance (DSST) and %FMD were examined using linear regression 
analysis (Prism™ v4.0, Graphpad Software Inc., San Diego, CA, USA). Relative 
magnimdes were calculated as the maxima minus the minima (i.e. the amplimde) and 
expressed as a percentage o f  the maximum obtainable value (for subjective measures and 
performance scores), or as a percentage o f the overall mean across the smdy period (for 
salivary melatonin concentrations and %FMD values) (Leproult et aL, 2003). D ata are 
expressed as the mean ± SEM. Statistical significance was defined as P  <0.05.
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5.4 Results
5.4.1 Pre-study habitual sleep-wake patterns 
In the three days before the study (pre-study conditions) there were no significant 
differences in habitual sleep timing (onset and offset) between the pre-menopausal and 
postmenopausal women (Table 5.1). In addition, there was no significant difference 
between the average length o f sleep between the pre-menopausal and postmenopausal 
women (Table 5.1).
Table 5.1 Pre-study sleep patterns in the pre- and postmenopausal women
Pre-menopausal 
women (n = 11)
Postmenopausal 
women (n = 8) Significance*
Age (years) ± SD 42 ± 4 55 ± 2 P <0.0001
Horne-Ostberg score ± SD 62 ± 7 63 ± 7 NS
PSQI Score ± SD 3 ± 7 4 ± 2 NS
Habitual sleep onset (h ± SEM) 23.1 ± 0.2 22.7 ± 0.2 (n = 7) NS
Habitual sleep duration (h ± SEM) 7.2 ± 0.2 7.1 ± 0.2 (n = 7) NS
Habitual sleep offset (h ± SEM) 6.2 ± 0.1 5.7 ± 0.3 (n = 7) NS
Sleep data are expressed in decimal hours. ^Unpaired Student’s t test. NS — Not significant
5.4.2 Salivary melatonin 
Salivary melatonin profiles in pre- and postmenopausal women plotted as a function o f  
clock time are shown in Figure 5.1. There was a large inter-individual variation in 
melatonin concentrations within each study group. Peak melatonin concentrations ranged 
from 10—58 pg /m l in the pre-menopausal women and 17--49 pg /m l in the postmenopausal 
women. Two-way repeated measures ANOVA carried out on the raw melatonin data 
showed a significant effect o f time (F(i^) = 17, P  < 0.0001) but no effect o f menopausal
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status and no interaction between time and menopausal status. The melatonin rhythm 
parameters in the pre-menopausal and postmenopausal groups are shown in Table 5.2.
Postmenopausal women had significantly earlier melatonin acrophase times (1.1 ±  0.5 h) 
compared to the pre-menopausal women (2.3 ±  0.3 h) (P <0.05). Postmenopausal women 
also had earlier melatonin onsets (20.9 ±  0.4 h) compared to the pre-menopausal women 
(22.3 ±  0.5 h), however this was just short o f  statistical significance (P =  0.057). The 
baseline melatonin values were higher in the postmenopausal women (16 ±  2 pg/m l) 
compared with the pre-menopausal women (11 ±  2 pg/m l) although this was not 
statistically different. The melatonin amplitude was reduced in the postmenopausal women 
(15 ±  2 pg/m l) compared with the pre-menopausal women (21 ±  5 pg/m l), which can be 
seen more clearly from the normalised data (Figure 5.1). There was no statistical difference 
between the melatonin amplitude measures or incremental AUCs between the two groups 
o f  women (Table 5.2).
5.4.3 Subjective alertness and sleepiness 
As expected, subjective alertness declined and sleepiness increased in both groups as the 
period o f sleep deprivation increased during the constant routine experiment (Figure 5.1). 
Two-way repeated measures ANOVA revealed a significant effect o f time on alertness 
(F(i^) = 18, P  <  0.0001) and on the two measures o f subjective sleepiness (KSS: F^ ^^ gz) ~  27, 
P < 0.0001; SP: F^j^^ = 31, P  < 0.0001). The greatest decline in alermess levels and 
increased sleepiness occurred between 22:00-06:00 h in both groups o f  women. The time 
o f  alermess offset (alert50%off) and sleepiness onset (sleep50%on) was no t significantly 
different between pre- and postmenopausal women (Table 5.2). There was also no 
significant difference in the amplimde o f the alermess/sleepiness rhythms between the pre­
menopausal and postmenopausal women (Table 5.2). The decline in alermess and
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increased sleepiness coincided with melatonin production with the melatonin profiles 
mirroring the alermess/ sleepiness profiles (Figure 5.1). Menopausal stams, however, had 
no significant effect on these measures and there was no interaction between time and 
menopausal stams.
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Figure 5.1 Clock time-dependent variation of (A-B) Salivarj^  melatonin, (C-D) Karolinska subjective sleepiness, 
(E-F) Samn-PerelH subjective sleepiness and (G-H) subjective alterness in pre-menopausal women (n = 11) (■) 
and postmenopausal women (n = 8) (□). Values are expressed as raw data (left panel) and normalised to 
baseline (taken as the mean of all values between 12:00-14:00 h for the melatonin data and the mean of aU values 
between 08:00-18:00 h for the subjective data (right panel). Data are expressed as mean ± SEM.
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Table 5.2 Melatonin and alertness/sleepiness rhythm parameters in the pre- and postmenopausal 
women
Pre-menopausal 
women (n = 11)
Postmenopausal 
women (n = 8) Significance*
Melatonin AUC 238 ± 105 247 ± 89 NS
Melatonin onset (h) (melon50%) 22.3 ± 0.5 20.9 ± 0.4 P = 0.057
Melatonin amplitude (pg/ml) 21 ± 5 15 ± 2 NS
Melatonin acrophase (h) 2.3 ± 0.3 1.1 ± 0.5 P <0.05
Alermess offset (h) (alert50%off) 23.2 ± 0.5 24.1 ± 1 NS
Alermess amplimde 
(arbitrary units)
1.2 ± 0.1 1.2 ± 0.2 NS
Sleepiness offset (h) 
(slcep50%ofQ KSS 
SP
23.5 ± 0.3
24.5 ±0.6
23.5 ± 0.8 
24.4 ± l(n = 7)
NS
NS
Sleepiness amplimde 
(arbitrary units) KSS 
SP
5.1 ± 0.4
5.1 ± 0.4
4.5 ± 0.4 
2.4 ± 0.4
NS
NS
Data are expressed in decimal hours as mean ± SEM. ^Unpaired Student’s t test.
(KSS: Karolinska sleepiness scale, SP: Samn-Perelli sleepiness scale, NS: Not significant)
The decrease in subjective alertness and increase in subjective sleepiness across the period 
o f sleep deprivation was no t significantly correlated with the amplitude o f the melatonin 
concentrations in either the pre-menopausal women (alertness: r  =  0.20; KSS: r  =  0.04;
SP: r  =  0.04; P  >0.05) or the postmenopausal women (alertness: r  =  0.16; KSS: r  =  0.07;
SP: r  =  0.02; P >0.05). The circadian phase adjusted rhythms o f subjective alertness and 
sleepiness are shown in Figure 5.2
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Figure 5.2 Circadian time-dependent variation of (A) salivary melatonin,
(B) Karolinska subjective sleepiness, (C) Samn-PereUi subjective sleepiness 
and (D) subjective alertness in pre-menopausal women (n = 11) (■ ) and 
postmenopausal women (n = 8) (□ ). Values are expressed as normalised to 
baseline. Data were corrected according to each individual’s circadian phase 
where melonSO% is designated as occuring at circadian time (CT) 14.
Data are expressed as mean ± SEM.
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5.4.4 Phase relationships
Melatonin onset (melon50%) preceded habitual sleep onset as well as the alertness offset 
and sleepiness onset in the constant routine protocol in both the pre-menopausal and 
postmenopausal women. The time interval (phase angle) between melatonin onset and 
alertness offset was significantly greater in the postmenopausal women (P <0.05) (Table
5.3). Similarly the phase angle between melatonin onset and sleepiness onset was larger, but 
no t significantly (P =  0.06), in the postmenopausal women (Table 5.3). In contrast, there 
was no significant difference in the phase angle between melatonin onset and habitual sleep 
onset (determined from subjects’ sleep diaries) between the pre- and postmenopausal
women.
Table 5.3 Time interval between melatonin onset, habitual sleep onset, alertness offset
Pre-menopausal 
women (n = 11) 
(minutes)
Postmenopausal 
women (n = 8) 
(minutes)
Significance*
Melatonin onset and habitual 
sleep onset
82± 16 100 ± 23 (n = 7) NS
Melatonin onset and alertness 
offset 90 ±25 226 ± 37 P <0.05
Melatonin onset and sleepiness 
onset KSS 
SP
85 ±19 
135 ± 31
180 ± 44 
207 ± 52 (n = 7)
P = 0.06 
NS
Data are expressed as mean ± SEM. ^Unpaired Student’s t test.
(KSS: Karolinska sleepiness scale, SP: Samn-Perelli sleepiness scale, NS = Not significant)
5.4.5 Subjective mood 
Two-way repeated measures ANOVA revealed a significant effect o f  time on m ood 
= 4, P  < 0.0001), anxiety =  5, P  <  0.0001) and energy (F^^^ =  27, P  < 0.0001). 
Subjective m ood and anxiety showed a moderate decline over time in both  pre- and 
postmenopausal women. M ood was lowest in the early morning hours between 03:00 h- 
05:00 h in both  groups o f women. Conversely, the greatest anxiety was experienced at the 
beginning o f  the study (08:00 h) in the pre-menopausal women, with very little change in
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anxiety levels throughout the study in the postmenopausal women (Figure 5.3). Subjective 
energy showed a decline comparable to the decline in alertness and the increase in 
sleepiness (Figure 5.1) in both study groups as the period o f  sleep deprivation increased 
(Figure 5.3). Energy was lowest between 23:00-06:00 h in both  the pre-menopausal and 
postmenopausal women. There was no significant effect o f  menopausal status, however, 
on these measures and there was no interaction between time and menopausal status for 
anxiety and energy. However there was a significant interaction between time and 
menopausal status for subjective measures o f m ood (F^^) = 2, P  <0.05), with higher 
m ood ratings in the pre-menopausal women during m ost o f the day, and no differences in 
m ood between the two study groups throughout the night and early morning hours (Figure
5.3). N o significant correlation was found between melatonin amplitude (expressed as a 
percentage o f the overall mean o f the 22 h study) and the subjective measures o f mood, 
anxiety and energy levels in either the pre-menopausal or postmenopausal women. The 
circadian phase adjusted rhythms o f subjective mood are shown in Figure 5.4.
5.4.6 Performance
A significant time o f  day variation was shown in DSST performance (the number o f 
symbol substitutions completed in 2 minutes) (F j^^  ^ =  4, P  < 0.001), with no effect o f 
menopausal status and no interaction between time and menopausal status (Figure 5.3). 
There was no significant correlation between melatonin concentrations and performance in 
either the pre-menopausal or postmenopausal women. The circadian phase adjusted 
rhythms o f  DSST performance are shown in Figure 5.4.
CHAPTER 5 133
^  Subjective m o o d B Subjective m o o d
1 0 - |
9 -
1
g
Improving y 
mood
C  Subjective anxiety
Reducing
anxiety
10-j
9 -
I
sS  6 -
f::
”  3 -  
§  2 -
g  Subjective energy
Increasing
energy
1 0 -1
9 -
s
-II
g
>
D S S T  Scores
100-1
7 0 -2
6 0 -
50
C lock  tim e (li)
140%-!
130% -
120% -
J  110% -
100%  ■
90%
o  80% -
70% -
60%
D Subjective anxiety
130% -
120% -
J
100% : '
2
1 80%-!
60%
Subjective energy
140% -,
I
80% -
2
-  60% -1 40% -z
20%
H D S S T  Scores
115% -.
S  1 1 0 % -
E
105%
100% -
95°/.
90% -
85% -
80% -1
8 10 12 14 16 18 20 22 24
C lock  tim e (h)
Figure 5.3 Clock time-dependent variation of (A-B) Subjective mood, (C-D) Subjective anxiety, (E-F) Subjective energ}^  
and (G-H) DSST Performance scores in pre-menopausal women (n = 11) ( ■) and postmenopausal women (n = 8) (□). 
Values are expressed as raw data (left panel) and normalised to baseline (taken as the mean of all values between 08:00 - 
18:00 h). Data are expressed as mean ± SEM.
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Figure 5.4 Circadian time-dependent variation of (A) subjective mood, (B), subjective anxiety,
(Q, subjective energy and (D) DSST performance scores in pre-menopausal (n = 11) ( g )  and 
postmenopausal (n = 8) (□ ) women. Values are expressed as normalised to baseline (taken as the 
mean of all values between 08:00-18:00 h). Data were corrected according to each individual’s 
circadian phase where melonSO% is designated as occuring at CT 14.
Data are expressed as mean ± SEM.
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5.4.7 Circadian phase adjusted rhythms in endothelial function
The profiles o f endothelium-dependent function (FMD) in pre- and postmenopausal 
women plotted as a function o f clock time and after adjustment for circadian phase are 
shown in Figure 5.5. The pattern o f  %FMD over time after correction for circadian phase 
mirrored the clock-dependent profile in the pre-menopausal women, with an apparent 
increase in %FMD occurring in the ‘morning’ hours. FMD in the pre-menopausal women 
was shifted by two hours after adjustment for circadian phase, with maximum values o f  
%FMD occurring at CT 22, corresponding to a clock hour o f approximately 06:30 h. In 
contrast, the maximum %FMD values occurred at CT 10 corresponding to a clock hour o f  
approximately 17:30 h  in the postmenopausal women (Figure 5.5). One-way ANOVA o f 
the data did not show any significant differences in %FMD with respect to circadian phase, 
in either the pre- or postmenopausal women. Linear regression analysis did no t show any 
significant relationship between melatonin concentrations and %FMD, in either the pre­
menopausal or the postmenopausal women.
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Figure 5.5 (A) Clock and (B) circadian time-dependent variation of endothelium-dependent flow-mediated 
dilatation (%FMD) in pre-menopausal (n = 11) ( ■  ) and postmenopausal (n = 10) ( □  ) women. 
Melon50% is designated as occurring at CT14. Data are expressed as mean ± SEM.
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5.4.8 Circadian phase adjusted rhythms in blood pressure and heart rate 
The profiles o f SBP and DBP and HR in pre- and postmenopausal women plotted as a 
function o f  clock time and after adjustment for circadian phase are shown in Figure 5.6. 
Two-way repeated measures ANOVA did no t show a significant effect o f circadian phase 
on SBP or DBP and no interaction between phase and study group. There was a significant 
difference in SBP between the pre- and postmenopausal women (F^ i =  5.77, P  <0.05), 
bu t no difference in DBP between the two smdy groups. SBP was higher in the 
postmenopausal women compared with the pre-menopausal women (section 4.4.5).
H R was significantly different between the two smdy groups (F^ 7^) = 5.99, P  <0.05).
H R varied significantly with circadian phase (^(22,374) ~  189, P  <0.05) with the lowest values 
occurring at CT15-16 corresponding to a clock time o f approximately 23:00 h-24:00 h  in the 
pre-menopausal women and a corresponding clock time o f approximately 20:00 h-21:00 h 
in the postmenopausal women, respectively.
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Figure 5.6 Clock (left panel) and circadian (right panel) time-dependent variation in (A-B) systolic and 
(C-D) diastolic blood pressure and (E-F) heart rate in pre-menopausal women (n = 11) (■ )  and 
postmenopausal women (n = 10) (□ ). Melon50% is designated as occuring at CT14.
Data are expressed as mean ± SEM.
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5.5 Discussion
5.5.1 Salivary melatonin rhythm 
A significant advance in the timing o f the melatonin rhythm was seen in postmenopausal 
women, with an advanced melatonin acrophase (peak) compared to the pre-menopausal 
women. The onset o f melatonin was also earlier in the postmenopausal women, although 
the data did not quite reach statistical significance. Similar findings o f an advanced timing 
o f  the melatonin rhythm have been reported in older adults. In a series o f experiments 
conducted under CR conditions, Duffy et al. (2002) found that the midpoint (defined as 
the midpoint o f  the upward and downward crossing o f the 24 h  mean value) o f the 
circadian rhythm o f plasma melatonin occurred approximately 1 h earlier in older subjects 
(men and women, mean age 67.8 ±  3 years) compared with younger men (23.4 ±  3.3 
years). In the present study, the acrophase o f melatonin production was advanced on 
average by 62 minutes in the postmenopausal women compared with that o f  the younger, 
pre-menopausal women. Yoon et al. (2003) also reported an earlier melatonin acrophase 
(37 minutes) in older subjects (men and women, mean age 66.2 ±  4.9 years) compared with 
younger subjects (men and women, mean age 23.7 ±  3.8 years). In both studies, there were 
also significant differences in at least one parameter o f the subjects’ habitual sleep-wake 
patterns. Duffy et al. (2002) reported earlier wake and bed times in the older subjects (> 1 
h). Similarly, Yoon et al. (2003) reported a 99 minute advance o f sleep offset (wake time) in 
older subjects but no difference in sleep onset between the two study groups. In  contrast, 
there were no significant differences between habitual sleep onset or sleep offset between 
the pre-menopausal and postmenopausal women in the present study, m ost likely reflecting 
the similarity in age between the two study groups. The difference in age between the 
young and older subjects in these studies (Duffy et al., 2002; Yoon et al., 2003) was much 
greater than in the present study. In addition, the data from the men and women in each 
age group were combined, thus any gender differences in the relative timing o f  the
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melatonin rhythms were not accounted for. I t is therefore difficult to compare the results 
o f the present study directiy with the findings o f  these published studies. W hether the 
phase advance observed in the present study is a result o f  the menopause and its associated 
hormonal changes or an effect o f age, or both, cannot be clearly distinguished.
The present study did not show a statistically significant difference in the amplitude o f  the 
melatonin rhythm between the healthy middle-aged pre- and postmenopausal women in 
CR conditions. This lack o f effect on amplitude is in agreement with the study o f Zeitzer et 
al. (1999), who studied the plasma melatonin profiles o f 34 healthy older men and women 
(aged between 65-81 years) compared with young men (aged between 18-30 years). The 
subjects were studied during a rigorously controlled 30 h CR protocol o f constant 
wakefulness, semi-recumbent posture whilst subjects’ were confined to bed under dim light 
o f  <15 lux, with equicaloric snacks and fluid given hourly. Under these controlled 
experimental conditions, there were no reported differences in the mean 24 h  melatonin 
production, melatonin acrophase or duration o f melatonin production between the young 
and older subjects (Zeitzer et al., 1999). This suggests that the reduced amplitude reported 
in numerous other studies (section 1.2.4.3) may be a result o f exogenous factors, such as 
the light-dark cycle, differences between study protocols such as the sampling rate or 
differences in subject selection criteria. The melatonin samples collected in the present 
study were obtained hourly ensuring that the melatonin onset and peak times were less 
likely to be missed. Another reason for the absence o f  a clear reduction in melatonin 
amplitude in the present study is the similarity in age between the pre-menopausal and 
postmenopausal women. This finding is in agreement with the results from an earlier study 
measuring 24 h 6-sulphatoxymelatonin (aMT6s) production in a larger group {n — 160) o f 
pre-menopausal and postmenopausal women (Skene et al., 1990). N o significant difference 
was observed in melatonin production between similarly aged pre-menopausal and
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postmenopausal women (age range 40-54 years). However, there was a significant decline 
in aMT6s excretion in older postmenopausal women (55-69 years) compared with pre­
menopausal women in the youngest age group (40-44 years), suggesting that age, rather 
than menopausal status, was responsible for the variation in urinary aMT6s excretion 
between the study groups (Skene et al., 1990). Postural changes have been shown to induce 
significant effects on endogenous melatonin production (section 1.2.4.3.2). A postural 
change, fiom  semi-recumbent to fully recumbent, occurred each time an ultrasound scan 
was conducted. However, these changes were introduced into each subject at roughly the 
same clock time, thus any effects o f posture on the melatonin rhythm would have been 
consistent for each subject. However, additional postural effects will have been introduced 
from the necessary toilet breaks. The frequency and duration o f  these changes was not 
recorded and will certainly have varied between individuals. N o effects o f differences in the 
ambient light levels were likely to have occurred as the lighting conditions both inside and 
outside (i.e. in the corridor, kitchen and bathroom areas) were all assessed prior to the start 
o f the study to ensure the levels were maintained below 10 lux (section 2.3).
In addition, the daytime levels o f melatonin were higher in the postmenopausal women 
although the differences in the basal melatonin values between the pre-menopausal and 
postmenopausal women were not statistically significant . I t is possible, however, that an 
increase in melatonin levels may have resulted from interference in the melatonin assay. 
However, there is no obvious reason for this difference since both the pre-menopausal and 
postmenopausal women were subjected to the same study conditions and restrictions and 
the same assay protocol was employed for analysis o f all the subject samples. Unfortunately 
there was insufficient sample remaining to be able to repeat the analysis in these subjects. 
Consequently, the actual value o f  the melatonin amplitude in the postmenopausal women 
in the present study may actually be an underestimate o f  the true value.
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Since the pte-menopausal women investigated in this study were aU assessed during the 
follicular phase o f  the menstrual cycle, the melatonin concentrations observed may thus be 
lower than seen in other phases o f  the menstrual cycle, as previous studies have reported 
higher melatonin levels in the luteal phase (Wetterberg et al., 1976; Webley et al., 1986,; 
Brun et al., 1987).
5.5.2 Subjective alertness and sleepiness 
There was no significant difference in the amplitude o f  the subjective alertness or 
sleepiness rhythms between the pre-menopausal and postmenopausal women in the 
present study m ost likely reflecting the small age differences between the two groups. Both 
the pre- and postmenopausal women showed similar patterns o f alertness and subjective 
sleepiness. Melatonin onset preceded both the decline in alermess and onset o f  sleepiness 
by approximately 1-2 h in the pre-menopausal women and by 2-4 h in the postmenopausal 
women. This finding is in agreement with previous studies investigating subjective alermess 
and sleepiness under CR conditions o f  prolonged wakefulness in which the decrease in 
alermess has been shown to occur 1 h  before to 4 h after melatonin onset (Leproult et al., 
2003) and an increase in subjective sleepiness occurs within 2 h  o f melatonin onset 
(Cajochen et al., 1999).
During the day when endogenous melatonin is lowest, subjective ratings o f  alermess were 
highest and sleepiness lowest while during the night, when melatonin levels are high, 
alermess declined and sleepiness increased. A similar decline in alermess during a 24 h 
period o f sleep deprivation has been reported previously in younger pre-menopausal 
women (aged 18-28 years) investigated under CR conditions across the luteal and foUicular 
phases o f the menstrual cycle (Wright J r  and Badia, 1999). Subjective alermess was found 
to be lowest for women during the follicular phase o f  the menstrual cycle, near the
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temperature minimum and midpoint o f melatonin secretion (Wright J r and Badia, 1999). 
The reduced alermess and increased sleepiness observed during the sleep deprivation 
period o f the CR protocol are m ost likely due to the interaction o f increased sleep pressure, 
related to the duration o f prior wakefulness and circadian phase (Dijk et al., 1992; M onk et 
al., 1997) and have been shown to result from global decreases in brain activity, 
predominantly throughout the thalamus and preffontal cortex o f  the brain (the regions 
which mediate attention and higher order cognitive processes) (Thomas et al., 2000).
5.5.3 Subjective m ood 
There were clear effects o f sleep deprivation on all the mood variables smdied in both  the 
pre-menopausal and postmenopausal women. Both subjective feelings o f  m ood and 
anxiety were lowest at the beginning o f the smdy, which could be attributed to an initial 
adjustment to the CR smdy conditions and anticipation o f  measurements being conducted, 
and during the early morning hours after several hours o f  sustained wakefulness, however, 
this is assumption is purely speculative. The self-reported decline in energy paralleled the 
decline in alermess and was inversely related to the increase in melatonin during the night. 
A  significant variation in m ood with circadian phase has been shown in younger subjects 
(aged 18-21 years) during a 30 h forced desynchrony protocol (Boivin et al., 1997). M ood 
was rated as subjective cheerfulness and happiness using a visual analogue scale, w ith a 
higher mood score relating to a more cheerful and happier disposition. The lowest scores 
for subjective m ood coincided with the circadian trough o f the endogenous temperature 
rhythm (corresponding to a clock time o f  approximately 06:00 h). In contrast, the highest 
scores for subjective mood occurred at an approximate clock time o f 14:00-22:00 h (Boivin 
et al., 1997).
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Subjective m ood is influenced by an interaction o f circadian phase and duration o f prior 
wakefulness, such that changes in the timing o f the sleep-wake cycle may have profound 
effects on subsequent m ood (Boivin et al., 1997). There were no significant differences in 
subjective m ood between the pre-menopausal and postmenopausal women in the present 
study. This finding is consistent with the results o f  a previous study, conducted under CR 
conditions, in young men and women (aged between 20-30 years) and healthy 80 year olds, 
showing no difference in temporal trends o f subjective m ood between the two age groups 
(Buysse et al., 1993).
5.5.4 Performance
Performance, as measured from the digit symbol substitution test (DSST), declined 
significantly as the period o f sleep deprivation increased, with the lowest performance 
levels occurring between 01:00 h and 08:00 h in both  groups o f  women. There were no 
significant differences in performance scores between the pre-menopausal and 
postmenopausal women throughout the study period. This decline in cogmtive 
performance associated with maintained wakefulness during the CR protocol has also been 
shown to occur in younger women (18-28 years), with the lowest levels o f performance 
occurring between 02:00 h and 08:00 h coinciding with the peak o f  melatonin secretion and 
the trough in core body temperature (Wright Jr. and Badia, 1999). Cognitive performance 
was also shown to be higher in young women during the luteal phase o f the menstrual 
cycle and in women on oral contraceptives, compared to women in the follicular phase o f 
the menstrual cycle (Wright Jr. and Badia, 1999). Since the pre-menopausal women in the 
present study were all investigated during the follicular phase o f the menstrual cycle, this 
may have resulted in lower performance scores than may be seen during other menstrual 
phases thus explaining the lack o f observable differences between the pre-menopausal and 
postmenopausal women. In addition, reduced performance on the DSST has been shown
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to be related to both increasing age (Gilmore et al., 1983) and male gender (MacDonald et 
al., 2003). The similarity in age between the two groups o f women in the present study 
could again account for the lack o f  difference in DSST performance scores between the 
two study groups.
In order to account for the influence o f  learning on the DSST, subjects were provided with 
sufficient practice sheets to be completed during the week prior to the CR study, iu their 
own time at home. However, compliance was difficult to determine, as many o f  the 
subjects did no t return the completed practice sheets. Thus influence o f  the learning 
process on the observed results cannot be excluded and the true magnitude o f  the 
impairments observed may have been masked by learning in some subjects.
5.5.5 Endothelial function 
A similar pattern o f endothelial function, with a slight increase in %FMD across the 
normal 'sleep period' reaching the highest values in the early morning and declining around 
the normal ‘wake’ period, exists for both clock time-dependent and ciccadian phase- 
adjusted data in pre-menopausal women.
Considering the data as a function o f clock time, a significant difference in endothelial 
function between ‘day’ and ‘night’ was observed in the pre-menopausal women with no 
such variation in the postmenopausal women (see Chapter 4). W hen the data are 
subsequently corrected for an individuals’ circadian phase, however, no phase-dependent 
variation in endothelial function was observed in the pre-menopausal women. This finding 
suggests that there is no endogenous circadian rhythm in endothelial function and the day- 
night variation obsen^ed in pre-menopausal women is hkely to be the result o f the interplay 
o f  as yet, unidentified exogenous factors. In  a previous study reporting a day-night
CHAPTER 5_________________________________________________________________ 145
variation in endothelial function in pre-menopausal women, CR methodology was no t 
employed and the authors did no t account for the individuals’ circadian phase (Ringqvist et 
al., 2000). Thus, it is likely that the observed day-night rhythm reported in this study is also 
influenced by additional confoundiag factors, such as hght, posture, meals and sleep.
As described earlier (section 2.3) the CR protocol is designed to minimise the influence o f 
exogenous factors on the variables being measured (Mills et al., 1978). However, in the 
present study it was difficult to exclude aU these variables completely. Some postural 
changes occurred during the present study as a consequence o f the FMD measurements. 
However, these were consistent for all subjects and occurred at the same clock time. Toilet 
breaks were allowed although these were encouraged to  occur in the periods in-between 
measurements. Nonetheless, the exact time, duration and frequency at which these 
occurred was no t recorded and will have differed between individual subjects. Light levels 
in the CIU were assessed before each study with the television set switched on and o ff to 
ensure there were no major variations in ambient light levels. However, minor variations in 
hght emanating firom the television set as the viewing programs changed were likely and 
this was not monitored continuously throughout the study. The ambient temperature o f  
the CIU was assessed at each measurement interval and remained stable throughout the 
study at between 22-25 °C, thus although there were slight variations in ambient 
temperature there were no reports o f extreme cold ‘shivering’ or extreme heat ‘sweating’ 
from the subjects which could have directly influenced the results. Despite the above 
changes in posture, light and temperature, these Hctors are Hkely to have had a minor 
effect on the measured endothelial function and the melatonin rhythms.
It is also possible that the rhythmic output o f  some other physiological variable, which was 
no t measured in the present study, may have an influence on endothelial function and the
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observed day-night variation. Rhythms in several cardiovascular variables have been 
reported such as N O , endothelin-1, cell adhesion molecules and fibrinolytic factors (see 
section 1.5.1), all o f which are known to interact with the vascular endothelium. Thus, 
future CR studies may be required to determine whether the reported rhythm iu any o f 
these variables is endogenous and what effect, if  any, they may have on the endothelial 
response.
The subjects in the present study were no t allowed to  sleep, thus removing any effects o f 
sleep on the observed rhythm. Studies iu healthy young men and women have shown that 
the increased sleep pressure (the homeostatic drive for sleep possibly resulting from  
accumulation o f a sleep-induced neurotransmitter in the brain) that occurs during a period 
o f  acute sleep deprivation (> 30 h) down-regulates cardiac autonomic activity, characterised 
by a decline in heart rate which itself is mediated by a decline in cardiac sympathetic activity 
and is posture dependent (Holmes et al., 2002; Zhong et al., 2005). This lowering o f cardiac 
activity during extended wakefulness has been postulated to be a protective mechanism 
against an increase in cardiac demand during sleep deprivation, possibly in response to 
stress and increased physical demands (Holmes et al., 2002). However, whether the 
increased sleep pressure resulting fi:om the sleep deprivation in the CR protocol has any 
effect on the observed rhythm in endothelial function is unknown. Future studies assessing 
the acute effect o f  sleep deprivation on endothelial function could address this question.
5.5.6 Blood pressure and heart rate 
The rhythm in heart rate observed as a function o f  clock time (chapter 4), also persisted 
after adjustment for circadian phase, in both the pre-menopausal and postmenopausal 
women. This finding is in agreement with previous studies reporting a sigmficant 
endogenous rhythm in heart rate in both men and women (section 1.2.5.1). In  contrast.
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there was no apparent circadian rhythm in blood pressure after correction o f the data for 
circadian phase, the reported time o f day variation in blood pressure thus being affected by 
exogenous factors rather than being endogenously ^nerated . This finding is consistent 
with the results o f previous studies conducted in young men (Kerkhof et al., 1998, Van 
Dongen et al., 2001) (section 1.2.5.1).
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Chapter 6: Endothelial function in young women: effect of diet
6.1 Introduction
Several dietary factors have been reported to affect vascular function postprandiahy 
(section 1.1.4.1). Circulating triglycerides are known to exhibit diurnal rhythmicity with 
increased levels during the evening compared with the day (Morgan et al., 1998). Increased 
circulating levels o f postprandial triglycerides in response to a high fat meal consumed 
during the day have been shown to impair endothelial function (Williams et al., 1999; 
Marchesi et al., 2000; Gaenzer et al., 2001; Gokce et al., 2001; Schinkovitz et al., 2001; Steer 
et al., 2003). However, in modem Westernised society, the majority o f individuals consume 
their main meals in the evening and hence the consequences o f eating a high fat meal in the 
evening on endothelial function was the focus o f the present study.
6.2 Aims
The aim o f the present study was to investigate the effects o f consuming either a high or 
low fat meal during the evening on endothelial function in young, healthy females.
6.3 Methods
The study described in this chapter was conducted as part o f an undergraduate final year 
project, which I supervised. I also co-conducted analysis o f all the endothelial data. Ethical 
approval for the study was obtained from the University o f Surrey Ethics Committee prior 
to study commencement.
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6.3.1 Subjects
Seven healthy non-smoking young women aged between 18-30 years (22 ± 0.8 years; mean 
± SD) with body mass indices (BMI 23 ± 2 kg/m ^ were recruited from the student 
population at the University o f Surrey, according to the inclusion/exclusion criteria 
outlined in Section 2.1. All subjects were taking the combined (oestrogen with 
progesterone) contraceptive piU on each o f the study legs (see Table 6.1 for subject details).
Table 6.1 Subject details
Subject Age BMI Oestrogen Dose
W
Progesterone Dose
W
Generic name
1 21 21.8 ethinylestradiol 0.03 levonorgestrel 0.15 Microgynon30
2 23 22.4 ethinylestradiol 20 gestodene 75 Femodette
3 22 20.4 ethinylestradiol 0.035 norgestimate 0.25 Cilest
4 21 20.9 ethinylestradiol 0.03 levonorgestrel 0.15 Microgynon30
5 21 20.1 ethinylestradiol 0.03 levonorgestrel 0.15 Microgynon30
6 22 23.3 ethinylestradiol 0.035 cyproterone
acetate
2.0 Dianette
7 22 24.3 ethinylestradiol 0.035 norgestimate 0.25 Cilest
BMI: Body Mass Index (Weight (kg)/[Height (m)]'
6.3.2 Study meals
The high- and low fat study meals are described in Table 6.2. In order to maintain a 
blinded study approach, the study meals were chosen with a similar visual appearance, 
smell and taste. The nutritional composition o f  the two meals were chosen to be as 
balanced as possible with comparable amounts o f carbohydrate and protein, such that the 
fat content was the main variable. Thus, the calorific content o f the high fat meal was 
consequently larger. Water was provided ad libitum.
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Table 6.2 Nutritional composition of the high and low fat test meal (CHO: carbohydrate; 
kcal: kilo calories)
HIGH FAT MEAL LOW FAT MEAL
Fat(g) CHO(g) Protein kcal Fat(g) C H O (^ Protein (g) kcal
Chicken tikka 
masala
47.3 60.0 47.9 858 8.1 90.0 32.8 567
Chocolate mousse 17.6 26.9 5.3 285 4.1 32.1 23.5 189
Orange juice 0.1 21.0 1.0 94 water was provided
Total composition 65.1 107.9 54.2 1237 12.2 122.1 56.3 756
6.3.3 Pre-study conditions 
All subjects were asked to adhere to the pre-study conditions outlined in section 2.2. 
Subjects were instructed to maintain a regular sleep-wake schedule, with an imposed 
bedtime o f 24:00 h and wake time o f 08:00 h for three days prior to each study leg. An 
initial baseline measure o f endothelial function was obtained at approximately 08:00 h, 
three days prior to the start o f the first study session (see Chapter 7). Subjects were asked 
not to consume any food or drink (with the exception o f water) from 12:00 h on each 
study day, to ensure they were in a fasted state prior to study commencement at 18:00 h.
6.3.4 Study sessions
6.3.4.1 Study session 1: High fat meal
Subjects arrived at the Clinical Investigation Unit (School o f Biomedical and Molecular 
Sciences, University o f Surrey) at 18:00 h. A qualified phlebotomist inserted a butterfly 
needle into the antecubital vein o f the subject's left arm. Subjects were studied for 6 h 
under conditions o f controlled light (<10 lux in the direction o f gaze), maintained 
wakefulness and in semi-recumbent posture (except during ultrasound investigations and
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when the toilet was required) (see section 2.3). Subjects consumed the high fat meal (see 
Table 6.2) between 20:00 and 21:00 h. The study protocol is shown in Figure 6.1. Two 
baseline blood samples were taken 10 minutes and immediately prior to consuming the test 
meal and at hourly intervals, for a further six hours after meal consumption. The blood 
samples were immediately centrifuged and the plasma aliquoted into separate containers 
and stored at -20 °C until required for analysis. Plasma TAG levels were determined 
according to the method described in Section 2.8. Endothelium-dependent FMD was 
assessed immediately after the baseline blood samples had been taken and prior to 
consuming the test meal and at intervals o f  2 and 6 h after consumption o f the meal 
according to the method described in Section 2.5. BP and HR were assessed (see Section 
2.6) approximately 30 minutes prior to consumption o f the meal and at hourly intervals 
thereafter. The timing o f each measurement was determined from the start o f each meal.
6.3.4.2 Study session 2: Low fat meal 
Study session 2 was conducted in exactly the same manner as session 1 (section 6.3.4.1) 
with the exception that the subjects were provided with and consumed a comparable low 
fat meal (see Table 6.2).
The two legs o f the study were randomised in a single blinded, crossover study design in 
order to reduce any order effects on the study outcomes. Subjects were randomly assigned 
to begin the study with either the high fat or low fat meal. The study was conducted over a 
period o f 4 weeks with a washout period o f 2 weeks between each study leg (Figure 6.1).
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6.3.5 Data analysis
Two-way repeated measures ANOVA was used to determine the effect o f meal and time 
o f day on all the parameters measured. When an overall effect o f time was observed, 
Tukey's post hoc analysis was performed. Data are expressed as mean ± SEM. Statistical 
significance was defined as P  < 0.05.
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6.4 Results
6.4.1 Triglycerides (TAG)
The variation in TAG levels over time for each o f the two study meals is shown in Figure 6.2. 
Two way repeated measures ANOVA revealed a significant effect o f  meal fat content 
(F(6,72) — 4.0, P <0.05) and time (P^ 6,iz) ~  4.1, P  <0.05) and a significant interaction between 
meal fat content and time (F(i42) ~  3.7, P  <0.01). Post hoc tests revealed the postprandial 
concentrations o f circulating TAG after consumption o f the high fat meal was significantly 
higher at 2 and 4 h postprandial (P <0.05) compared with the values o f TAG obtained 
after consumption o f the low fat meal. Thus as expected as time after meal consumption 
increased the effect o f the high fat meal on TAG levels was more pronounced than after 
eating the low fat meal (Figure 6.2). The levels o f  TAG in the blood rose more sharply and 
peaked at 4 h (1.4 ±  0.2 m m ol/L; mean ± SEM) after consumption o f the high fat meal. 
The TAG levels rose steadily from 2-6 h postprandial after consumption o f the low fat 
meal, thus the time o f the peak TAG concentration could not be determined. The levels o f 
TAG had not returned to basal levels by the end o f the sampling period after either study 
meal.
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Figure 6.2. Postprandial variation of triglyceride concentrations following consumption o f a 
high fat ( #  ) and a low fat ( O ) test meal in healthy young pre-menopausal women (n = 7). 
Data are expressed as mean ± SEM.
6.4.2 Endothelial function 
The variation in endothelial function over time for each o f the two study meals is shown in 
Figure 6.3. Two-way repeated measures ANOVA revealed a significant effect o f  time on 
endothelial function (F^ 2,20) ~  3.6, P <0.05; n  = 6), but no interaction between time and 
meal fat content and no difference between the two meals. Post hoc tests revealed a 
significant difference (P <0.05) between baseline FMD values and after 6 h postprandial, 
after both the high and low fat study meals.
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Figure 6.3. Postprandial variation o f  endothelium-dependent flow-mediated 
dilatation (%FMD) following consumption o f a high fat ( g  ) and a low fat ( Q )  
test meal in healthy young pre-menopausal women. Data are expressed as mean ±  SEM. 
* * P  <0.05 compared to corresponding baseline (0) values.
6.4.3 Blood pressure and heart rate 
Two-way repeated measures ANOVA did not show any difference in either SBP or DBP 
over time, no difference between the two study meals and no interaction between time and 
study meals (Figure 6.4). In contrast, there was a significant effect o f  time on H R 
(P(i,6) “  3.6, P  <0.005) but no difference between the two study meals and no interaction. 
Post hoc analysis revealed HR was significantiy lower (P <0.05) at 5 and 6 h after 
consumption o f the high fat meal and at 5 h after consumption o f the low fat meal 
compared to baseline (t = 0) values.
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Figure 6,4 (A) Systolic and (B) diastolic blood pressure and (C) heart rate 
following consumption of a high fat meal ( # )  and a low fat (Q )  test meal 
in healthy young pre-menopausal women (n = 7). Data are expressed as 
mean ± SEM.
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6.5 Discussion
6.5.1 Triglycérides
The results from this study show that consumption o f a high fat meal in the evening 
produces a rapid increase in circulating TAG levels with peak values being reached four 
hours after meal consumption. In comparison, consumption o f  a low fat meal at the same 
time o f day did not show the same rise in TAG levels, this occurred more gradually after 
consumption o f the low fat meal. The increase in TAG levels following consumption o f  a 
test meal at night has been reported previously. Consumption o f a standard mixed meal 
(37% fat, 52% carbohydrate and 11% protein), preceded by consumption o f a low fat pre­
meal (3% fat), was shown to produce higher levels o f plasma TAG when both the pre-meal 
and the test meal were consumed at night (20:00 h and 01:30 h, respectively) compared to 
during the day, in healthy male (mean age 25.4 ± 0.9 years) and female (mean age 23.9 ± 
0.7 years) subjects (Sopowski et al., 2001). The fasting TAG levels in the female subjects 
were 0.89 + 0.10 mmol/1 and are comparable with the values observed in the present study 
(low fat study: 0.84 ± 0.06 mmol/1 and high fat study: 0.90 ± 0.06 mmol/1). However, as 
would be expected, the nocturnal peak levels o f postprandial TAGs were higher in the 
present study, following consumption o f  the higher fat test meal (47% fat; peak TAG: 1.41 
+ 0.2 mmol/1) and lower after consumption o f the low fat test meal (15% fat; peak TAG: 
0.99 + 0.1 mmol/1) compared with the values reported following consumption o f  a 
standard mixed meal (peak TAG: 1.33 ± 0.15 mmol/1) (Sopowski et al., 2001). These 
results suggest that the magnitude o f the TAG response to a meal consumed in the evening 
is partly dependent on the quantity o f fat consumed, although the composition o f  fatty 
acids is also known to be a determining factor with peak TAG levels shown to be 
significantly higher and to occur at an earlier time after a meal composed mainly o f 
monounsaturated fatty acids compared with a meal rich in saturated fatty acids ^ o u ts a r i  et 
al., 2004). The peak in TAG levels occurred 5 h following consumption o f the standard
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mixed meal (corresponding to a clock time o f 06:30 h) (Sopowski et al., 2001). This was 1 h 
later than seen in the present study after consumption o f the high fat meal. The time o f the 
peak in postprandial TAG following consumption o f the low fat test meal could no t be 
accurately determined, as the TAGs had not returned to basal levels by the end o f the 
present study. One possible reason for the difference in the timing o f the postprandial peak 
in TAG levels between the different studies is the time at which the meals were consumed. 
The meals in the present study were all consumed during the evening (between 20:00-21:00 
h) compared with a much later time o f meal consumption in the previous study (01:30 h) 
(Sopowski et al., 2001).
Plasma TAG levels are also shown to be influenced by the endogenous circadian clock. 
Higher nocturnal levels o f plasma TAG have been reported to occur in healthy young 
women (19-20 years o f age) in CR conditions o f constant nutrient intake, maintained 
wakefulness in dim light (< 42 lux) whilst seated at a desk (Morgan et al., 1998). Under 
these controlled experimental conditions, fasting plasma TAG concentrations o f 1.3 ± 0.1 
mmol/1 (which are higher than those observed in the present study) were shown to reach 
peak values o f approximately 1.8 mmol/1 between 22:00-06:00 h clock time, independently 
o f the influence o f exogenous stimuli. Thus, it is not surprising that the combination o f an 
endogenous circadian riiythm in circulating TAGs and the ingestion o f a reasonably fatty 
meal in the evening results in higher concentrations o f circulating TAGs at night compared 
with during the day even in young, healthy normolipidaemic females. Further studies are 
required to determine whether a similar response to an evening meal occurs in older 
women and particularly in women after the menopause.
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6.5.2 Endothelial function 
The results from this study did no t show a significant reduction in endothelial function 
(%FMD) following evening consumption o f a high fat meal in young, healthy female 
subjects. In contrast, the results showed an increase in %FMD over time after meal 
consumption with the greatest FMD occurring 6 h after consumption o f both the study 
meals. There was no difference between the effect o f either the high fat meal or the low fat 
meal on the endothelial response. It is possible that the observed increase in %FMD 
between 22:00-02:00 h is related to the rhythm in endothelial function observed in older 
pre-menopausal women under CR conditions, with increased %FMD between 18:30-06:30 h 
compared with the day (see chapter 4).
It is not likely that the observed increase in FMD was due to the type o f  meal consumed 
(i.e. an Asian-style mild curry) as the levels o f chilli (which contains capsaicin which acts on 
the nervous system to induce histamine-mediated vasodilation) were very low and any 
effect would be likely to be observed within the first 2 h after consumption o f the study 
meal. Although the peak TAG levels occurred 4 h after consumption o f the high fat meal, 
%FMD continued to rise 6 h after meal consumption. It may be argued that since no FMD 
measurements were taken 4 h postprandial (when TAG levels peaked), that any suppressive 
effect o f the high fat meal on the vascular response may have been missed. However, the 
transient changes in endothelial function following fat ingestion are often reported to occur 
as early as 2 h and this change is dependent on the circulating levels o f TAG after meal 
consumption (see section 1.1.4.1). The majority o f studies reporting a decline in %FMD 
after fat ingestion show an average increase in the concentration o f  circulating TAGs o f 
between 1.3-2.5 mmol/1, which appears to be dependent on the amount o f  fat consumed 
with meal fat content ranging from 34-50% and differences in the ratio o f  saturated to 
poly- and monounsaturated fatty acids. Modifications to the fatty acid composition rather
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than the levels o f circulating TAG have also been shown to impair endothelial function. 
Williams et al. (1999) reported a significant decline in endothelial function in middle-aged 
men (mean age 38 ± 6 years) following consumption o f a meal rich in used cooking fat 
compared with an unused cooking fat meal o f identical composition (64.4 g fat). There was 
a significant increase in plasma TAG after both fat meals, however, the greatest increase in 
plasma TAG occurred 4 h after consumption o f  the unused fat meal (reaching peak levels 
o f 2.05 ± 0.7 mmol/1), but endothelial function was unaffected. The authors concluded 
that components o f the used fat, such as products derived from oxidative modification o f 
polyunsaturated fatty acids, and not the fat content or other constituents o f  the meal, were 
likely to be responsible for the postprandial impairment in endothelial function (Williams et 
al., 1999). In addition, fat-induced suppression o f endothelial function has been shown to 
differ between men and women. Previous studies have reported that in healthy young men 
the decline in endothelial function that occurs 2-4 h after consumption o f a high fat meal 
coinciding with the peak TAG levels at 4 h, does not occur in healthy age-matched pre­
menopausal women possibly related to the lower TAG levels in the pre-menopausal 
women at 4 h (1.14 i: 0.50 mmol/1) compared with the young men (1.35 ± 0.58 mmol/1) 
(SchiUaci et al., 2001). This gender difference in TAG responses is thought to be attributed 
to the higher circulating levels o f endogenous oestrogens in pre-menopausal women ( ti  et 
al., 1996). The peak TAG concentration, after consumption o f the moderately high fat 
meal used in the present study, was 1.41 ± 0.2 mmol/1. This is higher than reported in 
similarly aged young men most likely due to the fact that the previously reported studies 
were all conducted during the day and since TAG is shown to be higher at night compared 
with the day (section 6.5.1) this would explain the elevated TAG levels seen in the present 
study.
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Orange juice was provided with the high fat meal. Some studies have reported that the 
impairment in endothelial function following consumption o f a high fat meal is prevented 
by acute administration o f vitamin C (1 g) either as a pre-treatment or following 
consumption o f a high fat meal (Plotnick et al., 1997; Nappo et al., 2002). However, in 
each o f  these studies, vitamin E  (800 IU) was co-administered and it has also been shown 
that vitamin E  alone can prevent endothelial dysfunction following ingestion o f  a high fat 
meal (Katz et al., 2001). In contrast, chronic administration o f vitamin C alone (1 mg daily 
for 6 weeks) and acute inter-arterial infusion o f vitamin C (25 m g/min) does not appear to 
have any effect oh endothelium-dependent vasodilation (Singh et al., 2002). In the present 
study only a small amount o f  vitamin C would have been ingested (approximately 50 mg in 
200 ml) and it is unlikely that this would have been sufficient to affect the findings o f the 
study. In addition, only water was consumed with the low fat meal, which also showed an 
increase in FMD over time.
6.5.3 Blood pressure and heart rate 
There was no effect o f the fat composition o f  the meal on either BP or HR in this study, 
most likely due to the young age and good health status o f the subject cohort. It is possible 
that in an older population, such as in postmenopausal women whose BP is elevated iti 
comparison to younger pre-menopausal women (see chapter 4), there may be some effect 
o f increased circulating TAGs resulting from consumption o f a fatty meal in the evening 
on SBP and DBP.
H R did decrease significantly over the duration o f the study in response to both study 
meals. This decline in HR is consistent with the observed circadian rhythm in H R seen in 
both younger pre-menopausal women and older postmenopausal women (see chapter 4).
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In conclusion, increased circulating level o f  TAGs in response to a high fat meal consumed 
in the evening does not induce endothelial dysfunction measured at 2 and 6 h 
postprandially, in young healthy female subjects. Further studies assessing endothelial 
function 4 h postprandially would further explore the relationship between peak TAG 
levels and endothelial dysfunction. In addition, since endothelial function is shown to be 
reduced in women after the menopause (see chapter 4) and hypertriglyceridaemia is 
associated with increased cardiovascular risk (section 1.1.4.1) studies in postmenopausal 
women would further investigate whether the TAG response to a high fat meal consumed 
in the evening is altered after the menopause and what effect, if  any, this may have on 
endothelial function.
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C H A P T E R  7:
E n d o th elia l resp on ses under norm al co n d itio n s  
and co n sta n t rou tin e co n d itio n s in  pre- and  
p o stm en o p a u sa l w o m en
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Chapter 7; Endothelial responses under normal conditions and constant 
routine conditions in pre- and postmenopausal women
7.1 In troduction
Most biological rhythms have both exogenous (external modifying factors) and 
endogenous E ternally produced) influences. A rhythm observed under normal 
nychthemeral study conditions, one in which subjects maintain their normal activity 
schedules during the day and sleep at night, represents the interaction between exogenous 
and endogenous factors. In order to isolate the endogenous component o f  a biological 
rhythm, the influence o f the external masking factors needs to be minimised. The CR 
protocol, previously described in this thesis (see section 2.3) was used to 'unmask' the 
endogenous component o f the rhythm o f interest.
The amplitude o f the rhythm observed under normal conditions is often larger than that o f 
the endogenous circadian component alone and direct comparison o f  the two study 
methods can indicate to what extent exogenous factors influence the output o f the 
observed rhythm.
7.2 Aim s
The aim o f the present study was to investigate the effect o f time o f day under ‘normal’ 
study conditions on endothelial function in young and postmenopausal women and to 
compare the profile o f  endothelial function under normal conditions with that in constant 
routine conditions in both pre-menopausal and postmenopausal women.
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7.3 Methods
7.3.1 Normal study conditions
7.3.1.1 Subjects
Seven healthy non-smoking postmenopausal women (n = 6 not on HRT; n = 1 on low- 
dose HRT) aged between 50-60 years (56 ± 2 years; mean ±  SD) with body mass indices 
(BMI) 23 + 2 kg/m^ were recruited from the general population, according to the 
inclusion/exclusion criteria outlined in section 2.1. The subject on HRT was taking oral 
combination HRT (0.625 mg oestrogen) at the time o f the study (see Table 7.1 for subject 
details). Ethical approval for the study was obtained from the University o f Surrey Ethics 
Committee prior to study commencement (section 2.1).
Table 7.1 Subject details
Subject
code
Age BMI Smoker HRT H O
Score
PSQI
SI 57 26 No N o 66 6
S2 56 22 N o No 55 4
S3 58 28 No No 50 6
S4 51 19 No No 64 2
S5 57 21 No No 54 2
S6 56 25 N o No 57 2
S7 56 26 No (0.625 mg oestrogen) 76 1
Sleep Quality Index
7.3.1.2 Pre-study conditions 
All subjects were asked to adhere to the pre-study conditions outlined in section 2.2.1. 
Subjects were instructed to maintain their habitual sleep-wake schedule for three days prior 
to each study leg. Subjects were asked not to consume any food or drink (with the 
exception o f  water) from 20:00 h the night before the day session and from 12:00 h on the
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day o f the night session, to ensure they were in a fasted state prior to study 
commencement. Subjects were provided with a standard meal (section 7.3.1.3) to be 
consumed as their last meal before fasting, prior to each study session to minimise any 
variability resulting from differences in dietary intake.
7.3.1.3 Pre-study meals
The nutritional composition o f  the pre-study meals was chosen to be as balanced as 
possible with comparable amounts o f fat, carbohydrate and protein (according to weight 
and overall calorie content) (Table 7.2).
Table 7.2 Typical composition o f the pre-study meal (CHO: carbohydrate; kcal: kilo calories)
Fat(g) C H O (^ Protein (g) kcal
Chicken and tomato 
tagliatelle
8.4 59.2 26.4 416
Fruit yoghurt 0.3 7.5 5.1 53
Wholemeal bread roll 
low fat spread
7.1 30.0 6.6 176
Total composition 15.8 96.7 38.1 645
7.3.1.4 Normal study conditions: Study protocol 
Subjects were asked to attend the CIU (School o f  Biomedical and Molecular Sciences, 
University o f Surrey) on two occasions during which time endothelial function, blood 
pressure and heart rate was assessed. All measurements were conducted between 08:00- 
11:00 h for the "day" session and between 20:00 - 23:00 h for the "night" session. Low 
light levels (< 1 0  lux) were maintained during both study sessions. Subjects were asked to 
attend the study at the equivalent clock hour (e.g. 08:00 h and 20:00 h) for each study
CHAPTER 7______________________________  1 ^
session. Study sessions were one week apart. Subjects were randomly assigned to begin the 
study with either the "day" or "night" session.
7.3.2 CR and Fat Study Data
The data from the CR study (see chapter 4) and fat study (see chapter 6) were used to 
compare the effects o f normal conditions versus CR conditions on endothelial function in 
pre-menopausal and postmenopausal women. The postmenopausal women in the CR 
study were from a separate study cohort and only two women who took part in the CR 
also took part in the normal conditions study.
All women were fasted prior to study commencement and all baseline measurements were 
conducted under the same experimental conditions at a similar dock time. The young 
women (22 ± 0.8 years) maintained an imposed sleep-wake schedule detailed in section
6.3.3 and were all taking the contraceptive pdl (section 6.3.1).
7.3.3 Data analysis
Paired Student's t-tests were used to determine any differences between the two-time 
points (i.e. 08:00—11:00 h and 20:00—23:00 h) in endothelial function, blood pressure and 
heart rate data. Unpaired Student's t-tests were used to compare the normal study data with 
the constant routine study data. Data from the CR study was grouped into two similar time 
periods o f “d a / ’ (08:30—12:30 h) and “night” (20:30—24:30 h). Data from two subjects in 
the CR study could not be included in the analysis. One postmenopausal woman had 
missing data after 18.30 h and one pre-menopausal woman had missing data between 
08.30-12.30 h. Data are expressed as mean ± SEM. Statistical significance was defined as 
P < 0 .0 5 .
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7.4 Results
7.4.1 Comparison o f normal and CR data 
The profile o f endothelial function under normal and CR conditions in postmenopausal 
women is shown in Figure 7.1. There was no significant difference in the baseline FMD 
measures between the two time periods (day 3.5 ±  0.24%; night 3.2 ± 0.25%) in the 
postmenopausal women under normal study conditions. Paired Student's t-tests showed a 
non-significant trend towards a difference between 'day' (08:00-11:00 h) and 'night' (20:00- 
23:00 h) in endothelial function in the postmenopausal women under normal conditions (P 
= 0.08), with higher FMD values (7.9 ±  0.7%) occurring at night compared to the day (6.2 
+ 0.8%). The data from the CR study (chapter 4) were grouped into two comparable time 
periods chosen as 'day' 08.30-12.30 h and 'night' 20.30-24.30 h. Paired Student's t-tests did 
not show any significant differences between the day (7.1 ± 0.6%) and night (6.5 ± 0.5%; 
n = 9) in the postmenopausal women. There were no significant differences in endothelial 
function between the two study conditions, comparing the values obtained during the day 
and night, in the postmenopausal women.
The data from the young women showed a significant difference between day and night 
(P <0.05) under normal conditions, with higher values at night (9.6 ± 1.6%) compared to 
the day (7.5 ± 1.2%) (Figure 7.1). These data were then compared with the 
postmenopausal women under normal conditions. The young women (n = 7) had higher 
FMD values (day 7.5 i: 0.2%; night 9.6 ± 1.6%) compared with the postmenopausal 
women (day 6.2 ± 0.8%; night 7.9 i: 0.7%), although these differences were not statistically 
significant (Figure 7.3). Comparison o f normal study conditions with CR conditions in 
either young or pre-menopausal women could not be conducted as there was no 
comparable data for these two study groups.
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Figure 7.1 Profiles of %FMD between study ‘day’ and ‘night’ in (A) postmenopausal women under 
normal study conditions, (B) postmenopausal women under CR conditions, (C) young women 
under normal conditions, (D) no data available, (E) no data available, (F) pre-menopausal women 
under CR conditions. -------- Group mean value.
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Figure 7.2 Endothelial responses (%FMD) under normal study conditions in postmenopausal 
women not on HRT ( ■ )  (n = 6) and young women on oral contraceptives ( □ )  (n = 7). 
Data are expressed as mean ± SEM.
7.4.2 Blood pressure and heart rate 
The profiles o f SBP and DBP and HR in postmenopausal women under normal study 
conditions are shown in Figure 7.3. Both SBP and DBP was higher at night (SBP 116 ±  3 
mmHg; DBP 70 ± 1 mmHg) compared with the morning (SBP 111 ± 3 mmHg; DBP 67 ± 
2 m m H ^. In contrast there was a small decline in HR at night (58 ±  1 beats/min) 
compared with the morning (59 ± 2 beats/min) in the postmenopausal women. Paired 
Student's t-tests did not show any differences between measures o f BP or HR pre- or post­
scan and no difference between the two time periods.
CHAPTER 7 173
A. Systolic blood pressure
125-1
120 -
110-
1 0 5 -
100
B. Diastolic blood pressure
80-1
7 5 -
fi
6 5 -
C. Heart rate
6 5 -
a 6 0 -
5 0 -
4 5 -
08:00-11:00 h 20:00-23:00 h
Clock time (h)
Figure 7.3 (A) Systolic and (b) diastolic blood pressure and (C) heart rate 
pre-scan (■ )  and post-scan ( # )  in postmenopausal women (n =  6) under 
normal study conditions during the day (08:00-11:00 h) and the night 
(20:00-23:00 h). Data are expressed as mean ±  SEM.
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7.5 Discussion
7.5.1 Comparison o f endothelial function in normal and CR conditions
7.5.1.1 Postmenopausal women
The results from the present study show a trend towards a day-night variation in 
endothelial function in postmenopausal women under normal study conditions, which was 
not seen under CR conditions. This finding suggests that the day-night variation observed 
is likely to be the sole result o f exogenous factors and that there is no endogenous circadian 
rhythm in endothelial function.
The data compared in this chapter are derived from separate studies involving different 
subjects, thus there is likely to be an effect o f  individual variation as well as experimental 
condition on the results obtained. The subjects studied under normal conditions were 
monitored while maintaining their regular habitual rest-activity patterns in contrast with 
those subjects studied under CR conditions who maintained a schedule o f  maintained 
wakefulness in a constant semi-recumbent posture. In addition, the postmenopausal 
women in the normal conditions study were in a fasted state prior to FMD measurement at 
each time point, in contrast to the women in the CR study who were in a constant fed state 
provided by regular nutrient intake. Ideally, the normal and CR studies should be repeated 
using the same study cohort so as to control for the effect o f individual variability on the 
results. However, both groups o f subjects were recruited according to the same criteria (see 
section 2.1) and were not taking any form o f HRT.
7.5.1.2 Young women
The results show a significant day-night variation in endothelial function in young women 
under normal study conditions with higher %FMD values at night (9.6 ± 1.6%) compared 
to the day (7.5 ± 1.2%). This is in agreement with the findings o f a previous study showing
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that in young, healthy pre-menopausal women not on oral contraceptives (19-31 years) 
%FMD gradually increased from 3.1 ± 0.4% at 14:00h, 4.4 ±  0.4% at 20:00 h, 5.1 ± 0.9% 
at 02:00 h and 3.9 + 0.8% at 08:00 h (Ringqvist et al., 2000). The %FMD values are lower 
than those observed in the present study, this may simply be due to individual differences 
between the two study cohorts or may have resulted from the different study conditions. 
The comparative measurements analysed in the present study were taken when the subjects 
were in a fasted state, in contrast there were no dietary restrictions on the pre-menopausal 
subjects (except to avoid caffeine and high levels o f  nitrate/nitrite-containing foods) in the 
previous study (Ringqvist et al., 2000), such that there may have been a diet-induced 
attenuation o f endothelial function in these subjects. This diurnal variation in endothelial 
function was not associated with a variation in the levels o f N O  or cGMP, although a 
diurnal pattern in the levels o f norepinephrine was detected, with the lowest levels at 02:00 
h, when endothelial function was greatest and at 08:00 h (Ringqvist et al., 2000). Thus it 
was suggested that the increase in %FMD at night may result from a decrease in 
sympathetic vasoconstrictor activity (Ringqvist et al., 2000). Future studies need to assess 
endothelial function o f young women in CR in order to establish whether NO-production 
displays a diurnal rhythm and the contribution o f  the circadian system to this rhythm.
Comparison o f the data from the postmenopausal women with the data from the young 
women showed higher values o f %FMD in the young women under normal study 
conditions. This difference is in agreement with the observed difference in absolute 
%FMD values between the older pre-menopausal and postmenopausal women under CR 
conditions (see chapter 4), even though the data were again obtained from a different study 
cohort. However, both groups o f  subjects were fasted prior to the start o f  the study and 
were examined under the same experimental conditions at a similar clock time.
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7.5.2 Blood pressure and heart rate
The results from the normal study conditions did not show any significant differences in 
either BP or H R between the two time periods in the postmenopausal women. 
Unfortunately only two measurements were taken during each study session. In contrast, 
repeated measurements o f BP and HR, such as during continuous ambulatory BP 
monitoring during a 24 h period (Noto et al., 2000) have shown that both BP and HR 
display a significant day-night variation in postmenopausal women.
BP and H R are influenced by numerous environmental factors, including posture, activity, 
food intake, stress and light levels (the latter known to affect H R only) (section 1.2.5.1), 
thus it is possible that the rhythm in BP and H R under normal study conditions is a result 
o f exogenous stimuli. Physical activity is shown to be an independent predictor o f  the 
diurnal variation in BP, with increased activity at night associated with a smaller nocturnal 
dip in BP levels (Leary et al., 2000b). H R also increases linearly with increasing levels o f 
physical activity (Cavelaars et al., 2004). In the normal study conditions, although subjects 
were rested in a supine position for 10 minutes prior to the measurements being taken, 
subject’s activity levels prior to the start o f each study session were not controlled for and 
were not recorded. Therefore it is possible that the amplitude o f the BP and H R rhythms 
may have been flattened. Thus the magnitude o f difference between the two measurements 
(i.e. day versus night) was less than that seen under CR conditions.
7.5.3 Low dose HRT
Endothelial function has been shown to be increased in postmenopausal women taking 
low dose HRT (section 1.1.5.5). However, whether there is any effect o f H RT on the day- 
night variation in endothelial function is not known. There was only one subject in the 
present study on low dose HRT, thus it is not possible to make assumptions based on the
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data. However, the data from this subject showed an increase in %FMD compared with 
the postmenopausal women not on HRT at both time periods. Future studies are required 
to further investigate the effect o f  low-dose HRT on the day-night variation in endothelial 
function in postmenopausal women.
In conclusion, the results from the study under normal study conditions show a significant 
day-night variation in endothelial function in young women and a non-significant trend 
towards a day-night variation in endothelial function in postmenopausal women, which is 
not seen under CR conditions. Comparison o f the postmenopausal data derived from the 
normal study conditions and under CR, does not show any significant differences between 
the day or night, which suggests that there is no clear rhythm in endothelial function in 
postmenopausal women. The evidence o f a trend towards a day-night variation in 
endothelial function in the postmenopausal women under normal study conditions in a 
similar direction to that seen in young women under normal study conditions, suggests that 
a similar phenomenon occurs in postmenopausal women but that the rhythm is flattened.
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Chapter 8: General Discussion
8.1 Main objectives o f the current thesis
The main aims o f this thesis were to investigate the effects o f  time o f day (during a period o f 
22 h in CR conditions), menopausal status (comparing the results obtained in pre-menopausal 
with those o f  postmenopausal women), age (comparing the results obtained in young and 
middle-aged pre-menopausal subjects with older postmenopausal women) and diet (specifically 
the effects o f either a high fat or low fat meal consumed in the evening) on endothelial 
function, measured using non-invasive ultrasound technology, in healthy women. The 
influence o f menopausal status on the endogenous rhythm o f melatonin was also investigated. 
In addition to these main study aims, the effects o f time o f day, menopausal status and age on 
measures o f blood pressure, heart rate, subjective mood and alertness and cognitive 
performance in middle-aged pre-menopausal women and postmenopausal women was also 
investigated.
8.2 Chapter 3
The method o f assessment o f endothelial function by non-invasive ultrasound has been 
scrutinised in the literature and reported values o f reproducibility vary considerably (section 
1.1.7.5). The measurement o f endothelial function (%FMD) results from very small changes in 
the diameter o f the artery in response to an increase in blood flow (section 1.1.7.2). The actual 
%FMD value was calculated from the change in diameter in relation to the initial baseline 
(resting) diameter (section 2.9.1). Thus, small differences in diameter between measurements 
produced relatively large changes in %FMD. Consequendy, the range o f values o f  brachial 
artery diameter (%FMD) obtained are difficult to evaluate on the basis o f a pre-defined cut-off 
point, as a single measurement screening test to indicate endothelial function (Sejda et al..
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2005). However, it is still considered to be a useful tool in research. The consistency o f the 
established method for assessing %FMD (endothelium-dependent, NO-mediated function) 
(section 1.1.2.2) and %GTN-mediated dilatation (endothelium-independent, smooth muscle 
function) (section 1.1.6) is greatly dependent on the accuracy o f the technique. The level o f 
accuracy is influenced by physiological factors (e.g. differences in arterial anatomy between 
different subjects), experimental controls (e.g. occlusion cuff position) and operator variability 
(section 1.1.7.5). In order to ensure good reproducibility o f  the ultrasound images, for %FMD 
analysis with repeated measurements all the measurements taken during the studies reported in 
this thesis were conducted by the same investigator (the author). In addition, photographs 
were taken at each baseline scan to aid the identification o f anatomic landmarks, subjects 
maintained the same positioning o f  the head, body and arm and were not allowed to speak 
during the measurements. In addition, the position o f the ultrasound transducer was measured 
and marked on the subject’s arm and aU details were recorded at the beginning o f  each 
measurement. Method standardisation ensured greater accuracy and reproducibility o f results 
and enabled the direct comparison o f data between the different studies. The reproducibility o f 
the technique used for the studies presented in this thesis was acceptable (15.1 %CV) and was 
supported by good reproducibility o f the baseline arterial measurements (< 3.5 %CV) (section 
3.4.1).
8.3 Chapter 4
8.3.1 Time o f day effects on endothelial function 
Since the incidence o f coronary events occurs more frequently in the early morning (Peckova 
et al., 1998) and endothelial function has been shown to be impaired in individuals with 
established CHD (Shaw et al., 2001), the existence o f an endogenously generated circadian 
rhythm in endothelial function with lowered functioning in the morning hours could have
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implications for individuals at risk o f coronary disease, such as postmenopausal women not on 
HRT. There are several reports in the literature describing a diurnal rhythm in endothelial 
function in both men and women (section 1.2.5.1). In these studies, however, CR conditions 
were not employed, thus the influence o f exogenous masking factors (e.g. Hght, posture, food 
intake and sleep), were not controlled for during the measurement period (refer to Table 1.1). 
In order to determine whether the reported rhythm in endothelial function is truly 
endogenous, a modified CR protocol (section 2.3) was employed in order to minimise the 
masking effects o f external stimuli including hght, posture, temperature, sleep and food intake, 
aU o f which are known to mask endogenous circadian rhythmicity. The results from the study 
detailed in chapter 4, revealed the endothehal response (%FMD) in pre-menopausal women to 
be  lower during the day (08:30-16:30 h) than at night (18:30-06:30 h). Possible mechanisms 
responsible for these changes in the endothehum may include cychc variations in the 
production o f vasoconstrictmg or vasodilating factors, including NO. However, to date no 
studies have rehably shown whether the levels o f these factors change significantly across the 
day. In contrast with these findings, there was no discernable rhythm iu GTN-mediated 
dilatation in either the pre-menopausal or postmenopausal women (section 4.4.4).
8.3.2 Possible mechanisms 
The identification o f high affinity melatonin receptors on human coronary vessels 
(Ekmekcioglu et al., 2001a, 2003) might suggest that the endogenous melatonin rhythm with 
higher circulating levels at night may be a contributing factor to the observed rhythm in 
endothelial function. Indeed, the expression o f the M Tl receptor in human coronary vessels 
has been reported to show diurnal rhythmicity, with low levels in the morning and a gradual 
increase in receptor expression throughout the day reaching peak levels around 24:00 h 
(Ekmekciouglu et al., 2001b). However, studies in rats have shown that melatonin receptors
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are mainly localised to the vascular smooth muscle (Masana et al., 2002). W hether these high 
affinity melatonin receptors are also found on the vascular endothelium is not known. 
Exogenous melatonin has been reported to have several effects on the cardiovascular system. 
Administration o f 1 mg o f exogenous melatonin during the day (between 02:30-17:30 h) results 
in decreased systolic and diastolic blood pressure, decreased norepinephrine levels and reduced 
vascular reactivity in young men (Arangino et al., 1999) and young women ^vestigated  during 
the follicular phase o f the menstrual cycle) (Cagnacci et al., 1998) and in postmenopausal 
women (52 ± 2 years) on HRT. More significantly, exogenous melatonin has been shown to 
increase the levels o f N O  in these postmenopausal women (Cagnacci et al., 2001). In contrast, 
no effects o f exogenous melatonin were found to occur in untreated age-matched 
postmenopausal women (Cagnacci et al., 2001). The increase in N O  in response to exogenous 
melatonin in HRT-treated postmenopausal women (Cagnacci et al., 2001) may be due to 
melatonin-induced upregulation o f  oestrogen-stimulated N O  biosynthesis (section 1.1.2.2). 
However, due to the limitations in the assessment o f endogenous circulating N O  (section 
1.1.7), it is difficult to determine the exact origin o f the N O  measured in venous blood 
samples. Thus, whether the increase in N O  levels in response to melatonin administration 
originates from the vascular endothelium is unclear. Equally, the increase in N O  levels may be 
due to decreased N O  catabolism, rather than increased biosynthesis, possibly associated with 
the antioxidant properties o f melatonin (Ignarro, 1990). In addition to the effects on blood 
pressure and N O  levels, the results from animal studies show that exogenous melatonin has 
both constricting and dilating effects on coronary vessels pre-contracted with serotonin 
(section 1.2.5.2). However, in the absence o f the endothelium, melatonin has also been shown 
to potentiate the relaxing effect o f GTN on the vascular smooth muscle in pre-contracted rat 
aorta (Satake et al., 1991). These results suggest that exogenous melatonin has an indirect effect 
on vascular function, enhancing the response to different vasoactive mediators. W hether direct
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binding o f melatonin to high affinity vascular receptors results in vasoconstriction or 
vasodilation, remains to be elucidated. W hether endogenous melatonin has similar effects on 
the vascular endothelium and underlying smooth muscle too those reported for exogenous 
melatonin administration remains to be shown.
8.3.3 Effect o f  age and menopause 
Physiological changes associated with the menopausal transition include changes in the 
circulating levels o f steroid hormones, in particular a decline in oestrogen levels (Overlie et al., 
1999). The responsiveness o f both the endothelium (%FMD) and the underlying smooth 
muscle (%GTN-mediated dilatation) was significantly impaired in the postmenopausal women 
compared to the pre-menopausal women, which is consistent with the findings o f previous 
studies (section 4.6.1). In general, ageing is associated with endothelial dysfunction in both 
men and women. However, the rate at which endothelial function declines appears to be 
gender dependent, with a rapid decline in endothelial function occurring in women o f 
menopausal age (section 4.6.1). The two groups o f women who participated in the present 
study were chosen to be o f  a similar age as possible in order to try to minimise age as a 
confounding variable in the analysis o f the results. However, there was no overlap in the age 
range o f the subjects in. the present study, the mean age difference being 12 years. Nonetheless, 
no relationship between endothelial function and age was found in either the pre-menopausal 
or postmenopausal women. However, when the data from both study groups were combined a 
significant inverse correlation between age and endothelial function was found (section 4.4.2). 
These findings suggest that although there may still be a general effect o f increasing age on 
endothelial function ta women, there is some additional factor that contributes to the increased 
rate o f decline in endothelial function in women after the menopause. Several studies have 
reported an improvement in endothelial function in postmenopausal women following
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oestrogen replacement therapy (see section 1.1.5.5), thus it seems reasonable to suggest that 
the decline in oestrogen production after the menopause may have a causal relationship with 
the decline in endothelial function in postmenopausal women.
One possible way to eliminate age as a confounding variable in the interpretation o f these 
results would be to investigate endothelial function in age-matched pre-menopausal and 
postmenopausal women, for example in the range o f 48-52 years. One possible difficulty 
associated with this method would be the recruitment o f  postmenopausal women who have 
undergone natural menopause, but who have not experienced symptoms o f early menopausal 
onset, as %FMD has been reported to be lower in women with premature ovarian failure 
compared with age- and BMI-matched pre-menopausal women (Kalantaridou et al., 2004).
8.3.4 Blood pressure and heart rate 
The results from studies investigating the effects o f menopause on BP in women have 
provided conflicting reports o f  either a decline in SBP and DBP or an increase in SBP only 
(section 4.6.5). In the present study, SBP was shown to be significantly higher in the 
postmenopausal women compared with the pre-menopausal women, with no difference in 
DBP between either study group (section 4.4.5). Changes in BP that occur with increasing age 
are associated with alterations in lipid metabolism and reduced levels o f oestrogen during the 
menopause (Akahoshi et al., 2001). The increase in absolute BP values seen throughout the CR 
study in the postmenopausal women compared to the pre-menopausal women is m ost likely a 
result o f these factors. However, the levels o f circulating lipids in the pre-menopausal and 
postmenopausal women were not assessed in the present study, as this would have meant the 
use o f invasive blood sampling, which may have induced stress in the subjects and would 
ultimately have influenced the endothelial response. Consequently, whether the increase in BP
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seen in the postmenopausal women in the present study was influenced by metabolic changes 
cannot be determined.
SBP is also reported to show diurnal rhythmicity in young women with increased SBP levels in 
the morning (08:00 h) in non-CR conditions (Ringqvist et al., 2000). Earlier studies 
investigating the rhythms o f blood pressure in young subjects under CR conditions (Kerkhof 
et al., 1998; van Dongen et al., 2001), failed to show this time-dependent variation. Therefore, 
these authors concluded that the day-night variations in BP under normal daily conditions are 
solely the result o f  exogenous factors (Kerkhof et al., 1998; van Dongen et al., 2001). 
However, the results from a recent study conducted under CR conditions in young male and 
female subjects (19-38 years) showed a significant variation in DBP, which was inversely 
correlated with the endogenous rhythm in CBT (Conroy et al., 2005).
HR rhythms were also investigated in postmenopausal subjects under CR conditions in the 
present thesis and the initial results indicated an effect o f time o f  day in HR measurements, 
with reduced levels at night (section 4.4.5). This finding o f reduced H R at night is consistent 
with the reports o f previous studies (Krauchi and Wirz-Justice, 1994; Burgess et al., 1997; 
Kerkhof et al., 1998; Scheer et al., 2004). The endogenous circadian rhythm in HR, that 
prepares us for daytime activity, is thought to be mainly due to the circadian rhythm in 
parasympathetic cardiac outflow (Burgess et al., 1997; van Eekelen et al., 2004), although there 
may be some involvement o f a diurnal variation in sympathetic output to the heart (Burgess et 
al., 1997; Scheer et al., 2004). The autonomic nervous system mediates circadian oscillations 
from the SCN to the peripheral organs and controls cardiovascular, respiratory and 
gastrointestinal functions (Mutoh et al., 2003). Experiments in rats and mice have shown that 
the circadian rhythm in HR, with increased levels in response to light are inversely related to
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changes in parasympathetic nerve activity. These light-evoked neuronal and cardiovascular 
responses are abolished following bilateral lesioning o f the SCN (Janssen et al., 1994; Sano et 
al., 1995; Mutoh et al., 2003). In addition, intracerebroventricular administration o f melatonin 
has been shown to attenuate the activity o f both the sympathetic and parasympathetic nervous 
system in a dose-dependent manner (Mutoh et al., 2003). These results suggest that the light- 
induced entrainment o f the rhythms in BP and H R resulting from changes in autonomic 
responses may be partly controlled by the SCN and are most likely mediated through the 
actions o f melatonin.
The relationship between endogenous melatonin, circadian phase and endothelial function was 
investigated in the study detailed in chapter 5 (see section 8.4). The onset o f  the endogenous 
salivary melatonin rhythm was chosen as the marker o f circadian phase, since saliva shows 
good correlation with other methods o f melatorun assessment (section 1.4.4) it is non-invasive 
and easy to collect and thus ensured subject compliance. In addition, the relationship between 
endogenous melatonin, circadian phase and the rhythms in BP and HR was also investigated in 
the study detailed in chapter 5 (see section 8.4).
8.4 Chapter 5
8.4.1 Circadian rhythm in endogenous melatonin 
Increasing age is associated with changes in the melatonin rhythm, with reports o f  a phase 
advance (Cagnacci et al., 1995a; Cagnacci et al., 1995b; Duffy et al., 2002; Yoon et al., 2003), 
phase delay (Sharma et al., 1989) and reduced melatonin amplitude (see section 1.4.2). These 
age-related changes may be a result o f reduced SCN function, reduced pineal gland function or 
reduced zeitgeber strength, e.g. light input, or reduced SCN firing (reviewed in W u and Swaab, 
2005).
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The findings in this thesis show the time o f the melatonin acrophase (peak) to be advanced in 
women after the menopause compared to middle-aged pre-menopausal women (section 5.4.2). 
Similar results have been shown in older subjects (> 60 years) compared with young men and 
women (< 25 years), with the peak in melatonin production occurring 37-62 minutes earlier in 
the older subjects (section 5.5.1). However, there was no difference in the melatonin amplitude 
between the pre-menopausal and postmenopausal women in the present study. The absence o f 
a clear age-related reduction in melatonin amplitude may be due to the similarity in age 
between the two study groups. This lack o f difference in melatonin amplitude attributable to 
similarities in age between subjects has previously been reported in women over an age range 
o f 40-54 years under non-CR conditions (Skene et al., 1990). In the present study, the daytime 
levels o f  melatonin were higher in the postmenopausal women. The reasons for this increase in 
melatonin concentration during the day are unclear. It may be that hormonal changes 
associated with the menopause can affect melatonin synthesis and metabolism. Nocturnal 
melatonin production has been shown to increase in women with amenorrhoea associated with 
changes in hypothalamic-pituitary-gonadal dysfunction (Berga et al., 1988; Brzezinski et al., 
1988). Levels o f foUicle-stimulating hormone (FSH) are shown to be negatively correlated with 
melatonin concentrations in postmenopausal women (Fernandez et al., 1990).
Melatonin concentrations have been reported to be greatest during the luteal phase o f  the 
menstrual cycle (section 1.2.4.3). Since the pre-menopausal women in the present study were 
all studied during the follicular phase, the melatonin concentrations may thus be lower than 
would be seen in other phases o f the menstrual cycle resulting in a smaller difference in 
melatonin amplitude between the pre-menopausal and postmenopausal women. W hether the 
phase advance seen in the present study is a result o f the menopause and its associated
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hormonal changes or an effect o f age, or both, cannot clearly be distinguished from the current 
findings.
Advances in the timing o f other circadian rhythms including sleep-wake and temperature 
(Campbell et al., 1989), activity (Lieberman et al., 1989) and cortisol (Sherman et al., 1985) are 
also associated with ageing. This suggests that during the course o f ageing there may be a 
weakening o f circadian organisation altering the relationship between the pacemakers driving 
these circadian rhythms (reviewed in Goldenberg, 1991).
8.4.2 Circadian rhythms in subjective mood, alertness and cognitive performance 
One disadvantage o f the CR protocol is the associated sleep deprivation that occurs from 16- 
24 h after waking. The reduced alertness, increased sleepiness (section 5.4.3) and decrements 
o f performance, observed as the period o f wakefulness increases (section 5.4.6), are most likely 
due to the interaction o f increased sleep pressure (Borbély et al., 1982) and chcadian phase 
(Cajochen et al., 1999; Wright Jr. and Badia, 1999; Leproult et al., 2003). Age-related changes in 
the rhythms o f subjective alertness have been reported with lower amplitudes in elderly people 
(Monk et al., 1996). In the present studies no such age-related differences in the amplitude o f 
either alertness or subjective sleepiness were observed most likely reflecting the small age 
differences between the two study groups. Melatonin onset preceded both the decline in 
alertness and onset o f sleepiness in both groups o f women, which is consistent with reports o f 
the decline in alertness and increased sleepiness occurring in the period 1 h before to 4 h after 
melatonin onset (Cajochen et al., 1999; Leproult et al., 2003). W hether the relationship 
between changes in the endogenous melatonin rhythm and neurobehavioural functions are 
causal or reflect a common site o f origin (such as the circadian clock) is not known.
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8.4.3 Circadian phase-adjusted rhythms in endothelial function, BP and HR 
Determination o f  a rhythm according to normal clock time does not account for the biological 
phase o f the endogenous clock. Therefore, correction o f the endothelial function data for 
circadian phase (derived from the salivary melatonin onset) in each individual subject was 
performed. Following correction for circadian phase there was no phase-dependent variation 
in endothelial function in either the pre-menopausal or postmenopausal women. Thus it was 
concluded that the observed day-night variation (section 4.4.3) is not circadian and is most 
likely the result o f  some exogenous factor/s, which occurred during the CR protocol. For 
detailed discussion see section 5.5.5.
The rhythm in HR, with reduced activity at night, persisted after correction for circadian phase 
in both the pre-menopausal and postmenopausal women revealing the endogenous circadian 
rhythm in HR. This finding is in agreement with previous studies reporting a circadian rhythm 
in H R in CR conditions (Krauchi and Wirz-Justice, 1994; Burgess et al., 1997; K erkhof et al., 
1998; Scheer et al., 2004). N o phase-dependent variation in BP was observed. The reasons for 
this lack o f  variation have been discussed previously (section 8.3.4).
8.5 Chapter 6
The acute effects o f  dietary fat consumption on endothelial function (%FMD) has been 
extensively studied with conflicting reports o f transient impairments in endothelial function 4 
h after consumption o f a high fat meal or no effect at all (reviewed in section 1.1.4.1). 
Differences in lipid composition between test meals, the levels o f  circulating lipids, time 
intervals between measurements and gender differences can all pardy explain these 
discrepancies. All these studies were conducted during the day and since the majority o f large 
meals in the Western world are consumed in the evening, the effect o f  a high fat meal on
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endothelial responses at this time o f day was investigated in young women. Previous studies 
from our laboratory have reported an increase in plasma TAG levels following a high fat meal 
consumed late at night (01:30 h) (Sopowski et al., 2001), which is related to the endogenous 
circadian rhythm in these lipid variables (Morgan et al., 1998). Thus it is no t surprising that in 
the present study TAG levels rapidly increased following consumption o f the high fat meal, 
peaking at 4 h postprandial.
The effect o f increased circulating TAG levels at night on endothelial function in women has 
not previously been studied. In the present study, endothelial function in healthy young pre­
menopausal women on oral contraceptives was found to increase significantly from 0 h to 6 h 
independently o f the fat content o f the meal consumed (section 6.4.2). This lack o f  an effect o f 
a fatty meal consumed in the evening on endothelial function result may be due to the 
protective effects o f oestrogen on vascular function in these subjects. However, it is also 
possible that a transient decline in endothelial function following the high fat meal may have 
been missed since no %FMD measurement was taken at 4 h, which corresponded to the peak 
in TAG levels (section 6.4.1). The present results agree with those from a previous study in 
which consumption o f a high fat meal did not affect endothelial function in healthy young pre­
menopausal women despite an increase in TAG levels at 4 h (SchiUaci et al., 2001). However, 
in contrast with these findings, healthy young men were shown to exhibit a decline in 
endothelial function 2-4 h after consumption o f a high fat meal coinciding with the peak TAG 
levels at 4 h (SchiUaci et al., 2001). This gender difference in TAG responses is thought to be 
related to the higher circulating levels o f endogenous oestrogens in pre-menopausal women (Li 
et al., 1996) and may explain the results o f the present study.
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8.6 Chapter 7
A major finding o f the current thesis is the absence o f  a discernable rhythm in endothelial 
function in postmenopausal women studied either under CR study conditions or under normal 
study conditions (section 7.4.1). To the author’s knowledge this phenomenon in 
postmenopausal women has not been reported previously. There are several explanations for 
these findings. Firstly, the responsiveness o f the endothelium to increased shear stress and the 
rate o f biosynthesis o f N O  may be lower in postmenopausal women throughout the day. 
Secondly the rhythm in endothelial function in postmenopausal women may simply be 
dampened, rather than completely absent, such that the magnitude o f change in endothelial 
function over time is not sufficient to be reduced and reach statistical significance. Thirdly, the 
postmenopausal women in the present study were not on any form o f HRT and since 
oestrogen replacement has been shown to result in an increase in endothelial function in 
postmenopausal women (section 1.1.5.5), it is possible that the rhythm in endothelial function 
is attenuated as a result o f low oestrogen levels. If  this were the case then H RT should restore 
the rhythm in endothelial function in postmenopausal women. This hypothesis remains to be 
tested.
8.7 Future work
Some o f the results described in this thesis must be considered as preliminary and further 
experiments need to be conducted, with larger subject numbers, to confirm some o f the 
findings. One o f the main reasons for the relatively small number o f  subjects included in the 
CR study was difficulties with subject recruitment. Although 140 subjects initially expressed an 
interest in the study, few were able or willing to commit the time necessary due to family and 
work commitments.
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The m echanism /s by which endogenous oestrogens confer protection to the vascular 
endothelium and what changes are induced by the onset o f menopause in women needs to be 
clarified.
There is little evidence o f  an endogenous circadian rhythm in endothelial function in middle- 
aged pre-menopausal women when corrected for circadian phase. The existence o f a day-night 
variation in endothelial function in younger women studied under normal study conditions 
needs further exploration. Is this rhythm truly circadian? What exogenous factors affect this 
rhythm observed in normal study conditions? Thus a repeat o f the CR study with a younger 
study cohort, young women aged between 18-30 years divided into two groups representing 
those on oral contraceptives and those not on oral contraceptives, or a cross-over study with 
the same group o f subjects studied under CR conditions at baseline and again after treatment 
with oral contraceptives, would enable direct comparison o f the results with those obtained in 
older pre-menopausal women and postmenopausal women. In addition to the CR protocol 
described in the current thesis (section 2.3), additional blood samples collected hourly for the 
determination o f circulating levels o f endogenous oestrogen, N O , ET-1 and cortisol would 
enable a more detailed understanding o f the possible haemodynamic changes associated with 
the rhythm in endothelial function.
In order to ensure that the rhythm in endothelial function can be adequately assessed inclusion 
o f a baseline night, conducted in the experimental laboratory prior to the start o f the CR, 
would help to minimise the variability between subjects resulting from differences in sleep- 
wake schedules, study meal compliance and variable light exposure. An imposed sleep-wake 
schedule, such as bedtime at 23:00 h and waking at 07:00h would ensure that there were no 
residual effects o f prior sleep-depdvation and the exact time at which the first study meal is
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consumed could be accurately recorded. In addition, maintaining the subjects in a temperature- 
controlled environment prior to the start o f  the CR, would reduce the effects o f changes in 
environmental temperature, such as the difference between outdoor and indoor temperatures, 
on endothehal function. There are currently no reports o f  a seasonal variation in endothehal 
function, however, this has only been investigated in women during the winter and summer 
months (see section 4.6.3).
The CR protocol in the present thesis was conduced for 22 h, however, a repeat o f this 
protocol could be extended to at least 24 h, as this would ensure that any residual effects of, 
for example prior wakefulness and variabihty in nutrient status at the beginning o f the study, 
could be accounted for. One difficulty associated with the determination o f  a rhythm in 
endothehal function under CR conditions, is that unless subjects are maintaiued in a fuUy 
recumbent posture for the entire duration o f the study, such as is required by the ultrasound 
technique (section 2.4) then postural changes cannot be avoided. However, it may be possible 
to reduce some effects o f additional postural changes associated with scheduled toilet breaks, 
by restricting subjects to bed and supplying alternative means, such as bedpans or a catheter. 
Although the hght levels in the studies described in this thesis were controUed and monitored 
with the television turned on, there may have been some shght variations in the hght levels as 
the television channels were changed. Thus, a repeat o f  the CR protocol without access to 
television or computer screens would reduce this variabihty.
Since the CR protocol requires that subjects are kept awake for the duration o f  the study, it is 
possible that there may have been some effect o f sleep deprivation on endothehal function in 
the pre-menopausal and postmenopausal women. In order to determine whether sleep 
deprivation has any effect on endothehal function, a study could be conducted with young.
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healthy male and female subjects involving a baseline night in the experimental laboratory as 
described above. A 24 h period o f total sleep deprivation (i.e. 0 h sleep) would then be 
followed by a recovery day. Endothelial function could be measured on four occasions, firstly 
on the baseline night before any sleep deprivation and at 07:00 h, 09:00 h and 11:00 h on the 
recovery day following sleep deprivation. Subjects would then remain in the experimental unit 
to sleep after the last measurement had been conducted. Direct comparison o f the endothelial 
response measured at baseline and after the period o f sleep deprivation, would help to clarify 
this.
The ability to cope with a period o f extended wakefulness as determined by subjective 
measures o f mood, alertness, sleepiness and cognitive performance did not differ between the 
pre-menopausal and postmenopausal women within an age range o f 34-57 years. The results 
may have differed, however, if  the age difference had been greater between the pre­
menopausal and postmenopausal women. A repeat o f the CR study including subjects 
representing a wider range o f  ages such as 19-30, 30-40, 40-50 and 50-60 years may help to 
clarify this.
The TAG response to a high fat meal resulted in peak levels occurring at 4 h postprandially. 
This was not, however, associated with a decline in endothelial function in young women. It is 
possible that any effect o f increased circulating TAGs on endothelial function may have been 
missed, since there was no corresponding measurement at 4 h. Thus a repeat o f the fat study, 
in young women, including a measurement at 4 h would confirm or deny this hypothesis. In 
addition, a repeat o f the study with an age-matched male study cohort, would clarify whether 
there are any gender differences in the endothelial response to a high fat meal consumed in the 
evening. Further to this, since endothelial function is shown to be reduced in women after the
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menopause, whether consumption o f  a high fat meal in the evening further attenuates the 
endothelial response in postmenopausal women requires further investigation.
Finally, whether treatment with low-dose HRT has any ‘^ restorative” effect on the diurnal 
rhythm in endothelial function in postmenopausal women under normal and CR study 
conditions could be determined by assessing endothelial function in healthy middle-aged and 
older postmenopausal women before and after treatment with low-dose HRT, using a similar 
protocol to the study described in chapter 7.
8.8 In conclusion
The initial study detailed in this thesis, reports on the novel findings o f an investigation into 
the rhythm in endothelial function in healthy pre-menopausal and postmenopausal women, 
during a 22 h “constant routine” (CR) protocol. The results show that the responsiveness o f 
the endothelium to increased shear stress is significantly reduced in postmenopausal women, 
compared with young and middle-aged pre-menopausal women. The present results obtained 
under CR conditions do no t support the existence o f an endogenously generated circadian 
rhythm in endothelial function, su^esting  that the day-night variation observed under normal 
study conditions is the sole result o f  the influence o f exogenous, environmental factors.
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Summary
The activity o f several components of the vascular system appears to be diumally regulated. 
EndothelisJ cell activation, leukocyte and platelet interactions and lipoprotein metabolism 
have all been shown to vary with time of day, but whether these variations are due to the 
endogenous circadian clock, exogenous factors, such as the light-dark cycle, or an interaction 
between the two r e m ^ s  to he determined.
Endothehum-dependent vasodilation also varies diumally. This rhythmicity is lost in individ­
uals with established coronary disease has been shown to occur in the early stages of athero­
sclerosis.
The incidence of coronary events appears to he higher in the early hours of the morning, this 
may be related to heightened activity of the autonomic nervous system at this time. Higher 
circulating levels o f catecholamines in the morning are associated with increased vascular 
tone, affecting circulating blood volume and blood pressure. Time dependent variations may 
be o f particular significance for individuals with dismpted drcadian rhythms, including rotat­
ing shift workers, transmeridian travellers and bhnd individuals with no light perception.
Variations in endothelial function are observed during the menstrual cyde, varying with dr- 
culating oestrogen levels. Oestrogen dehdency in postmenopausal women may contribute to 
endothelial dysfunction, together with other modifiable risk fectors. The absolute risk of coro­
nary disease is greater for men than for pre-menopausal women. Following the menopause 
gender differences in coronary risk are thought to diminish, although this remains controver­
sial. This review focuses on the influence o f both endogenous biological rhythms and environ­
mental factors on the function and health of the human vascular system.
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Background
Disrupted circadian rhythms have been implicated in 
the genesis o f cardiovascular and cerebral disease; and 
myocardial infarction, cardiac arrhythmias, sudden car­
diac death and stroke, have a peak incidence in the 
morning hours (06:00 to 12:00 hrs) and a lower inci­
dence at night [1]. Studies have also shown that there is 
a time-dependent change in leukocyte activation and 
endothelial function, and these may play a critical role 
in the pathophysiology o f thrombotic events and other 
inflammatory disorders [2]. However, the biological 
rhythmicity in these functions is modulated by both 
endogenous and exogenous influences.
Biological rhythms may be circadian (with a periodicity 
of approximately 24 hours), drcatrigintan (such as the 
menstrual cycle in women) and circannual (seasonal 
variation brought about by changes in day length). Dis­
ruption of biological rhytluns may affect several physio­
logical and behavioural functions, directly or indirectly. 
In mammals, circadian rhythms are endogenously gene­
rated by a ‘pacemaker’ located in the suprachiasmatic 
nuclei (SCN), a distinct cluster of cells localised within 
the hypothalamus. More recent studies have shown evi­
dence o f peripheral oscillators, however it is generally 
considered that oscillations generated from peripheral 
sites are kept ‘in phase' by the SCN oscillator. The pineal 
gland is a neuroendocrine transducer, which receives 
information directly from the SCN in response to sig­
nals from retinal photoreceptors via the retinohypoth^- 
amic tract. In response to information from the retina, 
the SCN stimulates the pineal to synthesise and secrete 
the hormones serotonin, during the day, and melatonin 
at night. The nocturnal rise in melatonin also depends 
on increased norepinephrine (NE) in sympathetic nerve 
terminals acting on P- and a-adrenergic receptors [3]. 
The ‘chronobiotic’ effects o f melatonin (AT-acetyl 5- 
methoxytryptamine) have been extensively studied [4]. 
However, the physiological effects o f endogenous mela­
tonin are poorly understood and little is known about 
its effects within the cardiovascular system.
The effects o f  melatonin are mediated by binding to 
specific, high affinity G-protein coupled receptors 
localised to the plasma membrane. Two mammalian 
receptor subtypes have been identified, MTj (Mel,^) and 
MTg (Meljg) [5,6]. Recent evidence suggests that mela­
tonin may have a direct influence on vascular function 
via the MT, receptors located on coronary arteries [5]. 
Many of the physiological factors that affect the vascular 
system, including plasma epinephrine (adrenaline), tis­
sue plasminogen activator (PA-1), platelet aggregation 
and fibrinolysis appear to be regulated by the circadian 
clock, either directly or indirectly [2].
Under natural illumination, and most laboratory light­
ing conditions, animals are entrained to the 24-hour 
period of the light-dark cycle [7]. The ‘masking’ effects 
of the light-dark cycle or other environmental stimuli 
may only be excluded in experiments conducted under 
constant conditions, i.e. temporal isolation from all time 
cues [8]. Unfortunately, many of the experiments inves­
tigating circadian variation in vascular parameters have 
not accounted for the exogenous effect of environmen­
tal influences. Consequently, it is not yet proven that the 
observed rhythms are indeed endogenously generated 
(i.e. circadian).
Diurnal variation of endotheual function
AND CORONARY HEART DISEASE________________________
The role o f  the vascular endothelium
Endothelial cells form the interface between the circu­
lating blood and the artery wall, and are therefore well 
placed to play a number o f important roles [9]. 
Circulating blood exerts shear forces on the endotheli­
um, inducing flow-mediated dilation. Shear stress has 
been shown to actively influence vessel wall remodelling 
[10]; a process that is dependent on intact endothelial 
function [II]. In response to sheer stress, and other 
stimuli such as, insulin, endothelin-I, acetylcholine, 
adenosine diphosphate (ADP), thrombin and bradyki- 
nin, the endothelium releases several vasoactive media­
tors that include nitric oxide (NO), endothelium- 
derived hyperpolarizing factor (EDHF) and prostacyclin 
(PCIg) [12]. NO diffuses from the endothelium, acting 
within the circulation to inhibit platelet aggregation, 
and also acts on the underlying vascular smooth muscle 
to induce relaxation [13]. NO probably also exerts an 
autocrine/ paracrine effect on the endothelium, by mod­
ulating the expression of cell adhesion molecules such 
as intercellular adhesion molecule-1 (ICAM-I) and vas­
cular cell adhesion molecule-1 (VCAM-I) [14]. This may 
be particularly important in preventing the early stages 
of atherogenesis.
Diurnal variation and endothelial dysfunction
Studies have shown time-dependent changes in 
endothelial function. Shaw et al (2001) [15] demonstrat­
ed that in healthy male subjects, endothelium-depen­
dent vasodilation is subject to a time of day variation, 
which may act as a cardioprotective mechanism to coun­
teract potentially adverse time-dependent changes in 
haemodynamic parameters including thrombosis and 
fibrinolysis. Significantly, individuals with hypertension 
and established CHD lose this diurnal rhythm, and this 
may contribute to the progression o f atherosclerosis 
[15].
Endothelial dysfunction presents early in the evolution 
of coronary disease. It is characterised by abnormal 
vasomotor function, loss of permeability barrier func­
tion, adhesion molecule upregulation and a prothrom- 
botic surface [16]. These changes are partially due to an 
imbalance in the expression o f endothelium-derived 
mediators [16]. The biological activity o f endothelium- 
derived NO is impaired in individuals with hyperten­
sion and atherosclerotic disease. Studies investigating 
the diurnal variation in urinary markers o f NO produc­
tion (nitrate and cyclic CMP) have shown evidence of 
time-dependent changes [17]. In response to shear 
stress induced by the flow o f blood along the endothelial 
surface [18,19] and the effect o f mediators, such as
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bradykinin, serotonin and acetylcholine, NO is continu­
ously released. Physical exercise causes an increase in 
blood flow and thus increases shear stress, which may 
also he responsible, in part, for the increased NO 
release observed during the day [20]. Bode-Boger et al 
(2000) [17] reported that differences exist in the rhyth­
mic production o f NO between healthy individuals, and 
patients with hypertension or peripheral arterial occlu­
sive disease. Individuals with atherosclerotic disease 
were found to have a reduced amplitude in the levels of 
NO produced in comparison with healthy individuals, 
and the twenty-four hour rhythm was absent in patients 
with hypertension [17].
Melatonin receptor subtype: expression  
on endothelial cells?
The expression of the MTj melatonin receptor has been 
localised to the SCN, pars tuheralis o f the pituitary, 
MCF-7 breast cancer cells and coronary vessels [5,6,21]. 
Evidence for the expression o f the MTj receptor in 
human vasculature was derived from Western blotting 
of sections o f isolated coronary artery, obtained from 
individuals undergoing orthotopic heart transplantation
[22]. Receptor expression in these tissues was confirmed 
by the identification of a band of approximately 39 kDa 
(relative to a previously predicted molecular mass o f 37 
kDa) and this was supported by positive findings using 
RT-PCR analysis.
However, the exact cellular localisation o f the receptor 
was not investigated. The authors also reported evi­
dence of a significant 24-hour variation in receptor 
expression, with lowest values recorded during the 
morning hours and peak values detectable in the early 
evening. This was determined by having the results 
from the Western blots against the exact time of apply­
ing the aortic damp and the rhythm calculated via cosi- 
nor analysis o f the data. However, only single clock 
hour samples were obtained [22]. Gauer et al (1993) 
[23,24] showed that in the rat pars tuheralis and SCN, 
melatonin receptor density is inversely proportional to 
drculating levels o f melatonin. Thus, melatonin recep­
tors appear to be directly regulated by melatonin itself, 
which could in part, explain the observed time-depen­
dent changes seen in human arteries [24].
There is good evidence for the presence o f melatonin 
receptors in the cerebral (drde of Willis at the base of 
the brain) and caudal arteries in rats [25]. The affinity 
of ligand for these binding sites is similar to that report­
ed in the SCN and PT [25]. It has been shown that 
melatonin causes vasoconstriction and reduced blood 
flow in rat cerebral arteries by directly binding to recep­
tors on smooth muscle cells [26]. In the rat caudal 
artery, vascular tone is regulated by norepinephrine 
(NE), originating from sympathetic nerves and mela­
tonin affects vascular tone in these tissues indirectly, by 
potentiating the effect o f NE [27]. Similar studies using 
pordne coronary arteries, have found that serotonin 
causes smooth muscle cell contraction, and endothe­
lium-dependent relaxation via the release o f NO [28, 
29]. Melatonin has been shown to inhibit the contractile
response to serotonin in isolated rabbit aorta vascular 
smooth m usde [30]. The findings suggest that the 
action o f melatonin on serotonin-induced contraction of 
coronary arteries may interfere with caldum influx 
from nifedipine-sensitive L-type voltage-sensitive cald­
um channels (VSCC) [30]. The effect o f melatonin on 
NO-mediated endothelium-dependent relaxation has 
yet to he studied.
The presence o f the MTj receptor in human coronary 
arteries therefore suggests melatonin may have an effect 
on vascular tone and blood flow following receptor acti­
vation [22]. The exact localisation o f the melatonin rece­
ptor in human coronary arteries also remains to be elu- 
ddated.
Autonomic function and cardiovascuiar disease
In the early morning, there is a marked rise in neural 
and hormonal sympathetic activity [31].
The observed diurnal rhythm of blood pressure coin- 
ddes with a rhythmic release o f catecholamines [32]. 
These changes in autonomic activity may also modulate 
plasma volume, vascular tone and blood coagulability 
[32], and influence the balance between coronary blood 
supply and oxygen demand. Additionally, the arteries of 
patients with established coronary disease and endothe­
lial dysfunction are likely to he more sensitive to the 
constrictor effects o f catecholamines, and increased sym­
pathetic nervous activity evident during the early morn­
ing [31].
It has been suggested that the SCN modulates auto­
nomic output to most organs o f the body [33]. The sym­
pathetic innervation o f the pineal gland and neural out­
flow from brain to adipose tissue were the first demon­
strations of SCN-peiipheral connections [34]. Studies hi 
rats [35] and humans [36] have shown that ambulatory 
heart rate is affected by exposure to light in a dose- 
dependent manner. This suggests a potential role for 
the retina-SCN pathway in the regulation of autonomic 
functions.
Apparent absence o f  circadian rhythmicity o f  blood  
pressure
Blood pressure fluctuates with the sleep-wake cycle in 
humans, with levels being generally higher during the 
day and lower at night. This is associated with increased 
sympathetic activity during the waking hours [37]. It is 
well established that the 24-hour blood pressure profile 
is affected by both environmental and behavioural fac­
tors. Furthermore, studies using constant routine tech­
niques, that minimise the influence o f environmental 
cues, have suggested that in healthy subjects exogenous 
factors are the sole determinants o f the observed 
rhythms [38,39]. Since the day/night blood pressure 
rhythm is largely independent of the circadian clock, it 
shows almost immediate adaptation to shifted phases of  
activity and sleep [39].
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Time dependent variation of endotheual cell adhesion
MOLECULES AND FIBRINOLYSIS_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Endothelial ce ll adhesion m olecules
Cell adhesion molecules (CAMs) are present on the cell 
membranes o f many cells including endothelial cells. 
They play a central role in the recruitment of the leuko­
cyte inflammatory process. They are released into the 
circulation as soluble adhesion molecules, following 
endothelial activation [40].
Both E-selectin and ICAM-I are found on the endothe­
lial cell surfece. E-selectin is activated by such inflamma­
tory markers as interleukin-1 (IL-I) and tumour necro­
sis factor alpha (TNF-a) [41]. It has been suggested that 
since E-selectin is uniquely expressed on endothelial 
cells, plasma levels o f soluble E-selectin may he an indi­
cator o f endothehal cell activation [42]. Studies in 
young, healthy subjects have shown a time-dependent 
variation in the plasma levels o f soluble (s)E- and 
(s)ICAM-I. A peak concentration occurs at approxi­
mately 12:00 hrs and a nadir at 24:00-04:00 hrs [40].
Diurnal variation o f  fibrinolytic activity
The proteolytic breakdown of fibrin by plasmin in the 
blood is activated by the endothelium-derived tissue- 
type plasminogen activator (tPA) and transiently inhibit­
ed by the actions of the irreversible plasminogen activa­
tor inhibitor type I (PAI-I). Under normal circum­
stances, free active plasmin is not detectable in the circu­
lation, so the fibrinolytic activity in blood is largely 
determined by circulating levels o f tPA, which is closely 
regulated by PAI-I [42]. The discovery that fibrinolytic 
activity shows a 24-hour variation, was reported by 
Feamley and co-workers [43].
Further studies have shown that the activities o f tPA and 
PAI-I are largely responsible for these day-night chan­
ges in blood fibrinolysis [44,45]. Andreotti et al [42] sho­
wed that the highest levels o f plasma tPA were detectab­
le at 18:00 hrs, falling dramatically to barely detectable 
levels at 03:00 hrs. Fluctuations in plasma PAI-I were 
closely related to those of tPA, with low levels at 18:00 
hrs and greatest inhibition at 03:00 hrs [42]. This varia­
tion in fibrinolytic activity, with reduced levels in the 
early morning could fevour thrombus formation in the 
early morning and be associated with the reportedly hi­
gher morning incidence of acute thrombotic events [44].
The menstrual cycle and cardioproteciive properties
OF OESTROGEN_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Oestrogen receptors are found throughout the arterial 
tree [46] and physiological levels o f oestradiol cause 
relaxation of coronary arteries and stimulate NO pro­
duction by endothelial cells [47]. The fluctuations in 
oestrogen concentrations during the menstrual cycle are 
reflected in changes in levels o f several other circulating 
factors including nitric oxide, vascular endothelial 
growth factor, adhesion molecules and homocysteine 
[48]. A reduction in large vessel endothelial function has
also been shown to occur in the late luteal phase [49]. 
Studies have shown that endothelium-dependent 
vasodilation o f the brachial artery increases from the 
menstrual to late follicular phase, decreases in the early 
luteal phase and increases again in the late luteal phase 
[49,50]. These changes are co-incident with variations in 
the levels o f endogenous oestrogens during the men­
strual cycle, which rise during the early stages o f the 
cyde. M l during early luteal development and rise 
slightly during the remainder of the cyde [50].
In addition, there is increasing evidence that melatonin 
may directly affect the biological responses to oestrogen. 
Studies investigating the modulation o f oestrogen 
receptor activity in MCF-7 human breast cancer cells 
have shown that melatonin can suppress oestrogen 
receptor-a (ER-a) gene transcription and repress its 
biological activity [21].
M enopause and increased CHD risk: is ageing the 
important factor?
Data analysis o f mortality rates fi-om all causes, induding 
coronary artery disease, in the UK, show that risk increases 
inexorably with age in both men and women [51]. It has 
been argued that, there is no acceleration of risk in women 
at or after 50 years, and no age at which risk in both men 
and women is the same [52]. Similar findings have been 
shown for other countries induding the USA [51].
However there is a large body o f evidence indicating 
that oestrogen is cardioprotective and therefore it must 
be considered as a contributor to the difference in CHD 
trends between men and women. Arterial endothelial 
function appears to decline at a significantly greater rate 
in postmenopausal women than men [52]. It is possible 
that oestrogen defidency in postmenopausal women 
contributes to endothelial dysfunction and hence may be 
responsible, in part, for the increased risk of CHD [53].
The menopause is also assodated with a number of 
other changes in coronary risk factor profile that may 
affect endothelial function. A significant increase in 
serum cholesterol precedes the natural menopause by 
several years [54]. Postprandial lipid metabolism is asso­
dated with endothelial function and studies have shown 
the pre/post-menopausal transition is assodated with 
increased levels o f triglycerides and cholesterol [55]. 
High oestrogen levels are assodated with greater fibri­
nolytic activity and lower PAI-I levels [56]. 
Consequently, the menopause is assodated with changes 
in haemodynamic function with increased blood pres­
sure and a decrease in the physiological M l in nocturnal 
blood pressure, effects that can be reversed by hormone 
replacement therapy [57,58].
CONDITIONS ASSOCIATED WITH INCREASED CARDIOVASCULAR
risk: possible circadian influence?_________________
Diabetes
Diabetes is an independent risk factor for CHD. Hyper- 
glycaemia and insulin resistance, are considered con­
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tributory factors to the development o f diabetic 
macrovascular disease. In both animal and human stud­
ies, insulin has been shown to have a direct effect on 
vascular function. In animal models, insulin has been 
shown to induce endothelial-derived nitric oxide release 
[59] and in humans, to stimulate nitric oxide-dependent 
basal blood flow [60].
Insulin resistance is associated with impaired endothe­
lium-dependent vasodilation [61] and is particularly 
prevalent in individuals with obesity or type II diabetes 
[62,63]. It has been suggested that there may be similar­
ities between the signalling pathways responsible for 
insulin-stimulated glucose uptake and msulin-sthnulat- 
ed endothelial function [64]. High glucose concentra­
tions have been postulated to have a direct effect on 
endothelial function, via an increased production o f  
vasoconstricting agents (prostaglandins) or increased 
generation o f reactive oxygen species (superoxide 
anions) [65,66].
It has also been well established that long term treat­
ment with insulin and other hypoglycaemic drugs, 
improves insulin-stimulated glucose uptake and other 
metabolic functions [67]. Rask-Madsen et al [68] investi­
gated the effect of two months of treatment with insulin 
treatment on endothelium-dependent vasodilation in 
individuals with type II diabetes or ischaemic heart dis­
ease. Their results showed a partial restoration of 
insulin-stimulated vascular function in both groups, 
although no improvements in endothelium-dependent 
vasodilation were observed [68].
Studies have shown that diabetic individuals with estab­
lished coronary artery disease are at increased risk o f  
recurrence compared with non-diabetic coronary 
patients [69] and that this risk may he associated with a 
disruption of the normal altered rhythm of autonomic, 
haemostatic and fibrinolytic functions [45]. Diabetic 
individuals exhibit a blunted circadian variation of tPA 
and PAI-I coupled with platelet hyperaggregabiUty, 
which persists throughout the day [70]. This sustained 
prothrombotic state may attenuate the relative protec­
tion from thrombotic events during the evening and 
night-time [45].
However the above studies do not appear to have con­
trolled for exogenous, confounding effects such as the 
light-dark cycle, such that the precise contribution of 
the endogenous circadian clock to these phenomenon 
has not yet been determined.
S h iftw ork
There is increasing evidence to suggest that shift work­
ers have an increased risk of developing coronary heart 
disease [71,73]. Maladaption of endogenous circadian 
rhythms to abrupt changes in shift times are associated 
with disturbed sleep and meal patterns and may con­
tribute to this risk. Heart rate and blood pressure of 
shift workers has been shown to increase during work 
and decrease during sleep, independently of clock time 
and type of shift (day or night shift) [74].
Since heart rate and blood pressure are under the con­
trol o f the autonomic nervous system, it is predicted 
that shift work also alters the circadian rhythm o f sym­
pathetic activity [75]. These changes may also be related 
to the increased cardiovascular risk associated with shift 
work [71,72]. Studies investigating the effect o f shift 
work on blood pressure, have shown the greatest 
change in the sleep/wake difference, in mean 
systolic/diastolic ambulatory blood pressure, occurs in 
day shift workers, compared to night shift workers, 
independent o f age and body mass index [32].
It is becoming increasingly accepted that triglycerides 
are an independent risk factor for coronary disease [76]. 
The predominance o f small low-density lipoproteins 
(LDL) is associated with increased coronary risk, as 
these particles are more able to infiltrate the arterial 
wall and are more easily oxidised, leading to enhanced 
atherogenesis [76]. Elevations in both plasma triglyc­
erides and cholesterol have been reported in some shift 
workers [77]. Studies investigating die effect of simulat­
ed shift work on the postprandial responses to a stan­
dardised mixed meal in young healthy subjects, showed 
that postprandial glucose, insulin and lipid levels are 
affected by circadian alterations [78,79]. Rotating shift 
workers are thus likely to demonstrate insulin resistance 
and altered Hpid responses when meals are consumed at 
the beginning of a period o f night-shift work and dur­
ing daytime shifts, when unadapted [79].
S easonal peak in cardiovascular mortality__________
Seasonal change o f  human circadian rhythms
The circadian clock not only regulates physiological 
functions in accordance with the twenty-four hour light- 
dark cycle, but also with the seasonal change in pho­
toperiod [80].
Melatonin plays an important role in the regulation of 
seasonal rhythms in photoperiodic mammals, being 
involved in regulating seasonal cycles o f reproduction, 
coat growth, milk production as well as fasting, ther­
moregulation and hibernation [81]. The duration o f the 
nocturnal melatonin peak changes according to pho­
toperiod, increasing in accordance with the length o f  
the dark period, such as during printer [82].
In contrast, until recently the only seasonal change in 
humans was a change in the tinting of the endogenous 
melatonin rhythm, being phase advanced in the sum­
mer in normal, healthy individuals [83-85]. The ability 
of early morning bright light to phase advance drcadian 
rhythms [86], may explain why the tuning o f drcadian 
rhythms is more advanced in summer than winter. 
However, more recently, in a carefully controlled study 
exposure o f subjects to 8hrs light : I6hrs complete dark­
ness for two months has been shown to increase the 
duration o f melatonin secretion compared with two 
months exposure to I4hrs hght : lOhrs dark [87].
Thus humans, like photoperiodic animals appear to 
possess the ability to respond to changes in photoperiod.
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Increased incidence o f  CHD during winter
It is well known that short-term climatic changes (e.g. 
heat wave) transiently influence cardiovascular mortality 
[87]. It has been suggested that climatic changes during 
the winter months may induce physiological stresses 
including sympathetic activation, hypercoagulability 
and infection, leading to an increased incidence o f acute 
coronary events and stroke [88]. Evidence suggests that 
the observed seasonal variation in CHD mortality is par­
ticularly associated with increasing age [89].
Acute exposure to cold in humans is known to he associ­
ated with the stimulation of several autonomic respons­
es including peripheral vasoconstriction, shivering, 
increased heart rate and blood pressure and particular­
ly in the elderly, whose coronary circulation is already 
compromised, the increased demand in oxygen con­
sumption could lead to ischaemia, and therefore angina 
pectoris or myocardial inferction.
The discovery of melatonin receptors in human coro­
nary arteries, and melatonin’s role in seasonality, sug­
gests that there may he a physiological basis to the 
increased incidence o f coronary events during winter. 
More studies are needed to investigate this further.
Conclusions______________________________________
It appears that several factors involved in the develop­
ment of cardiovascular disease are temporally modulat­
ed. Blood pressure, vascular tone, lipid metabolism, 
platelet and leukocyte reactivity and fibrinolysis vary 
with time of day, hut it is unclear whether this is due to 
an intrinsic rhythm, or driven by environmental cues. 
There is however emerging evidence that the hormone 
melatonin may contribute in part to the diurnal varia­
tion in vascular function, as receptors for it are present 
in the coronary circulation. The physiological impor­
tance o f control by the circadian clock remains to be 
established. The attenuation of diurnal variation in vas­
cular function, found in association with coronary risk 
factors, and the potential disturbance of these biological 
rhythms during shift work may further contribute to 
cardiovascular risk, and requires further evaluation.
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RHYTHMS INVESTIGATED IN CONSTANT ROUTINE CONDITIONS
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Surrey, Guildford, Surrey, England 
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England
Although studies have reported the effects o f  the menstrual cycle on melatonin 
rhythmicity, none has investigated the effects o f  menopause on the melatonin 
rhythm. The circadian rhythm in melatonin and its relationship to subjective alertness 
was investigated in pre- and postmenopausal women under constant routine con­
ditions (controlled posture, dim lighting, calorie intake, temperature, and prolonged  
wakefulness). Eleven healthy pre-menopausal (42 ± 4 y r )  and 10 postmenopausal 
women (55 ±  2 yr) participated in the study. Salivary melatonin samples and subjective 
measures o f alertness and sleepiness were assessed hourly during the 22 h constant 
routine protocol. Postmenopausal women had a significantly earlier melatonin acro- 
phase (1.1 ±  0.5 h clock time in decimal h; mean ±  SEM,/> <  0.05) compared to the 
pre-menopausal women (2.3 ±  0.3 h). There was no significant difference between  
melatonin onset and amplitude between the pre-menopausal and postmenopausal 
women. Self-rated alertness declined in both study groups as the length o f  sleep depri­
vation increased. Melatonin onset preceded the onset o f self-rated sleepiness in both 
groups. The time interval between melatonin onset and the onset o f  sleepiness and 
alertness offset was significantly greater in the postmenopausal women compared to 
the pre-menopausal women. In conclusion, under controlled experimental conditions 
the timing o f  the melatonin rhythm was advanced in postmenopausal women altering 
its phase relationship to subjective alertness and sleepiness.
Keywords Melatonin, Circadian, Constant Routine, Menopause, Alertness, Sleepiness
INTRODUCTION
T he circadian clock, located in the hypothalamic suprachiasmatic nuclei 
(SCN), is direcdy o r indirecdy involved in  the control o f physiological
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and behavioral circadian rhythms. In  humans, the circadian pattern  o f 
melatonin production typically begins in the late evening (Arendt, 1995), 
preceding the onset o f sleepiness and the fall in body tem perature (Wyatt 
e t al., 1999). Peak melatonin production occurs around 0 2 :0 0  h  (Arendt, 
1995).
Previous studies have shown a reduction in the am plitude o f the mela­
tonin rhythm  to be associated with aging in both  m en and  women (Touitou 
e t al., 1981; Iguchi e t al., 1982; Sack e t al., 1986; Sharm a e t al., 1989; 
O hashi et al., 1997; O katani et al., 2000; Zhao et al., 2002; 2003; Magri 
e t al., 2004). Recently this phenom enon has been challenged by Zeitzer 
and  colleagues (1999), who investigated the plasma m elatonin profiles o f 
19 older m en (> 6 5 yr) and  20 older women (> 6 0 yr) during  a 3 0 h  
constant routine, in which subjects rem ained awake, sem i-recum bent 
and  in constant dim  light (< 15  lux) and were provided with hourly isoca­
loric snacks and  fluids. U nder these controlled experim ental conditions, 
the am plitude o f the circadian rhythm  o f m elatonin in  the older group 
was reported  to be similar to that observed in young m en (Zeitzer e t al., 
1999). In  contrast, Zhou and colleagues (2003) showed that in healthy, 
m iddle-aged (41 to 53 yr) and  older (66 to 72 yr) women studied in their 
norm al working environm ent, with nocturnal sampling perform ed while 
subjects w ere in a supine position, the am plitude o f the salivary 
m elatonin rhythm  was 60% o f that observed in younger m en and 
women. T he conflicting results from  these studies suggest that diflerences 
in experim ental conditions (light/dark  control, constant routine con­
ditions) and  strict selection criteria for subjects may influence the observed 
patterns o f m elatonin (reviewed in Skene and  Swaab, 2003).
M enopause is associated with a decline in estrogen production and  
with changes in gonadotrophin and prolactin levels (Fernandez et al., 
1990). T he effect o f endogenous estrogen production on m elatonin 
synthesis and  metabolism in hum ans is controversial. Studies investigating 
the m elatonin rhythm  during  the m enstrual cycle have also provided con­
flicting results, with some studies reporting  increased m elatonin levels in 
the luteal phase (W etterberg et al., 1976; Webley et al., 1986; B run  
et al., 1987), decreased m elatonin am plitude during  the luteal phase 
(Shibui et al., 2000), o r no difference between the m enstrual phases 
(Brzezinski e t al., 1988; W right J r  et al., 2001). In  addition to alterations 
in melatonin production, m enstrual cycle and age-related changes in the 
circadian rhythm  o f subjective alertness have also been reported  in 
women (Monk et al., 1996; W right J r  et al., 2001).
T he aim o f the present study was to determ ine w hether the m elatonin 
rhythm  and its relationship to alertness are  affected by m enopause. T he 
study was designed to assess the effect o f the m enopause and horm onal 
status on the m elatonin rhythm  in pre- and postm enopausal w om en 
with ages m atched as closely as possible in o rder to reduce the effect o f
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age as a confounding variable in the interpretation o f the results. Constant 
routine conditions were adopted for the study to reduce the effects o f 
potentially confounding variables such as light exposure and  activity. Sali­
vary melatonin, which has been shown to be well correlated with plasma 
m elatonin (Nowak et al., 1987; Voultsios et al., 1997), was selected as the 
circadian phase m arker. M elatonin and subjective alertness and sleepiness 
w ere assessed hourly in the pre- and  postm enopausal wom en during  a 
22 h constant routine protocol.
MATERIALS AND METHODS 
Participants
Eleven dium ally active pre-menopausal women aged between 35 and  50 
(42 ±  4; m ean ±  SD)yr and 10 postmenopausal women aged between 
50 and 60 (55 ±  2yr) with body mass indices o f 23 +  2 (range: 19-25) 
kg/m ^ participated in the study. All participants were healthy non-smokers, 
free o f any medication including oral contraceptives and horm one replace­
m ent therapy (HRT), and had no history o f diabetes, cardiovascular 
disease, o r sleep disorders (confirmed using the Pittsburgh Sleep Quality 
questionnaire, PSQl < 5) (Buysse et al., 1989), and  had  no t travelled 
across m ore than  two time zones in the m onth preceding the study. 
S tandard biochemistry screening was conducted before inclusion into 
the study. T he pre-m enopausal women were all studied during  the follicu­
lar phase o f the m enstrual cycle (confirmed by analysis o f  estradiol, p ro ­
gesterone, luteinizing horm one [LH], and  follicle-stimulating horm one 
[FSH]). M enopausal status, defined as no evidence o f m enstruation for 
at least 12 m onths, was confirm ed by blood horm one analysis (estradiol 
< 1 0 0 p g /m L ; FSH > 4 0  lU /L ; LH > 4 0  lU /L ). W ritten inform ed 
consent was obtained from  each participant and  from  their general p rac­
titioner following a full explanation o f the purpose o f the study and  
nature o f procedures to be employed. Ethical permission for the study 
was obtained from  the University o f Surrey Ethics Committee and  the 
conduct o f the research respected the ethical principles and standards o f  
the Jou rna l (Touitou e t al., 2004).
Experimental Protocol
All participants were asked to m aintain their own regular sleep-wake 
pattern  for 3 days p rio r to the study, avoiding bright light exposure 
from  18 :00  h each day. Compliance was assessed using subjective sleep 
diaries and  wrist actigraphy and light recordings (Actiwatch L, Cam bridge 
N eurotechnology Ltd., Cambridge, UK). Participants w ere asked to 
refrain from  consuming alcohol and caffeine and from  strenuous exercise
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th roughout the day before and  during  the study. Participants were also 
instructed no t to consume any food o r drink  (with the exception o f 
water) in their hom e environm ent from  2 0 :0 0  h  the night before until 
07 :00 h  the following m orning.
T he study was conducted in the Clinical Investigation U nit (School o f  
Biomedical and  Molecular Sciences, University o f Surrey). Participants 
were studied for 22 h  u n d er ‘constant routine’ conditions (Mills et al., 
1978) starting at 0 8 :0 0  h, during  which time subjects rem ained in  a 
sem i-recum bent position (except for occasional visits to the toilet), awake 
and  u n d er dim  light (< 10  lux white light in the direction o f gaze). Partici­
pants were given liquid ‘study meals’ o f Fortisip (Nutricia Clinical Care, 
Trow bridge, Wiltshire, UK.) at 1 h  intervals on the h ou r th roughout the 
study period. Each ‘meal’ contained 48% carbohydrate, 13% protein, 
and  39% fat. Each participant was given 38 kcal/kg body weight hourly, 
and water was provided ad libitum throughout. N orm al time cues w ere 
presen t th roughout the study, including via access to clocks, radio, and  
television (study lighting conditions were assessed with the television 
tu rned  on to ensure levels were m aintained below 10 lux). Saliva 
samples were collected at 1 h  intervals by chewing on a non-citrated 
cotton salivette (Sarstedt Ltd, Leicester, UK.) for 2 m in p rio r to consum ing 
each study ‘meal.’ Saliva samples w ere frozen (— 20°C) immediately upon  
collection, for later analysis.
Subjective Alertness and Sleepiness
Measures o f subjective alertness and  sleepiness were assessed hourly, 
following collection o f the saliva sample. Alertness was recorded using a 
visual analog scale, w here participants were asked to m ark a line on  a 
10 cm scale (0 =  very drowsy; 10 =  very alert). Subjective sleepiness was 
determ ined using two methods, the Karolinska Sleepiness Scale (KSS; 
A kerstedt and  Gillberg, 1990) where sleepiness is rated on a scale o f 1 to 9 
(1 =  very alert; 9 =  very sleepy) and  the Samn-PereUi (Samn and  Perelli, 
1982) sleepiness scores (participants requested to answer a series o f  10 
questions relating to their levels o f sleepiness).
Melatonin Assay
Saliva samples were thawed on the day o f assay and  centrifuged at 
3500 rpm  for 10 m in at 4°C. Melatonin was m easured by radioim m uno­
assay (English e t al., 1993). This published work em ployed a rabbit 
anti-melatonin antiserum . T he assay used in the present study em ployed 
a sheep anti-melatonin antiserum  (batch no: A B/S/08), supplied by 
Stockgrand Ltd. (University o f Surrey, G uildford, Surrey, UK.) Separation 
o f the bound fraction was achieved using cellulose linked donkey
Effect of Menopause on Melatonin and Alertness Rhythms 863
anti-sheep IgG (SAC-CEL). T he limit o f detection o f the assay was < 2  p g / 
m L. T he intra-assay coefficients o f variation (GV) were 12%, 5%, and 12% 
and  the inter-assay CVs were 13%, 16%, and  9% for the low (7 pg/m L ), 
m edium  (15 pg/m L), and  high (50 pg/m L) pooled saliva samples, respect­
ively. Samples m easured using the two antisera (sheep anti-melatonin and 
rabbit anti-melatonin) (English et al., 1993) showed a good correlation 
(r =  0.89, n =  23, y in tercept =  2.2, p  <  0.0001).
Data Analyses
Data are expressed as the m ean ±  SEM. All clock times were expressed 
as time in decimal hours. M elatonin concentrations were analysed as absol­
u te  values and the increm ental area u n d er the curve (AUG) calculated 
using the trapezoid m ethod. T he time o f m elatonin onset was defined as 
the time o f m elatonin onset at m idrange (melon 50%) and was used as 
the prim ary m arker o f m elatonin phase (W arm an e t al., 2003). Individual 
m elatonin rhythm s were normalized to baseline (mean o f each subject’s 
m elatonin values between 1 2 :00  to 1 4 :00  h). T he am plitude o f the m ela­
tonin rhythm  was defined as the difference between the baseline and  the 
peak (mean o f the three highest m elatonin values). Single cosinor analysis 
(program  provided by D.S. Minors, University o f M anchester, UK) was 
used to determ ine the m elatonin acrophase (peak time o f production). 
M elatonin offset (meloff 50%) and m elatonin duration could no t be calcu­
lated as most o f the m elatonin profiles failed to re tu rn  to basal levels by the 
end  o f the sampling period (06 : OOh). Data from  two postm enopausal 
wom en had to be excluded from  the analysis as one woman failed to com­
plete the entire study and the o ther had no detectable m elatonin rhythm .
Alertness and  sleepiness data were norm alized to a daytime baseline 
(m ean o f all values between 0 8 :0 0  and 18 : OOh). T he am plitude o f 
the alertness/ sleepiness rhythm  was defined as the difference between 
the baseline and peak (mean o f the th ree highest values). Alertness offset 
(alert 50% ofi) and  sleepiness onset (sleepiness 50% on) were defined as 
the time m idrange between the baseline and  peak values. All data were 
subjected to two-way repeated measures analysis o f variance (ANOVA) 
(factors: time and  m enopause) (Statistica v5, StatSoft Ltd, Bedford, UK). 
Param eters derived from  the m elatonin and  alertness rhythm s were 
com pared between the pre- and postm enopausal women using unpaired  
S tudent’s (-tests. Statistical significance was defined as p  <  0.05. L inear 
regression analysis was used to determ ine correlations between subjective 
alertness/ sleepiness and  m elatonin concentrations.
RESULTS
In  the 3 days before the study (pre-study conditions), there  were 
no significant differences in habitual sleep timing (onset and offset)
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TABLE 1 Pre-Study Sleep Patterns in Pre-and Postmenopausal Women
Variable
Pre-menopausal 
women (n =  11)
Postmenopausal 
women (n =  8)
Statistical
significance"
Age (y) ±  SD 42 +  4 55 +  2 p  <  0.001
Horne-Ostberg score +  SD 62 +  7 63 +  7 NS
PSQI Score +  SD 3 +  7 4  +  2 NS
Habitual sleep onset (h +  SEM) 23.1 +  0.2 22.7 +  0.2 (n =  7) NS
Habitual sleep duration (h +  SEM) 7.2 +  0.2 7.1 +  0.2 (n =  7) NS
Habitual sleep offset (h +  SEM) 6.2 +  0.1 5.7 +  0.3 (n =  7) NS
Sleep data are expressed in decimal hours. 
"Unpaired Student’s f-test.
between the pre-m enopausal and postm enopausal women (Table 1). 
In  addition, there was no significant difierence between the average 
length o f sleep between the pre-m enopausal and  postm enopausal 
w om en (Table 1).
Salivary melatonin profiles in pre- and postm enopausal women plotted 
as a function of clock time are shown in Figure 1. T h ere  was a large in ter­
individual variation in m elatonin concentrations within each study group. 
Two-way repeated  measures ANOVA carried ou t on the raw m elatonin 
data showed a significant effect o f time (F(j 22) =  17, jî? <  0.0001) b u t no 
effect o f m enopausal status and no interaction between time and  m eno­
pausal status.
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FIGURE 1 Salivary melatonin concentrations during a 2 2 h  constant routine in pre-menopausal 
(■ n =  11) and postmenopausal (□  n =  8) women plotted according to clock time. The longitudinal 
lines designate the mean melatonin onset (melon 50%) in the pre-menopausal (• - • 22.3 decimal h) 
and postmenopausal women (------- 20.9 decimal h).
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T he melatonin rhythm  param eters in the pre-m enopausal and  postm e­
nopausal groups are shown in Table 2. Postmenopausal women had signifi­
cantly earlier m elatonin acrophase times (L I ±  0 .5 h) com pared to the 
pre-m enopausal women (2.3 +  0.3 h) (^<0.05). Similarly, the postm eno­
pausal women had  earlier melatonin onsets (20.9 ±  0.4 h) than the p re ­
m enopausal women (22.3 ±  0.5 h) (data not quite significant, p  =  0.057). 
T h e  postm enopausal w om en had  higher baseline m elatonin values 
(16 ±  2pg /m L ) com pared with the pre-m enopausal women (11 +  
2pg /m L ), bu t these differences were not statistically significant 
(Figure 1). T he m elatonin am plitude was reduced in the postm enopausal 
wom en (15 +  2pg /m L ) com pared with the pre-m enopausal women 
(21 + 5 p g /m L )  (Figure 2a). However, m easures o f increm ental area 
u n d er the curve (AUC) and  am plitude were not statistically different 
between the two groups o f women (Table 2). Statistical evaluation o f the 
norm alized m elatonin am plitudes also did no t show any significant differ­
ences between the pre- and postm enopausal women.
As expected, subjective alertness declined and sleepiness increased in 
both  groups as the period o f sleep deprivation increased (Figure 2). 
Two-way repeated measures ANOVA revealed a significant effect o f time 
on alertness (F(i 22) =  18, <  0.0001) and on the two m easures o f subjec­
tive sleepiness (KSS: F(i 22) =  27 ,^  <  0.0001; SP: F(i 22) =  31,y? <  0.0001).
TABLE 2 Melatonin and Alertness/ Sleepiness Rhythm Parameters in Pre-and Postmenopausal
Pre-menopausal Postmenopausal Statistical
Variable women (n =  11) women (n =  8) significance"
Melatononin AUC 238 ±  105 247 +  89 NS
Melatononin onset (h) 22.3 ±  0.5 20.9 +  0.4 p  =  0.057
(melon 50%)
Melatononin amplitude 2 1 + 5 15 +  2 NS
(pg/m L)
Melatononin acrophase (h) 2.3 +  0.3 1.1 +  0.5 p  <  0.05
Alertness offset (h) 23.2 +  0.5 24.1 +  1 NS
(alert 50% off)
Aertness amplitude 1.2 +  0.1 1 .2 +  0.2 NS
(arbitrary units)
Sleepiness offset (h)
(sleep 50% off)
KSS 23.5 +  0.3 23.5 +  0.8 NS
SP 24.5 ±  0.6 24.4 +  1 (« =  7) NS
Sleepiness amplitude
(ai'bitrary units)
KSS 5.1 +  0.4 4.5 +  0.4 NS
SP 5.1 +  0.4 2.4 +  0.4 NS
Data are expressed in decimal hours as mean +  SEM.
“Unpaired Student’s /-test. KSS =  Karolinska sleepiness scale; SP =  Samn-Perelli sleepiness 
scale.
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FIGURE 2 (a) Salivary melatonin, (b) subjective sleepiness KSS, (c) subjective alertness and (d) subjec­
tive sleepiness using the Samn-Perelli scale normalised to baseline in pre-menopausal (N «  =  11) and 
postmenopausal (□  n =  8) women. The data were adjusted according to circadian phase and plotted 
according to circadian time (CT). T he longitudinal line (—) indicates melon 50% designated as 
CT 14 (Youngstedt et al., 2001).
Ejfect of Menopause on Melatonin and Alertness Rhythms 867
M enopausal status, however, had  no efifect on these measures and there 
was no interaction between time and  m enopausal status.
T he greatest decline in alertness and  increased sleepiness occurred 
between 22 :00 and 06: 00 h  in both  groups o f women. T he time o f alert­
ness offset (alert 50% off) and sleepiness onset (sleep 50% on) was no t sig­
nificantly different between pre- and postm enopausal women (Table 2). 
T h ere  was also no significant difference in the am plitude o f the 
alertness/ sleepiness rhythm s between the pre- and postm enopausal 
w om en (Table 2). However, the postm enopausal women showed lower 
levels o f sleepiness and increased alertness during  the night com pared 
with the pre-m enopausal women (although no t statistically significant) 
(Figure 2). In  both groups, the decline in alertness and  increased sleepi­
ness coincided with m elatonin production with the m elatonin profiles 
m irroring the alertness/ sleepiness profiles (Figure 2). Linear regression 
analysis showed a significant inverse correlation between m elatonin (as 
a function o f time) and  subjective alertness (r =  —0.68, p < 0.05) and 
sleepiness scores (KSS: r  =  0.69, p <  0.05; SP: r  =  —0.70, p  <  0.05) in 
the pre-m enopausal women. T here  was no significant correlation 
between m elatonin and alertness o r sleepiness param eters in  the post­
m enopausal women.
M elatonin onset (melon 50%) preceded habitual sleep onset as well as 
the alertness offset and sleepiness onset in the constant routine protocol in 
both the pre-menopausal and postmenopausal women. T he time interval 
(phase angle) between m elatonin onset and  alertness offset was signifi­
cantly greater in the postm enopausal women {p <  0.05) (Table 3). Simi­
larly, the phase angle between m elatonin onset and  sleepiness onset was 
larger, bu t no t significantly {p =  0.06), in the postm enopausal women 
(Table 3). In  contrast, there was no significant difference in the phase
TABLE 3 Phase Angles Between Melatonin Onset, Habitual Sleep Onset, Alertness 
Offset and Sleepiness Onset
Variable
Pre-menopausal 
women (n =  11)
Postmenopausal 
women (n =  8)
Statistical
significance"
Melatonin onset and 80 ±  16 100 ±  23 (n =  7) NS
habitual sleep
onset
Melatonin onset and 90 +  25 226 +  37 p  <  0.05
alertness offset
Melatonin onset and
sleepiness onset
KSS 8 5 + 1 9 180 +  44 p  =  0.06
SP 135 +  31 207 +  52 (M =  7) NS
Data are expressed in minutes as mean ±  SEM.
“Unpaired student’s /-test. KSS =  Karolinska sleepiness scale, SP =  Samn-Perelli 
sleepiness scale.
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angle between m elatonin onset and habitual sleep onset between the pre- 
and  postm enopausal women.
DISCUSSION
O ur findings show a significant advance in the tim ing o f the m elatonin 
acrophase in the postm enopausal com pared to the pre-m enopausal 
women. W hether this phase advance is a result o f the m enopause and  its 
associated horm onal changes o r is an  effect o f age, o r both, cannot be 
clearly distinguished. Previous studies investigating the effect o f age on 
the m elatonin rhythm  have provided conflicting results. In  agreem ent 
with the findings from  the present study, a phase advance in the melatonin 
rhythm  has been reported  in older m en and women (Cagnacci e t al., 
1995a, b; Duffy et al., 2002; Yoon et al., 2003), while o ther studies have 
reported  a phase delay (Sharma e t al., 1989) o r no change in the tim ing 
o f the m elatonin rhythm  (Youngstedt et al., 2001). Among the suggested 
reasons for the discrepancy in the findings o f the aging studies are differ­
ences in the sampling rate. T he  m elatonin samples collected in  the present 
study were obtained hourly ensuring that the m elatonin onset and  peak 
times w ere less likely to be missed.
I t  is m ore difficult to address the question o f w hether the observed 
changes in  the tim ing o f the m elatonin rhythm  are a result o f m enopause 
and its associated horm onal changes. Studies investigating plasm a m elato­
nin rhythm s during  the m enstrual cycle in pre-m enopausal w om en have 
reported  no change in  the tim ing o f the rhythm  (Parry et al., 1997). 
However, this study was no t conducted in  constant routine conditions. 
W hether the tim ing o f the m elatonin rhythm  is altered in postm enopausal 
women on horm one replacem ent therapy has yet to be elucidated.
T he present study, undertaken  in  controlled constant routine con­
ditions, foiled to show a significant difference in  the am plitude o f the 
m elatonin rhythm  between healthy m iddle-aged pre- and  postm enopausal 
women. At least two reasons may explain the discrepancy between the 
p resent findings and  the well reported  reduction in m elatonin am plitude 
observed with aging (Touitou e t al., 1981; Iguchi e t al., 1982; Sack et al., 
1986; Sharm a et al., 1989; Ohashi et al., 1997; O katani et al., 2000; Zhao 
et al., 2002; Zhou et al., 2003; Magri et al., 2004). First, the present 
study was conducted in constant routine conditions and agrees with the 
findings o f  Zeitzer and colleagues (1999), showing no age-related differ­
ence in m elatonin am plitude when subjects are studied in constant 
routine conditions. Second, there was not a large difference in age 
between the pre- and  postm enopausal women in the cu rren t study. An 
earlier study m easuring 24 h 6-sulphatoxymelatonin (aMT6s) production 
in a larger group o f similarly aged women (40 to 54 yr) also failed to
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detect a significant difference in  aMT6s production over this age range 
(Skene e t al., 1990).
I t may be that horm onal changes associated with the m enopause can 
affect m elatonin synthesis and  metabolism. N octurnal m elatonin p ro ­
duction has been shown to increase in women with am enorrhoea in associ­
ation with changes in hypothalamic-pituitary-gonadal dysfunction (Berga 
e t al., 1988; Brzezinski et al., 1988; W alker e t al., 1996). A negative corre­
lation between FSH and m elatonin levels has also been  described in post­
m enopausal women (Fernandez et al., 1990). T he pre-m enopausal women 
exam ined in this study w ere all assessed during  the foUicular phase o f the 
m enstrual cycle. T he m elatonin concentrations observed in the pre-m eno­
pausal women may thus be lower than those seen in o ther phases o f the 
m enstrual cycle, as previous studies have reported  higher melatonin 
levels in the luteal phase (W etterberg et al., 1976; Webley et al., 1986; 
B run et al., 1987).
Age-related changes in the circadian rhythm  of subjective alertness 
have been reported  with lower am plitudes in elderly people (~71 yr) 
com pared with m iddle-aged m en (37 to 52 yr) (Monk et al., 1996). T he 
present study did no t show any significant difference in  the am plitude 
o f the alertness o r sleepiness rhythm s between the pre-m enopausal and  
postm enopausal women most likely reflecting the small age differences 
between the two groups. Both the pre- and  postm enopausal w om en 
showed similar patterns o f alertness and  subjective sleepiness, with declin­
ing levels o f  alertness occurring from  22 :00  to 0 6 :0 0  h, m irroring the 
m elatonin profile. T he close association between the circadian variation 
o f alertness and  the m elatonin rhythm  during  extended wakefulness has 
also been dem onstrated in young m en (Akerstedt et al., 1979). T he  
reduced alertness and increased sleepiness observed during  the sleep 
deprivation period are most likely due to the interaction o f increased 
sleep pressure and  circadian phase. M elatonin onset preceded both the 
decline in  alertness and  onset o f sleepiness in both  groups o f women. 
O u r results are consistent with those o f similar studies investigating subjec­
tive alertness and  sleepiness u n d er conditions o f  prolonged wakefulness 
tha t have shown decrease in alertness occurring 1 h  before to 4 h  after m el­
atonin onset (Leproult et al., 2003) and an increase in subjective sleepiness 
occurring within 2 h  o f m elatonin onset (Cajochen et al., 1999).
T here  was no difference in the tim ing o f the alertness offset o r sleepi­
ness onset between the pre- and postm enopausal women. However, as the 
time o f m elatonin onset was advanced in the postm enopausal women, the 
time interval between m elatonin onset and  alertness offset was significandy 
greater in the postm enopausal com pared with the pre-m enopausal 
women. This finding is in agreem ent with results from  a previous study 
(Yoon et al., 2003). T he alertness and sleepiness profiles were significantly 
correlated with the melatonin rhythm . W hether the relationship between
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changes in  the m elatonin rhythm  and changes in the rhythm s o f alertness 
and  subjective sleepiness are causal o r reflect a com m on site o f origin {i.e., 
the circadian clock) is no t known.
O ne limitation o f the study is the small num ber o f subjects in the study 
groups. However, m any o f the constant routine studies found in the litera­
tu re  rep o rt subject num bers o f com parable size o r smaller owing to the 
extremely onerous nature o f the constant routine protocol for bo th  
study investigators and  subjects alike, involving no sleep, constant calorie 
intake, constant posture, and  consequently restricted motility.
In  conclusion, the present study has dem onstrated a significant 
advance in the tim ing o f the m elatonin rhythm  (advanced m elatonin 
onset and  acrophase) in postm enopausal women, resulting in  a larger 
time interval between m elatonin onset and  the onset o f sleepiness/offset 
o f alertness in  this group com pared to the pre-m enopausal women. 
These differences may be a consequence o f m enopause and its associated 
horm onal changes, although an effect o f age cannot be entirely excluded.
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13 Abstract
14 Objective: The present study was undertaken to investigate the possible existence of an endogenously generated circadian
15 rhythm in endothelial fimction in women and whether this rhythm is altered after the menopause.
16 Methods: Healthy non smoking women (11 pre menopausal and 13 postmenopausal women) were studies during a 22 h period
17 under constant routine conditions; endothelium-dependent (flow-mediated dilation (%FMD)) and -independent (glyceryl-trintrate
18 (GTN)-mediated) function was assessed every 2 and 4h, respectively, by high-resolution ultrasound of the brachial artery.
19 Results: %FMD and %GTN was significantly higher in pre-menopausal women (9.9±1.0%FMD (mean ±  S.E.M.);
20 18.2± 1.8%GTN; f  <0.01) compared with postmenopausal women (6.5±0.5%FMD; 11.5± 1.6%GTN). A significant
21 day-night variation in %FMD was observed pre menopausal women (day 9.23=0.8%; night 10.43=1%; f  <0.05) with an
22 attenuated rhythm in postmenopausal women (day 6.8 =h 0.6%; night 6.0 3= 0.4%).
23 Conclusions: The findings show a circadian rhythm in %FMD in pre menopausal women, which disappears after the menopause.
24 The reduction in %FMD and an absence of a day-night variation in %FMD in postmenopausal women may have important
25 implications for the incidence of coronary heart disease in women after the menopause.
26 © 2005 Published by Elsevier Ireland Ltd.
27 Keywords: Endothelial function; Menopause; Circadian rhythm; Constant routine
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The diurnal pattern in the incidence of angina pec­
toris, myocardial infarction and sudden cardiac death 
is well reported in the literature, with the peak onset
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occurring in the morning hours after waking with a sec­
ond lower peak in the late afternoon or evening [1-6]. 
Studies have also shown a similar diurnal variation in 
the onset of myocardial ischaemia in both men and 
women [7]. Several physiological triggers have been 
held accountable for this temporal variability. These 
include alterations in blood coagulability [8], fibri­
nolysis [9], vascular tone [10] and nocturnal waking 
associated with increased heart rate [11]. Thus whether 
the observed diurnal rhythm is a result of exogenous 
factors or endogenously generated by the circadian sys­
tem has not yet been elucidated.
Endothelial function has also been reported to show 
diurnal rhythmicity in both men and women [12-15]. 
However, in these previous studies constant routine 
conditions were not employed and hence light, pos­
ture and food intake were not controlled for and sub­
jects were allowed to sleep whilst measurements were 
taken [12-15]. It has also been reported that rhythmic­
ity in endothelial function is attenuated in individuals 
with established coronaiy heart disease (CHD) [16]. 
CHD is one of the leading causes of morbidity in 
middle-aged women, with oestrogen deficiency widely 
considered to contribute to this increased incidence, 
although it remains controversial as to whether the rel­
ative risk with age in women increases to the same 
extent as in men [17]. Arterial endothelial function has 
been shown to decline at a significantly greater rate 
in women after the menopause [18,19]. Studies have 
also reported that endothelial function in women varies 
according to the menstrual cycle and is associated 
with changes in the endogenous levels of oestradiol. 
Endothelial function appears to be highest during the 
follicular phase, to fall again after ovulation and sub­
sequently to increase during the luteal phase [20,21]. 
Cardiovascular risk has been associated with a life­
long histoiy of menstrual irregularity in both young 
and middle-aged women [22]. This finding combined 
with the increased risk after the menopause [18,19] pro­
vides strong evidence to support an interaction between 
circulating oestradiol levels and cardiovascular func­
tion in women. Whether the reported diurnal rhythm 
in endothelial function [12-15] is altered after the 
menopause has not previously been investigated. The 
constant routine protocol, in which the confounding 
effects of the light-dark cycle, the sleep-wake cycle 
and other cues are excluded, is considered to be the 
‘gold standard’ for determining the existence of intrin­
sically generated circadian rhythms [23,24]. Many of 
the previous studies investigating diurnal variation in 
vascular function have not accounted for the potential 
elfects of exogenous environmental stimuli and have 
only taken a small number of repeated measurements in 
a24 h period [12-15,25]. It is unclear therefore whether 
the observed rhythms are due to environmental influ­
ences or are endogenously generated by the circadian 
oscillator located in the hypothalamic suprachiasmatic 
nuclei.
In the present study endothelium-dependent and 
endothelium-independent function was assessed using 
the non-invasive method of flow-mediated dilata­
tion (FMD) and glyceryl-trinitrate-induced dilatation 
(GTN) by ultrasound of the brachial artery [26]. Both 
pre- and postmenopausal women were examined under 
constant routine conditions during a 22 h period to test 
the hypothesis of an endogenously generated circadian 
rhythm in endothelial function and whether this rhythm 
is altered after the menopause.
2. Materials and methods
2.1. Participants
2.1.1. Menopause study
Healthy, non-smoking women (n=24) were 
recruited from the general population. Eleven pre­
menopausal women, aged between 35 and 50 years 
(42 ± 4  years; m eaniS.D .) and 13 postmenopausal 
women, aged between 50 and 60 years (55 ± 2  
years; meandbS.D.) with body mass indices (BMI) 
of 23±2kg/m^ and normal serum total cholesterol 
participated in the study. All participants were free 
from any prescribed medication including oral con­
traceptives and hormone replacement therapy (HRT), 
supplementary vitamins or a specific diet. Participants 
had no histoiy of liver or kidney disease, diabetes, 
cardiovascular disease (with no family history of 
premature vascular disease) and were normotensive. 
The pre-menopausal women were all studied during 
the follicular phase of the menstrual cycle, when 
endothelial function is reported to be greatest [20,21]. 
Standard biochemistiy screening was conducted 
before inclusion into the study. The time from last 
menstrual flow could not be accurately determined 
for most postmenopausal participants. Both menstrual
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cycle phase and menopausal status (defined as no 
evidence of menstruation for at least 12 months) 
were confirmed by blood hormone analysis (Chem­
ical Pathology Laboratory, Southampton University 
Hospitals NHS Trust, Southampton, Hampshire, 
UK). Plasma oestradiol levels were 656 ±274pmol/l 
(meandbS.D.) for the pre-menopausal women and 
<73 pmol/1 for the postmenopausal women. Written 
consent was obtained from each participant and their 
general practitioner following a full explanation of the 
purpose and nature of procedures to be used in the 
study. Ethical permission for the study was obtained 
from the University of Surrey Ethics Committee and 
the investigation conformed to the principles outlined 
in the Declaration of Helsinki.
2.1.2. Reproducibility study
Ten healthy subjects (five men and five women), 
aged between 22 and 53 years (30dbl0 years; 
meaniS.D.) were recruited for a separate study 
designed to assess the reproducibility of endothelial 
function measurements (%FMD). All subjects were 
light or non-smokers, with no history of cardiovascu­
lar disease or diabetes and were asked to refrain from 
consuming any alcohol and caffeine. Subjects were 
asked to eat approximately the same meal at a sim­
ilar time on each occasion prior to each ultrasound 
scan. Endothelial function (%FMD) was assessed in 
each subject, under conditions of dim light (<10 Ix) 
and controlled ambient temperature (22-24 °C) on five 
different occasions (by the same investigator) at the 
same clock time (all scans were conducted between 
08:00 and 14:00 h) on different days at least 1 week 
apart.
158 2.2. Experimental protocol
All participants were asked to reduce consumption 
of nitrate/nitrite-containing foods for 48 h prior to the 
laboratory study and to refrain from consuming alcohol 
and caffeine and doing strenuous exercise throughout 
the day before and during the study period. Partici­
pants were also instructed not to consume any food or 
drink (with the exception of water) from20:00 h the day 
prior to consuming the first ‘study meal’ at 07:00 h the 
following morning in their home environment. Partici­
pants arrived at the Clinical Investigation Unit (School 
of Biomedical and Molecular Sciences, University of
Surrey) and were studied for 22 h under constant rou­
tine conditions starting at 08:(X)h. During this time 
they remained in a semi-recumbent position (except 
for visits to the toilet), awake and under dim light 
(<10 Ix white light in the direction of gaze). The ambi­
ent temperature was mmntained between 22 and 24 °C 
throughout Participants were provided with access to 
television (study lighting conditions were assessed with 
the television turned on to ensure levels were main­
tained below 10 Ix) and radio and were allowed to read 
in order to keep awake.
Liquid ‘study meals’ of Fortisip (Nutricia Clini­
cal Care, Trowbridge, Wiltshire, UK) were provided 
at hourly intervals on the hour throughout the study 
period. The standard liquid diet consisted of 48% car­
bohydrate, 13% protein and 39% fat; each subject was 
given 38 kcal/kg body weight. Water was provided ad 
libitum throughout the study.
2.2.1. Assessment o f endothelial function
Endothelium-dependent FMD was assessed eveiy 
2h, beginning at 08:30 h, with an additional measure 
of endothelium-independent GTN-mediated dilatation 
eveiy 4h using high-resolution B mode ultrasound. 
At each examination, participants were recumbent and 
rested whilst the right brachial artery was scanned in 
longitudinal section, 2-15 cm above the elbow, using 
a 7 MHz linear array transducer and an Ultramark- 
9 system (ATL Ultrasound, Philips Medical Sys­
tems, Reigate, Surrey, UK) according to the protocol 
described by Celermajer et al. [26]. Participants were 
requested to remain still and were not permitted to 
speak during the examinations to reduce the effect 
of movement on image quality. When a satisfactoiy 
image of the artery was identified with the clearest pic­
ture of the anterior and posterior wall interface, the 
transducer was fixed into position using a clamp devel­
oped ‘in house’. The participant’s arm was marked 
to ensure the same position was identified on each 
examination and a photographic record taken at each 
baseline scan. All scans were continuously recorded 
onto super-VHS videotape for subsequent analysis. A 
baseline scan was recorded for 1 min. Increased blood 
flow was then induced by inflation of a calibrated 
tourniquet placed around the forearm, to a pressure 
of 250 mm Hg for 5 min. Scans were recorded for 
a further 5 min after cuff deflation for assessment of 
endothelium-dependent dilatation (FMD). Following
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this the vessel was allowed to recover for 10 min prior 
to the measurement of another baseline scan followed 
by administration of 25 p-g glyceiyl trinitrate (Servier 
Laboratories Ltd., Fulmer, Slough, Berkshire, UK) 
sublingually and recordedforafurther5 min for assess­
ment of endothelium-independent GTN-mediated 
dilatation.
224 2.3. Data analysis
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2.3.1. Ultrasound image analysis
Brachial artery diameter was assessed from 
recorded images using automated edge-detection soft­
ware (Brachial Analyzer™, Medical Imaging Appli­
cations, lA, USA) at the Vascular Physiology Unit, 
Institute for Child Health, London, UK. Briefly, images 
were captured onto a computer equipped with a frame 
grabber (each frame capturing 3 s of recording). The 
measurements were obtained from a manually defined 
region-of-interest that was centred in the lumen of the 
vessel image in a region with clear, contrasted ante­
rior and posterior walls and calibrated to 10 mm. The 
baseline diameter was then calculated as the average of 
the first twenty 3 s frames. Percentage change in diam­
eter (P) (%FMD or %GTN-mediated dilatation) was 
then defined as AD/Dbaseiine x  100. Data from three 
postmenopausal subjects who participated in the study 
had to be excluded from the analysis. One participant 
became hypertensive during the study, another experi­
enced nausea due to intolerance of the study meal and 
in these cases the study was terminated. The data from a 
third participant had to be excluded due to poor quality 
of the ultrasound images.
2.3.2. Statistical analysis
One-way ANOVA (Statistica, StatSoft Ltd., Bed­
ford, Bedfordshire, UK) was used to determine the 
effect of time of day on vascular function for each study 
group (due to missing data at some time points two-way 
repeated ANOVA could not be performed). Vascular 
function data were also grouped into two time periods: 
“day” 08:30-16:30 h and “night” 18:30-06:30 h (these 
periods were defined as the presence or absence of the 
pineal hormone melatonin, an endogenous marker of 
darkness). Data were compared within the study group 
(paired Student’s f-tests) and between groups (unpaired 
Student’s f-tests). Linear regression analysis was also 
used to assess any correlation between age and the
clinical variables measured. Statistical significance was 
defined as P  < 0.05.
3. Results
3.1. Assessment of reproducibility
The reproducibility of repeated brachial artery 
measurements within the subject group {n = 10) 
was 3.3%CV at baseline (mean arterial diameter: 
3.6 ±  0.50 mm); maximum diameter was 3.4%CV and 
%FMD 15.1%CV (at a range of 3.8-11.9%FMD). The 
overall variation in arterial diameter and endothelial 
responses between subjects was much greater, the base­
line diameter ranging from 2.9 to 4.6 mm and the cor­
responding %FMD ranging from 2.9 to 13.0%FMD.
In the menopause study, reproducibility for baseline 
brachial artery diameter was 3.3 ±  0.04 (1.2%CV) and 
3.4 ±  0.04 mm (1.2%CV) for pre- and postmenopausal 
women, respectively. Reproducibility for the reputed 
measurement of %FMD was not assessed in the 
menopause study itself as scans were all performed 
at different clock times on the same day in each indi­
vidual.
3.2. Endothelium-dependent and -independent 
function in pre- and postmenopausal women
The average endothelial response (%FMD) in the 
pre-menopausal women ( n = l l ,  9.9±1.0% ; mean±  
S.E.M.) women was significantly greater (P<0.01) 
throughout the study than in the postmenopausal 
women (n= 10,6.5 ±0.5%; mean±S.E.M. (unpaired 
Student’s f-test). GTN-mediated dilatation was 
also significantly greater (P < 0.005) in the pre­
menopausal (18.2 ±1.8%; mean±S.D.) than in the 
postmenopausal women (11.5 ±1.6%; mean±S.D.). 
When the data were analysed separately according 
to menopausal status (i.e. pre-menopausal or post­
menopausal) there was no statistically significant 
relationship between either %FMD and %GTN- 
mediated dilatation with age (Fig. 1). However, linear 
regression analysis revealed a significant inverse 
correlation between %FMD and age (r = —0.44, 
d.f. = 20; f  <0.05) when the data from both study 
groups were combined. A similar inverse relationship 
was found between %GTN-mediated dilatation and 
age (r = —0.59, d.f.=20; f  <0.01).
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Hg. 1. Absence ofa relationship between age and (a) %FMD and (b) 
%GTN-mediated dilatation of the brachial artery in pre-menopausal 
(•) (/I = 11) and postmenopausal (Q ) (« = 10) women.
304 3.3. Time of day and endothelial function
305 The %FMD in the pre-menopausal and post-
306 menopausal women over the 22 h study is shown
in Fig. 2. Pre-menopausal women showed a vari­
ation in %FMD over time with the lowest values 
observed during the early part of the day, gradu­
ally increasing through the evening and night. One­
way ANOVA of the data, however, revealed no sig­
nificant differences in %FMD over the 12 time- 
points in either the pre- or postmenopausal women. 
Grouping the data into the two time periods: “day” 
08:30-16:30 h and “night” 18:30-06:30 h, %FMD was 
found to vary significantly in the pre-menopausal 
women, %FMD being significantly lower ( f  <0.05) 
in the day (9.2 ±0.8%) compared to the night 
(10.4±1% ) (paired Student’s f-test) (Fig. 3). In con­
trast, there was no significant variation in %FMD in 
the postmenopausal women (day 6.8 ±0.6%; night 
6.0 ±0.4%) (Fig. 3), postmenopausal women having 
significantly reduced %FMD during both time periods 
compared to the pre-menopausal women (day; P < 0.05 
and night; P < 0.005). The majority of women in the 
pre-menopausal group (9/11 ; 82%) showed an increase 
in endothelial function at night compared with the day. 
The postmenopausal women, however, did not show 
this increase in %FMD at night. To the contrary, there 
was a trend towards a decline in endothelial function 
at night 80% (8/10) postmenopausal women showing 
a decline in endothelial function.
Endothelium-independent (GTN) function over the 
22 h study is shown in Fig. 4. One-way ANOVA of 
the data showed no significant differences over time
14.0 -1
12.0 -
g
C/3 10.0 -
i  ■
0) 8 .0  -J
E
g
4.0 -
2.0 -
0.0
08:30 10:30 12:30 14:30 16:30 18:30 20:30 22:30 00:30 02:30 04:30 06:30
Clock time (h)
Hg. 2. Time course of flow-mediated dilatation (%FMD) of the brachial artery during 22h of constant routine in pre- (■) (n = l l )  and post­
menopausal (□) (« = 10) women. Pre-menopausal women had significantly higher (P<0.01) %FMD (9.9 ±  1.0%; mean ±  S.E.M.) compared to 
the postmenopausal women (6.5 ±  0.5%; mean ±  S.E.M.).
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Fig. 3. Variation in %FMD in pre-menopausal (■ ) (n = II) and post­
menopausal (□) (n=10) women. In pre-menopausal women %FMD 
varied significantly between the two time periods (*P<0.05 com­
pared to the day). Postmenopausal women had significantly reduced 
%FMD during both time periods compared to the pre-menopausal 
women (**P<0.05 compared to the pre-menopausal women during 
the day, ***P<0.005 compared to pre-menopausal women during 
the night).
in either the pre- or postmenopausal women. Separa­
tion of the data into “day” and “night” periods also 
failed to show differences in the pre-menopausal (day 
17.9± 1%; night 17.9 ±2% ) and postmenopausal (day
g -  25.0- 
Ui
C  2 0 .0 -
■D 1 0 . 0 -
"© 5.0-
06:3010:30 18:30 
Clock time (h)
22:30 02:3014:30
Fig. 4. Time course of %GTN-mediated dilatation of the brachial 
artery during 22 h of constant routine in pre-menopausal (■) 
(n = l l )  and postmenopausal (□) (« = 10) women. Pre-menopausal 
women had significantly greater (P< 0.005) responses to GTN 
(18.2 ±1.8% , mean±S.E.M.) compared to the postmenopausal 
women (11.5±  1.6%, mean ±  S.E.M.).
12.5 ±  2%; night 11.9 ±  1 %) women. There was a non­
significant trend towards a decline in GTN-mediated 
dilatation at night with over half of the pre-menopausal 
women (55%) and 50% of the postmenopausal women 
showing reduced GTN-mediated dilatation at night.
4. D iscussion
The results from this study show that endothelium- 
dependent function (%FMD) is reduced in 
postmenopausal women compared with some­
what younger, pre-menopausal women. This finding 
supports the results of other studies investigating 
endothelial changes in older and middle-aged women 
[18,19,27]. Larger studies have shown that the age- 
related decline in endothelial function occurs at a 
steady rate in women up until menopausal age (early 
to mid-50s), at which time there is a rapid decline 
in endothelial function compared with men [28]. In 
older normotensive and hypertensive women (>60 
years of age), age-related endothelial dysfunction is 
similar to that of men of the same age [18,28]. Linear 
regression analysis of the combined data from the 
pre-menopausal and postmenopausal women showed 
that there is a significant negative correlation between 
%FMD and age. However, when the data from 
each study group were analysed independently, this 
inverse relationship between endothelium-dependent 
function with increasing age was lost. This supports 
the findings of other studies [29,30]. Thus although 
there may still be a general effect of increasing 
age on endothelial function, there appears to be an 
additional factor that influences the rate of decline in 
endothelial function in women, which does not occur 
in men. In the present study endothelium-independent 
(GTN-mediated) function was also significantly 
greater in the pre-menopausal women compared with 
the postmenopausal women suggesting that both the 
endothelium and underlying smooth muscle are less 
responsive in women after the menopause. These 
findings support the work of McCrohon et al. [19] who 
reported an impaired response to sublingual GTN in 
postmenopausal (61 ±  3 years) women compared with 
younger pre-menopausal (28 ± 5  years) women. A 
significant inverse correlation between GTN-mediated 
dilatation and age was also found when the data from 
both study groups were analysed. This relationship
MAT 4644 1-10
J.R Walters et al. / Maturitas xcc (2005) xxx-xxx
disappeared when the data from the pre-menopausal 
and postmenopausal women were independently anal­
ysed. Other studies have reported a weak correlation 
between endothelium-independent function (measured 
in response to sodium nitroprusside) and age [18] or 
no difference with increasing age [28] in both men 
and women as we have found.
The exact cellular and molecular mechanisms asso­
ciated with the menopause-related decline in endothe­
lial function are unknown. One possible explanation 
for the observed difference in endothelial and smooth 
muscle function between the pre- and postmeopausal 
women in the present study could be an imbalance in 
the circulating levels of vasoactive mediators, such as 
an increase in the production of constricting factors 
such as norepinephrine (NE) and endothelin (ET-1), 
with a concomitant reduction in the levels of vasodila- 
tory mediators such as nitric oxide (NO) favour­
ing enhanced vasoconstriction in the postmenopausal 
women. Indeed, in pre-menopausal women the circu­
lating levels of both NE and ET-l have been shown to 
be lowest during the follicular phase [31,32] whereas 
NO levels are increased [33]. This increase in the lev­
els of NO in pre-menopausal women may be related 
to the higher endogenous circulating levels of oestro­
gen during the follicular phase, since NO levels are 
inversely correlated with progesterone concentration 
[33]. It is unlikely that an increase in catecholamine 
levels in the postmenopausal women is responsible for 
the observed endothelial dysfunction, since the lev­
els of NE in untreated postmenopausal women are 
shown to occur at a similar physiological concentra­
tion to that observed during the follicular phase of the 
menstrual cycle [34]. However, an influence of ET-l 
augmented vasoconstriction cannot be excluded. Under 
normal conditions, increased NO production inhibits 
the expression and production of ET-l [35]. Conse­
quently a reduction in the synthesis and release of NO, 
and possibly other factors such as prostacyclin and 
endothelium-derived hyperpolarizing factor (EDHF), 
could result in a loss of this feedback inhibition result­
ing in increased ET-l production.
Proposed mechanisms for the decline in NO 
bioavailability and increased vasoconstrictor response 
include an increase in the vascular formation of reac­
tive oxygen species (ROS) such as superoxide anions 
[36,37] coupled with decreased biological activity of 
antioxidant enzymes such as superoxide dismutase
(SOD) [38]. Physiological levels of oestradiol have 
been shown to induce both endothelium-dependent 
and -independent relaxation in animal and human 
coronary arteries [39-41]. Indeed, in postmenopausal 
women oestrogen replacement has been shown to 
acutely improve the endothelium-dependent vasodila­
tor response [42-45]. It is plausible that the antioxidant 
properties of oestrogen could potentially counteract the 
damaging effects of oxidative stress on the vascular 
endothelium in healthy pre-menopausal women. This 
theory is supported by evidence from intervention stud­
ies, showing that endothelial dysfunction associated 
with menopausal status and/or age can be reversed by 
acute administration of Vitamin C, a potent anti oxidant 
in postmenopausal women [46].
Thus, it seems likely that the endothelial dysfunction 
that occurs in women around the time of the menopause 
results from the synergistic effects of physiological 
ageing combined with the decline in the circulating 
levels of endogenous oestrogen that occurs during the 
menopause [47,48].
A major finding of this study is the apparent 
absence of a day/night rhythm in endothelial func­
tion (%FMD) in postmenopausal women under con­
trolled constant routine laboratory conditions. This 
has not been reported previously. In contrast in pre­
menopausal women, %FMD showed a circadian vari­
ation with the lowest values observed during the 
early part of the day, gradually increasing through the 
evening and night. A significant increase in endothe­
lial function (%FMD) was observed in pre-menopausal 
women at night compared to the day. Our finding sup­
ports the results of previous studies in young men 
and pre-menopausal women [12-15] showing that the 
sensitivity of the vascular endothelium to shear stress 
induced by increased blood flow is maximal at night 
and lowest in the morning hours in healthy individu­
als under normal conditions. Since the mechanism of 
vasodilatation is mediated by endothelium-derived fac­
tors, in particular nitric oxide (NO), this implies that the 
release of these mediators may also be under circadian 
control.
The observed rhythm in endothelial function in pre­
menopausal women, with values being lower during 
the day and increasing at night, mirrors the circadian 
profile of the pineal hormone melatonin, which shows 
an evening rise and peak between 02:00 and 05:00 h 
[49]. The effects of endogenous melatonin on the car-
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481 diovascular system, however, are less clear. A reduction
482 in nocturnal melatonin production has been reported in
483 patients with coronary artery disease [50-52], which
484 has been associated with decreased melatonin receptor
485 expression [53]. The expression of the MTl recep-
486 tor has also been shown to vary over 24 h in human
487 coronary vessels with the lowest values detectable in
488 the morning, when circulating levels of melatonin are
489 lower, with a gradual increase up to midnight [54].
490 Vascular reactivity to exogenous melatonin has also
491 been shown to vary over the oestrous cycle in animals,
492 with circulating levels of oestradiol associated with
493 enhanced melatonin MT2 receptor-mediated vasodi-
494 latation [55].
495 In contrast to endothelium-dependent vasodilatation
496 (%FMD), endothelium-independent (GTN-mediated)
497 vasodilatation failed to show a variation over time.
498 This finding supports the study of Gaenzer et al.
499 [13] who reported no significant difference in GTN-
500 induced brachial artery dilatation over time with val-
501 ues of 15.7%, 15.0% and 13.7% at 08:00, 12:00 and
502 16:00 h, respectively in young men (28-37 years).
503 More recently, Otto et al. [15] reported similar results
504 in older men and women (mean age 42 years) over
505 different time periods (17.3%, 17.2% and 18.5% at
506 21:00, 06:00 and 11:00 h, respectively). If the smooth
507 muscle response to stimulation is preserved through-
508 out 24 h, increased bioavailability of endothelium-
509 derived NO balanced with the production of other
510 substances at night (including other vasodilating sub-
511 stances and inhibitors such as asymmetric dimethy-
512 larginine (ADMA) and reactive oxygen species) could
513 lead to enhanced vasodilatation and could, in part,
514 explain the observed increase in endothelial function
515 (%FMD) in the present study. Elherik et al. [25] demon-
516 strated a significant diurnal variation in endothelin-
517 1 (an endothelium-derived vasoconstrictor) in men
518 (20-41 years), with peak levels occurring at 20:00 and
519 08:00 h in a 24 h period (not using constant routine con-
520 ditions). Nitric oxide levels also showed a trend towards
521 a diurnal variation with higher levels at 20:00 h and low
522 levels at 04:00 h, although the variation was not stati s-
523 tically significant [25]. However, this study also did not
524 control for the effects of diet and sleep, which may have
525 masldng effects on the observed rhythms. Currently
526 there are no studies that have investigated the rhythmic
527 production of endothelial vasodilators and inhibitors in
528 women before or after the menopause. Further studies
are required to investigate the circadian control o f  these 529
vascular endothelium-derived factors. 530
A limitation o f the current study is small sample 531
size, however, the day/night comparisons showed large 532
effect sizes ( d > 0 .8 )  and power > 0 .6 .  Within-subject 533
variations in endothelial function (%FMD) have been 534
described in both men and women [5 6 ] . However, most 535
studies investigating the reproducibility o f  endothelial 530
function have taken repeated measurements on differ- 537
ent days and at different clock times. Reproducibility 53a
o f our technique as assessed in a smaller study, with 539
repeated rneasurements taken at the same clock time 540
on five different days in each individual was accept- 541
able. In the present menopause study, 12 measurements 542
were taken on each individual in a single 22  h period 543
by the same investigator and various methods were 544
employed to ensure the accuracy and reproducibil- 545
ity o f each measurement. Photographs were taken at 546
each baseline scan to aid identification o f anatomic 547
landmarks; the positioning o f the head, body and arm 548
o f each individual was controlled throughout using 549
the position o f the transducer marked onto the fore- 550
arm. In addition, exogenous factors known to affect 551
endothelial function were controlled for in the constant 552
routine protocol. Reproducibility for baseline brachial 553
artery diameter was good (<2% in both pre-menopausal 554
and postmenopausal women). The recorded scan data 555
were subsequently analysed using sophisticated edge- 55e
detection software, which provides a more accurate 557
determination o f  changes in arterial diameter as mea- 553
surements are taken at 3 s intervals rather than at single 559
time points. This allows a greater number o f  mea- seo
surements to 1% averaged to give the baseline reading 56i
and ensures that the actual time at which the maximal 562
change in diameter occurs is less likely to be missed. 563
The results o f this study provide further evidence 564
o f a circadian rhythm in endothelial function, which is 565
shown to occur even in the absence o f  external influ- see
ences (i.e. in constant routine conditions) and which 567
is attenuated in older women after the menopause, see
Further studies are required to investigate the mech- sæ
anisms involved in this circadian variation in endothe- 570
liai function. The findings may also have implications sn
for the increased incidence o f coronary events in the 572
earlier part o f  the day and the mechanism by which 573
endogenous oestrogens confer protection to the vascu- 574
lar endothelium and what changes are induced by the 575
onset o f menopause in women also needs to be clar- 576
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577 ified. The decline in endothelial function that occurs
578 around the time of the menopause may be related to the
579 concomitant decline in oestrogen production in post-
580 menopausal women.
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A P P E N D IX
A ppendix I 
RECRUITMENT QUESTIONNAIRE
Date: Reference Number:
CONTACT DETAILS
Title: ............
Family Name: 
First Name:
DOB:
Age:
./. /.
Address: Ethnicity:
Telephone: Day:
Evening:
Email address:
Weight (Kg) ........................................  Height (m) BMI,
GP DETAILS
Name:
Address:
Telephone: Email:
Participant Reference Number:
Weight (Kg) ....................   Height (m) BMI,
GENERAL HEALTH
Condition/Disorder YES NO
Psychiatric Disorders 
(incP anorexia nervosa)
Drug/Alcohol dependence
Epilepsy
Sleep disorders
Endocrine disorders (e.g. 
Diabetes, polycystic ovary)
Cardiovascular disease
Blood pressure disorders
Renal (Kidney) disease
Hepatic (Liver) disease
Gastrointestinal disease
Unexplained vaginal bleeding
Breast cancer
Athsma
Other
Any additional information:
HORMONE REPLACEMENT THERAPY INFORMATION:
HRT: YES/NO Started: .....................
IF  YES:
Type: ........................................................................................
Dose: ........................................................................................
Frequency ........................................................................................
OTHER PRESCRIBED MEDICATIONS
Medication YES NO
Anti-depressants
Tranquilisers
Sleeping Aids 
e.g. Benzodiazapines
Anti-hypertensives 
e.g b-blockers
Sulphonylureas
Non-steriodal anti­
inflammatories 
e.g. Ibuprofen
Aspirin
Anti-epileptic drugs
Ventolin (Athsma medication)
Other
Any additional information:
NON-PRESCRIBED MEDICATION
Medication YES NO
Antihistamine
Vitamin E
Vitamin C
Vitamin D/calcium
Vitamin B
Cod liver oil
Herbal supplements 
e.g sleeping aids ‘Nytol’
Other
Any additional information:
Any drug allergies
IF  YES:
Details: ........
YES/NO
Any food allergies
IF  YES:
Details: ........
YES/NO
Phobia of needles YES/NO
Phobia of sight of blood YES/NO
GENERAL QUESTIONS
Nicotine: YES/NO
Smoker: LIGHT (<4/day) MODERATE (<10/day) HEAVY (>10/day)
Average caffeine consumption/day ......................................................................................
Average alcohol consumption/week ......................................................................................
Transmeridian travel within last 2 weeks YES/NO
Experimental drug taken within last 2 months YES/NO
Blood donation (>400 ml) within past 3 months YES/NO
PSQI SCORE
MORNINGNESS-EVENINGNESS QUESTIONNAIRE
SUBJECT CODE: DATE:
INSTRUCTIONS
a) Please read each question very carefully before answering.
b) Answer all questions.
c) Answer questions in numerical order.
d) Each question should be answered independently of others. Do NOT go back and check
your answers.
e) For some questions, you are required to respond by placing a cross alongside your answer. 
In such cases, select ONE answer only.
0 Please answer each question as honestly as possible. Both your answers and results will be
kept in strict confidence.
QUESTION 1
Considering only your own feelings, at what time would you go to bed if you were entirely free to plan 
your day?
Time (iirs/mins) :  ......................................
QUESTION 2
Considering only your own feelings, at what time would you get up if you were entirely free to plan your 
day?
Time (hrs/m ins) ; ........................................................
QUESTION 3
If there is a specific time you have to get up in the morning, to what extent are you dependent on being 
woken up by an alarm clock?
a. Not at all dependent [ ]
b. Slightly dependent ( ]
c. Fairly dependent [ ]
d. Very dependent [ ]
QUESTION 4
Assuming adequate environmental conditions, how easy do you find getting up in the morning?
a. Not at all easy { 1
b. Slightly easy I J
c. Fairly easy { 1
d. Very easy I 1
QUESTION 5
How alert do you feel during the first half hour after having woken in the morning? 
a, Not at all alert ( ]
b- Slightly alert [ 1
c. Fairly alert [ I
d. Very alert [ 1
QUESTION 6
How is your appetite during the first half hour after having woken in the morning?
a. Not at all good [ 1
b. Slightly good [ 1
c. Fairly good [ 1
d. Very good [ ]
QUESTION 7
During the first half hour after having woken in the morning, how tired do you feel?
a. Not at all tired [ 1
b. Slightly tired [ I
c. Fairly refreshed [ 1
d. Very refreshed [ ]
QUESTION 8
When you have no commitments the next day. at what time do you go to bed compared to your usual 
bedtime?
a. Seldom or never later [ j
b. Less than one hour later [ ]
c. 1-2 hours later [ ]
d. More than 2 hours later [ ]
QUESTION 9
You have decided to engage in some physical exercise. A friend suggests that you do this one hour 
twice a week and the best time for him is between 0700 and OBOOh. Bearing in mind nothing else but 
your own inclinations, how do you think you would perform?
a. Would be on good form [ ]
b. Would be on reasonable form I ]
c. Would find it difficult [ ]
d. Would find it very difficult [ ]
QUESTION 10
At what time in the evening do you feel tired and in need of sleep? 
Time (hrs/mins) ; .............. ................ ........
QUESTION 11
You wish to be at your peak for a test which you know is going to be mentally exhausting and lasting for 
two hours. You are entirely free to plan your day. when would you do this task?
a. 0800- 1000 [ ]
b. 1100- 1300 [ ■• / ]
c. 1500- 1700 [ 1
d. 1900-2100 { ]
QUESTION 12
If you went to bed at 2300h at what level of tiredness would you be?
a. Not at all tired ( )
b. A little tired [ 1
c. Fairly tired [ 1
d. Very tired [ 1
QUESTION 13
For some reason you have gone to bed several hours later than usual, but there is no need to get up at 
any particular time the next morning. Will you:
a. Wake up at the usual time and not go back to sleep [ J
b. Wake up at the usual time and doze { ]
c. Wake up at the usual time and go back to sleep [ ]
d. Wake up later than usual [ ]
QUESTION 14
One night you have to remain awake between 0400 and OBOOh. You have no commitments the next 
day. Which suits you best:
a. Not to go to bed until OBOOh [ ]
b. Nap before 0400h and sleep after OBOOh [ ]
c. Sleep before 0400h and nap after OBOOh [ J
d. Sleep before 0400h and remain awake after OBOOh [ ]
QUESTION 15
You have to do two hours physical work. Which hours would you prefer to do it between:
a. 0800- 1000 ( ]
b. 1100- 1300 [ ]
c. 1500- 1700 [ ]
d. 1900-2100 I 1
QUESTION 16
You have decided to engage in some physical exercise. A friend suggests that you do this between 
2200 and 2300h twice a week. How do you think you would perform:
a. Would be on good form { ]
b. Would be on reasonable form [ ]
c. Would find it difficult [ ]
d. Would find it very difficult [ ]
QUESTION 17
Suppose that you can choose your own work hours, but had to work five hours in the day. Which five 
consecutive hours would you choose:
Hours:
QUESTION 18
At what time of day do you feel your best? 
Time (hrs/mins) : ..........................
QUESTION 19
One hears of "morning" and "evening" types. Which do you consider yourself to be?
a. Morning type [ ]
b. More morning than evening [ ]
c. More evening than morning [ j
d. Evening type [ ]
PLEASE COMPLETE & RETURN: Pittsburgh Sleep Quality Index
Subject code: 
Date:
STUDY:
Instructions:
The following questions relate to your usual sleep habits during the past month only. Your answers should indicate the 
most accurate reply for the majority of days and nights in the past month. Please answer all the questions.
1) During the past month, when have you usually gone to bed at night?
Usual bed time
2) During the past month, how long (in minutes) has it usually take you to fall asleep each night?
Number of minutes
3) During the past month, when have you usually got up in the morning?
Usual getting up time
4) During the past month, how many hours of actual sleep did you get at night? (This may be different from the 
number of hours spent in bed.)
Hours of sleep per night
For each of the remaining questions, check the one best response. Please answer all questions.
5) During the past month, how often have you had trouble sleeping because you.....
a) Cannot get to sleep within 30 minutes 
Not during the Less than
past month once a week
Once or twi^e 
a week
Three or more 
times a week
b) Wake up in the middle of the night or early morning
Not during the Less than
past month  once a week___________
Once or twice 
a week
Three or more 
times a week
c) Have to get up to use the bathroom
Not during the Less than
past month   once a week_
Once or twice 
a week
Three or more 
times a vveek
d) Cannot breathe comfortably
Not during the Less than
past month  once a week
e) Cough or snore loudly
Not during the Less than
past month  once a week_
I) Feel too cold
Not during the Less than
past month  once a week_
Once or twice 
a week
Once or twice 
a week
Once or twice 
a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
10) Do you have a bed partner or roommate?
No bed partner or roommate?
Partner/roommate in other room
Partner in same room, but not same bed 
Partner in same bed________
If you have a roommate or bed partner, ask him/hef how often in the past month you have had)...
a) Loud snoring 
Not during the 
past month_____
Less than 
once a week
b) Long pauses between breaths while asleep
Not during the Less than
past month  once a week 
c) Legs twitching or jerking while you sleep
Not during the Less than
past month  once a week_
d) Episodes of disorientation or confusion during sleep? 
Not during the Less than
past month  once a week
Once or twice 
a week
Once or twice 
a week
Once or twice 
a week
Once or twice 
a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
e) Other restlessness while you sleep; please describe
Not during the 
past month___
Less than 
once a week
Once or twice 
a week
Three or more 
times a week
Appendix IV
SLEEP DIARY
Subject name:...................................  Date:............................................
This form is to be completed in the morning each day for three days prior 
to the study
What time did you go to bed last night?
What time did you try starting to sleep 
at?
How long did it take you to fall asleep?
How many times did you wake up?
How long were you awake for?
Please estimate the time and duration o f  
each night awakening
What time did you wake up this 
morning?
What time did you get up?
Would you describe this as a typical 
night?
How would you rate your quality o f  sleep?
1 2 3 4 5 6 7
Best sleep ever
8 9
Worst sleep ever
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